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High rates of Cardiovascular disease (CVD) and ischemic heart disease (IHD) have led to ever-
increasing numbers of percutaneous coronary interventions (PCI) performed.  The prevalence of 
IHD and subsequent PCI has been found to limit bed availability and access to cardiovascular 
care.  Historically, the standard of care following elective PCI has included overnight 
observation (OO) though clinical advances to PCI procedures have made it possible for same day 
discharge (SDD) following elective PCI.  There are many benefits of SDD following elective 
PCI that include increased access to cardiovascular care, hospital cost savings, and patient 
satisfaction without compromising patient safety.  The DNP project took place at an inpatient 
facility in Pulaski County, Arkansas where practice most often included OO following elective 
PCI.  The purpose of the project was to increase access to cardiovascular care through the 
creation and implementation of a SDD protocol following elective PCI.  The overall project aim 
was to increase the percentage of SDD to 50% by March 31, 2021.  The project did not meet this 
goal as implementation failed during the planned implementation period at the clinical site due to 
the lack of physician engagement.  Despite the lack of SDD protocol implementation, data from 
the 10-week collection period was analyzed to describe baseline data and current practices at the 
clinical site. During the 10-week collection period, 20 of 55 patients, or 36.36%, were discharged 
via other non-established SDD methods.  The SDD protocol is still projected to become the 
standard of practice at the clinical site after future implementation.  
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cardiovascular care 
Implementation of Same Day Discharge Following Elective Percutaneous Coronary 
Intervention 
 The purpose of this paper is to detail a DNP quality improvement project designed to 
increase access to cardiovascular care in Pulaski County, Arkansas through the creation of a 
same day discharge (SDD) protocol following elective percutaneous coronary intervention 
(PCI).  The paper will discuss the incidence of elective PCIs completed at the clinical site, the 
significance of the problem, a review of literature related to establishing a SDD protocol, 
protocol development, methodology, and outcomes following SDD protocol implementation. 
Background and Significance 
Cardiovascular Disease 
Cardiovascular disease (CVD) is the leading cause of death worldwide (WHO, 2017).  In 
2017, CVD was responsible for 17.9 million deaths worldwide and 647,000 deaths within the 
United States (Centers for Disease Control and Prevention [CDC], 2019); WHO, 2017).  
Ischemic heart disease (IHD) is the most common type of CVD and was responsible for almost 
366,000 deaths within the United States in 2017 (CDC, 2019).  Arkansas had much higher death 
rates per 100,000 in both genders and all races above 35 years old compared to national data 
between 2016 and 2018 (CDC, 2020).  Mortality rates due to IHD within Arkansas per 100,000 
was 263.6, which are substantially higher than national numbers per 100,000 at 181.2.  While 
death rates per 100,000 due to IHD in Pulaski County, Arkansas are lower than the state’s 
numbers at 226.9; mortality remains much higher than national numbers per 100,000 (CDC, 





Ischemic heart disease is associated with inadequate blood flow to the heart due to 
calcified coronary arteries (Kannam, Aroesty, & Gersh, 2020).  Patients with IHD may have 
disease that is either chronic and stable or acute and unstable. Patients with chronic IHD often 
experience angina pectoris, or chest discomfort, that results as one’s oxygen demand surpasses 
his or her available oxygen supply.  The mismatch of oxygen supply and demand in stable IHD 
is associated with known atherosclerosis of coronary vessels (Kannam, Aroesty, & Gersh, 2020).  
Elective angiography and revascularization via PCI is considered as a treatment option for many 
patients with stable IHD (Cutlip & Levin, 2019).  Revascularization is defined as a surgical 
technique used to provide additional or improved blood supply to the heart (Merriam-Webster, 
2020).  The most common procedure for revascularization of coronary arteries occurs through 
PCI with balloon angioplasty and coronary stenting (Abdelaal, 2013; Amin et al., 2018; 
Chambers et al., 2009).  Revascularization via PCI is considered for patients with stable IHD if 
angina interferes with lifestyle despite maximum guideline directed therapy, if PCI is to be 
completed to improve quality of life and activity level, and if PCI is proven beneficial for 
survival based on location of disease such a disease of the left main coronary artery (Cutlip & 
Levin, 2019; Kannam, Aroesty, & Gersh, 2020).  PCI through balloon angioplasty and coronary 
stenting increases the lumen diameter of coronary arteries leading to improved blood flow and 
decreased chest discomfort (Abbott & Cutlip, 2020; Kannam, Aroesty, & Gersh, 2020).   
History of Coronary Interventions 
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The use of percutaneous transluminal coronary angioplasty (PTCA) in the treatment of 
ischemic heart disease began in 1977 (Venkitachalam et al., 2009).  At that time, PTCA relied 
upon balloon dilatation of coronary arteries that provided a controlled injury of occluded arteries 
(Cutlip & Abbott, 2019; Newsome, Kutcher, & Royster, 2008).  Two major complications 
occurred as a result of PTCA.  These complications included acute vessel collapse and vessel 
restenosis.  Acute vessel collapse occurred within the first 24 hours in 6% to 8% of cases with 
PTCA alone (Newsome, Kutcher, & Royster, 2008).  Severe complications, including acute 
coronary syndrome (ACS) and the need for emergent coronary artery bypass grafting (CABG), 
often occur following acute vessel collapse (Iqbal, Gunn & Serruys, 2013).  Vessel restenosis is 
defined as a gradual narrowing of the ballooned portion of an artery that happens within 3 to 12 
months following PTCA (Levin & Cutlip, 2019).  Restenosis is often associated with angina 
pectoris but can present as ACS in up to 10% of patients (Levin & Cutlip, 2019).  Vessel 
restenosis following PTCA often occurred within the first six months due to mechanical and 
histological factors (Newson, Kutcher, & Royster, 2008).  PTCA was associated with a high 
incidence of restenosis requiring repeat revascularization in 20% to 35% of patients within the 
first year (Byrne et al., 2009; Cutlip & Abbott, 2019).   
The next innovation was the development of bare metal stents (BMS), which represented 
a major advancement in the treatment for symptomatic ischemic heart disease (Byrne et al., 
2009; Cutlip & Abbott, 2019).  The first BMS implantation within coronary arteries occurred in 
1986 (Newsome, Kutcher, & Royster, 2008).  BMS were used to maintain lumen dilatation 
following balloon angioplasty (Byrne et al., 2009).  BMS were approved to treat acute 
impending vessel closure following PTCA in the US in 1993 (Newsome, Kutcher, & Royster, 
2008).  Two landmark trials confirmed that BMS enhanced angiographic and clinical outcomes 
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quickly leading to its acceptance as standard of care.  By 1999, almost 85% of coronary 
interventions involved BMS implantation (Newsome, Kutcher, & Royster, 2008).  Following 
BMS use, rates of target lesion revascularization decreased from 20 to 35% with only PTCA to 
10-15%.  Though BMS had decreased abrupt vessel closure rates, stent thrombosis between 
implant and 30 days occurred in 16% to 24% of patients.  At that time, the use of aggressive 
anticoagulants was implemented (Newsome, Kutcher, & Royster, 2008).  The use of dual 
therapy with aspirin and clopidogrel reduced BMS thrombosis rates to 1.2% (Newsome, 
Kutcher, & Royster, 2008).  Stent restenosis in BMS occurred in 20-25% of patients within six 
months (Newsome, Kutcher, & Royster, 2008).  Restenosis was due to neo-intimal hyperplasia, a 
similar process as scar tissue formation at stent implantation sites, often requiring repeat 
revascularization (Byrne et al., 2009; Newsome, Kutcher, & Royster, 2008).   
In 2007, the use of drug eluting stents (DES) was recommended as an alternative to BMS 
to prevent neo-intimal hyperplasia and consequent restenosis and revascularization (Cutlip & 
Abbott, 2019; Newsome, Kutcher, & Royster, 2008).  DES have a metal stent platform, a robust 
polymer, and an antirestenotic drug found within the polymer that is slowly released to eliminate 
or delay tissue formation (Cutlip & Abbott, 2020).  First generation DES utilized sirolimus and 
paclitaxel to prevent neo-intimal hyperplasia while current generation DES utilize everolimus 
and zotarolimus (Levin & Cutlip, 2019; Newsome, Kutcher, & Royster, 2008).  Stent restenosis 
rates in first generation DES were between 13% and 16% at five years, while stent restenosis 
rates for current DES are 5% to 6.3% at up to five years post placement (Levin & Cutlip, 2019).  
Though uncommon, stent thrombosis between implant and greater than one year can occur 
following DES placement (Newsome, Kutcher, & Royster, 2008).  The risk of late restenosis 
following DES placement prompted the use of long-term dual antiplatelet therapy including 
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aspirin plus a platelet P2Y12 receptor blocker (Cutlip & Nicolau, 2019).  The most common drug 
combination used is aspirin and clopidogrel for 6 to 12 months following DES placement (Cutlip 
& Nicolau, 2019).  The use of DES has continued as the preference during PCI today (Cutlip & 
Abbott, 2020). 
Percutaneous Coronary Interventions 
Since the development of DES, PCI with DES has become the most common method of 
coronary revascularization (Chambers et al., 2009).  Within the United States, about 600,000 
percutaneous coronary interventions (PCI) take place each year (Amin et al., 2017; Amin et al., 
2018).  According to data from the NCDR CathPCI registry of 667,424 patients found that 
35.3% percent of procedures were elective PCI procedures (Masoudi et al., 2017).  Demographic 
information of 667,424 patients who underwent PCI in 2014 were reported in the NCDR 
CathPCI Program of 1,612 hospitals and centers in the US (Masoudi et al., 2017).  Of the 
667,424 patients, 68.7% were male and 31.3% were female.  The mean age was 64.6 years old.  
Caucasians held the majority of procedures completed at 86.5%.  Of the procedures completed, 
8.8% were African Americans, 2.8% were Asian 2.8%, and 5.8% were Hispanic or Latino.  
Clinical characteristics of the 667,424 patients who underwent PCI in 2014 were also collected 
in the NCDR CathPCI registry.  Common comorbidities found in patients who underwent PCI 
were diabetes at 38.8%, prior myocardial infarction at 30.4%, heart failure within 2 weeks at 
13.9%, previous PCI at 41.2%, and previous CABG at 17.8%.  The average body mass index 
(BMI) of the 667,424 patients who underwent PCI in 2014 was 29.6 ± 5.4, though it is important 
to note that 36.9% were overweight with BMIs from 25 to 29.9 and 42.5% were obese with 
BMIs greater than or equal to 30 (Masoudi et al., 2017).   
Previous Recommendations 
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In 2009, the Society of Cardiovascular Angiography and Interventions (SCAI) published 
an expert consensus regarding the length of stay (LOS) following elective PCI (Chambers et al., 
2009).  The SCAI proposed assessing clinical characteristics, co-morbidities, anatomy of the 
disease, and procedural requirements when considering SDD.  Additionally, the criteria 
stipulated that the patient must not have any perioperative or postoperative complications, live or 
stay within 20 miles from the facility, and have adequate home and emergency medical service 
support available.  The expert consensus recognized the final decision regarding length of stay 
following PCI up to physician discretion (Chambers et al., 2009).  Though SDD was addressed 
in the expert consensus, preprocedural, peri-procedural and post-procedural criteria severely 
limited the number of patients that qualified for SDD despite procedure success, leading to very 
minimal adaptation (Shroff et al., 2016).  The SCAIs inclusion criteria for SDD was very 
restricted and required patients to meet a defined set of ten systematic criteria (Chambers et al., 
2009).  Some of the most restricted criteria included that the patient be asymptomatic, be less 
than 70 years old, have no significant co-morbidities, normal renal and left ventricular function, 
and a single vessel disease (Chambers et al., 2009; Shroff et al., 2016).  A case series of 100 
consecutive patients that were safely discharged home via SDD following PCI were compared to 
the SCAIs 2009 recommendations.  Only 15% of the 100 patients would have qualified as 
appropriate candidates for SDD after applying the SCAIs recommendations (Shroff et al., 2016). 
Further Clinical Advancement 
Concerns regarding acute ischemic events due to sudden vessel closure, vascular access 
site complications, and the management of comorbidities were reasons that patients with elective 
PCI remained in the hospital for overnight observation (OO) (Chambers et al., 2009; Shroff et 
al., 2016).  Since the 2009 consensus document was published, many advancements in clinical 
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practice have occurred.  The practice of OO has persisted despite many improvements in PCI 
procedures including improvements in stent designs, the use of transradial approach (TRA), 
adjunctive pharmacotherapy, and vascular closure devices used to reduce bleeding complications 
(Abdelaal et al., 2013; Amin et al., 2018; Shroff et al., 2016).  The first reported use of TRA was 
in 1989 and has been identified as one of the most significant improvements made to PCI 
procedures over the past several years (Elfandi & Safirstein, 2018).  TRA is associated with 
fewer bleeding and access site complications, rapid ambulation, increased patient comfort, and 
improved mortality outcomes in high risk patient populations (Israeli et al., 2017).  The 
incorporation of TRA has improved the safety and feasibility of discharging patients who have 
met criteria for SDD following elective PCI (Alyasin, 2016; Elfandi & Safirstein, 2018).  Within 
the US, the use of TRA is now recommended as the standard of practice when feasible.  Since 
2007, the use of TRA has increased from 1.2% to 37% in 2017 within the US (Seto et al., 2018). 
Current Recommendations 
In 2018, experts from SCAI published an updated consensus regarding LOS following 
elective PCI.  It was concluded that advances in clinical practice have made selective SDD safe 
and feasible when considering clinical stability, success of the procedures, and process measures 
(Seto et al., 2018).  SCAIs 2018 updated consensus suggests using three categories to determine 
a patient’s readiness for discharge.  The three categories include procedure, patient, and program.  
Procedural factors include successful procedure, adequate hemostasis, and no complications.  
Patient factors include clinical stability at baseline mental status with stable vital signs and 
comorbidities.  Program factors include safe monitoring at home, appropriate guideline directed 
medical therapy, compliance with PCI performance measures, and timely follow up (Seto et al., 
2018).  PCI via SDD is also associated with high patient satisfaction and cost savings, especially 
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via TRA (Amin et al., 2018, Shroff et al., 2016).  Though selective SDD following PCI has been 
found to be effective, it has not been adopted by many facilities nationwide due to resistance to 
change and lack of knowledge.   
Problem Statement 
The problem statement for this DNP quality improvement project is that this inpatient 
facility in Pulaski County, Arkansas is currently experiencing limited access to cardiovascular 
care due to the lack of cardiac beds available.  The implementation of a SDD protocol following 
elective PCI has emerged as a solution to increase access to cardiovascular care by decreasing 
bed shortages (Madan et al., 2019).  Approximately 2,000 elective PCI procedures occur per 
year at the clinical site.  The Needs Assessment yielded that approximately 85% of these 
patients stay for overnight observation thus limiting cardiac bed availability and subsequent 
access to cardiovascular care.  The Needs Assessment found increasing access to care as the 
most critical health outcome to be improved through SDD.  Key influencers expressed their 
interest in instituting a SDD protocol in an attempt to increase access to care, improve health 
outcomes, decrease hospital spending, and increase patient satisfaction. 
Purpose Statement 
 The purpose statement for this DNP quality improvement project was to increase access 
to cardiovascular care through the creation and implementation of a SDD protocol following 
elective PCI at an inpatient facility in Pulaski County, Arkansas.  Establishing a SDD protocol 
would facilitate an increase in the number of elective PCI procedures able to be completed, 
increase cardiac bed availability, improve bed utilization, and decrease hospital costs. 
PICOT Question 
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To improve quality care at an inpatient facility in Pulaski County, Arkansas, a focused 
PICOT question will guide the DNP project.  The question is as follows: In patients who undergo 
elective percutaneous coronary intervention at an inpatient facility in Pulaski County, Arkansas 
(P), how does instituting a same day discharge protocol (I) compared to standard practice of 
overnight observation (C) affect access to care (O) within 6 months (T)? 
Needs Assessment of an Inpatient Facility in Pulaski County, Arkansas 
Objective  
The objective of the Needs Assessment was to ascertain common adverse effects 
following elective PCI and potential barriers to establishing a safe, effective SDD protocol at an 
inpatient facility in Pulaski County, Arkansas through key informant interviews.  These members 
of the project team will help combat potential problems before implementation begins to 
improve protocol processes and effectiveness. 
Participants 
The participants of the Needs Assessment include key influencers and target group 
members with a variety of professional qualifications to identify complications and potential 
barriers of establishing a SDD protocol.  Key influencers included in the Needs Assessment are 
members of administration who influence the target group.  The President of the heart institute 
has a master’s in Health Services Administration and has served for 24 years.  The Market 
Director of the Cardiovascular Service Line for the last five years holds a master’s in business 
administration.  The target group includes a Doctor of Medicine who has been the director of 
interventional cardiology for one year; an advanced practice nurse who has worked with the 
cardiology group for 10 years; and two registered nurses from the Catheterization (Cath) lab with 




Rationale of the Needs Assessment 
Ischemic heart disease remains responsible for almost 33% of deaths in individuals over 
35 (Wilson & Douglas, 2018).  More than 600,000 PCI procedures are performed each year 
within the United States (Amin et al., 2018).  Historically, overnight observation was the 
standard of care following uncomplicated PCI; however, current evidence indicates that 
hospitalization is no longer required, especially via a TRA (Amin et al., 2017; Amin et al., 2018; 
Seto et al., 2018).  The clinical site reports that approximately 85% of the patients who undergo 
elective PCI procedures are admitted for OO.  Identifying potential barriers to implementation, 
current barriers to TRA, and complications following elective PCI is crucial in establishing a 
safe and effective protocol.  Information yielded from the Needs Assessment will be used by the 
project team to establish a SDD protocol with clear criteria that addresses potential 
complications.  This will improve health outcomes, access to care, and cost savings. 
Data Collection Tool 
 The Needs Assessment of an inpatient facility in Pulaski County, Arkansas applied key 
informant interviews to gather concepts related to gaps in care and barriers to establishing a SDD 
program.  The main agenda was to identify health outcomes to be improved with SDD.  
Additional concepts to be assessed include common complications, use of TRA, readiness for 
change, and potential barriers including resistance and physician buy-in.  The questionnaire 
utilized 11 open ended questions that were formulated and presented to two key influencers and 
four members of the target group.  See Appendix J for Needs Assessment Questionnaire. 
Sample, Sample Size, and Sample Procedure 
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 The participants interviewed for the Needs Assessment were chosen based on their 
influence on proposed changes in current processes and their knowledge of patients who undergo 
elective PCI.  A convenience sample was used in selecting participants for interviews.   A total 
of six open ended interviews took place with key influencers and target group members between 
February 25, 2020 and March 4, 2020.  Interviews took approximately 15 minutes to conduct. 
Implementation and Data Analysis 
 Interviews were conducted via phone conference or in person in a quiet, uninterrupted 
setting for approximately 15 minutes.  Interviews took place by appointment with each key 
influencer between February 25, 2020 and March 4, 2020 based on individual availability.  
Clarification and prompts were offered when requested during interviews. 
 Key findings via open-ended questions identified that 100% of participants found 
increasing access to cardiovascular care the most crucial health outcome to be improved.  
Additional findings indicated that 66.67% of participants found increasing TRA usage with 
subsequent decreases in bleeding complications as a key health outcome to be improved.  The 
interventional cardiologist was asked an additional question regarding readmission and acute 
illness following elective PCI.  Chest pain, hematoma, and acute kidney injury were identified as 
complications seen following elective PCI.  The most common complication before discharge 
identified in 100% of the target group was bleeding.  One hundred percent of participants 
identified physician resistance and 33.3% identified staff nurse resistance as a potential barrier.  
All participants agreed to help develop a protocol for SDD.  All agreed that management would 
support improvement efforts. 
 It was identified that there were process improvements, health outcomes, and common 
complications that can be improved through SDD.  The data collected was used to address all 
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concerns including complications, hospital readmission, TRA, and resistance to change when 
establishing a SDD protocol following elective PCI.  After evaluation of the Needs Assessment 
results, the project team met to discuss health outcomes and possible barriers to protocol 
implementation.  See Appendix A and Appendix B for global aims and process flowchart. 
Aim and Objectives 
The aim for this DNP quality improvement project was to improve access to healthcare 
by creating and implementing a SDD protocol following elective PCI at an inpatient facility in 
Pulaski County, Arkansas.   Following protocol implementation, the project expected to increase 
the percentage of patients that underwent SDD following elective PCI from 15% to 50% by 
March 2021.  The objectives are as follows: 
• To create a tool to determine each patient’s pre-procedure eligibility for SDD 
based on clinical and socio-demographic factors 
• To implement SDD protocol for all identified patients who meet criteria for SDD 
following elective PCI 
• To evaluate care management of patients undergoing PCI following SDD 
protocol implementation 
 Review of Literature 
 An electronic search of two scholarly databases, CINAHL Complete and MEDLINE 
Complete, was conducted.  Additional searches were conducted via UpToDate and the Centers 
for Disease Control and Prevention (CDC).  The search terms included same day discharge and 
percutaneous coronary intervention.  Inclusion criteria included scholarly peer reviewed articles 
between 2015 and 2020 and articles that pertained to the DNP topic.  Exclusion criteria included 
articles written before 2015, editorials, articles not written in English, and research unrelated to 
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the DNP topic.  Twelve landmark articles pertaining to the history of PCI, advancements in PCI, 
previously recommended standards of care, and original studies of SDD utilization have been 
included in the review despite the fact that they were published prior to 2015.  A research 
librarian assisted with the literature search.  The initial search of MEDLINE complete and 
CINAHL using the search terms same day discharge and percutaneous coronary intervention 
yielded 190 results.  After applying inclusion and exclusion criteria, 41 articles remained.  A 
total of 23 articles were included in the review of literature based on relevance to the safety and 
implementation of a SDD following elective PCI.  See Appendix C for EMSON Evidence Table. 
Ischemic Heart Disease, the Use of PCI, and SDD 
Ischemic heart disease is associated with an inadequate blood supply to the heart tissue 
due to obstructed coronary arteries (Kannam, Aroesty, & Gersh, 2020).  The most common 
method of coronary revascularization for patients with IHD is now PCI (Abdelaal, 2013; Amin et 
al., 2018; Chambers et al., 2009).  Revascularization is considered when angina interferes with a 
patient’s lifestyle despite maximum guideline directed therapy, if PCI is to be completed to 
improve quality of life and activity level, and if PCI is proven beneficial for survival based on 
location of disease such a disease of the left main coronary artery (Cutlip & Levin, 2019; 
Kannam, Aroesty, & Gersh, 2020).  Though PCI is the most common form of treatment, there is 
variability in the length of stay following elective PCI across the US despite advances in 
practice.   
Traditionally, patients who underwent PCI stayed for overnight observation (OO) due to 
concern for complication.  Following clinical advancements in recent years, the use of SDD has 
been implemented in facilities across the world.  Changes in reimbursement for elective PCI has 
pushed facilities throughout the US to implement SDD (Seto et al., 2018).  Same day discharge 
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specifically means that a patient presents for an elective PCI, undergoes the procedure, and, 
following a specified recovery time, is sent home or to a nonmedical facility, for example, a 
hotel, on the same calendar day (Chambers et al., 2009; Seto et al., 2018).  Utilization of SDD 
offers an opportunity for facilities to reduce length of stay, increase bed availability, and improve 
resource efficiency (Chen, Lin, & Marshall, 2018; Din et al., 2017).  The safety, feasibility, and 
impact of SDD will be discussed below. 
Safety of SDD 
Several studies within and outside the US have demonstrated the feasibility and safety of 
SDD following PCI (Abdelaal et al., 2013; Amin et al., 2018; Brayton et al., 2013; Din et al., 
2017; Heyde et al., 2007; Madan et al., 2019).  In a 10 year, single-center study, 1,035 patients 
were treated via SDD.  Of the 1,035 patients, only two patients required readmission due to chest 
pain.   None of the patients required repeat PCI, experienced major adverse cardiac events 
(MACE), death, or stent thrombosis (Rubimbura et al., 2019). 
As advancements in practice have been made, the rates of postprocedural complications 
have declined.  Some of the advancements in practice include improvements in stent design, the 
transradial approach (TRA), adjunctive pharmacotherapy, and vascular closure devices 
(Abdelaal et al., 2013; Amin et al., 2018; Din et al., 2017; Madan et al., 2019; Shroff et al., 2016; 
Seto et al., 2018).  These improvements have led to decreases in bleeding complications, reduced 
concerns regarding inadequate platelet inhibition, and lower rates of restenosis (Din et al., 2017; 
Seto et al., 2018).  According to a National Cardiovascular Data Registry (NCDR) CathPCI 
Registry, the overall incidence of complications within the hospital from 2016 to 2017, 
comprising over 600,000 patients, was 4.8%.  This includes the incidence of stroke at 0.2%, 
bleeding within 72 hours of the procedure at 1.4%, pericardial tamponade at 0.1%, heart failure 
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at 0.9%, and acute kidney injury (AKI) that required dialysis at 0.2%.  Mortality within the 
hospital was 0.93% overall, including those who went for CABG (Seto et al., 2018).  The 
advances in clinical practice support the safety and feasibility of SDD following elective PCI. 
In a landmark study conducted by Heyde et al.  (2007), 800 consecutive patients were 
randomized before elective PCI into SDD or OO.  The study was designed to evaluate the safety 
and feasibility of SDD following elective PCI.  Patients with acute coronary syndrome were 
excluded due to their risk of acute stent thrombosis.  There were 403 in the SDD group and 397 
in the OO group.  Some patients in the SDD group did cross over into OO due to procedural 
complications or issues that developed during the observation period.  It was found that there 
were no differences in complications between SDD and OO in primary endpoints which included 
death, myocardial infarction, coronary artery bypass graft surgery, repeat PCI, or puncture 
related complications within 24 hours following PCI (Heyde et al., 2007).  This study further 
supports the safety of SDD. 
Growing evidence indicates hazards of hospitalization.  These hazards can include 
contraction of an infection, accidents, medication errors, and post-hospitalization stress 
syndromes (Shroff et al., 2016).  Evidence indicates that a single night stay in the hospital carries 
significant risks of adverse events (Hauck & Zhao, 2011).  Hauck & Zhao (2011) report the risk 
of suffering an adverse medication reaction is 3.4%, infection is 11.1%, and pressure ulcer is 
0.4%.  The implementation of a SDD protocol following elective PCI is an approach to be taken 
to decrease exposure to the hazards of hospitalization (Shroff et al., 2016).   
Timing of Adverse Events 
Evidence has shown that OO is not superior to SDD in regard to complication rates 
following elective PCI (Koshy, George, & Das, 2020; Seto et al., 2018).  In the STRIDE study 
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conducted by Jabara et al.  (2008) 450 patients underwent PCI via TRA and were monitored for 
adverse events between six and 24 hours following the procedure.  Of the 450 participants, 24 
post-procedural complications occurred.  Twenty of the 24 complications occurred within 6 
hours following the procedure while zero occurred between six and 24 hours (Jabara et al., 
2008).  Furthermore, the DISCHARGE study included approximately 2,000 patients who 
underwent TRA PCI who were monitored for adverse events following PCI.  Among the 1,174 
higher-risk patients that stayed for OO, all complications either occurred within 6 hours 
following the procedure, or after 24 hours (Small et al., 2007).  Data indicates that complications 
following elective PCI are rare.  This data supports the notion that adverse events are not 
impacted by OO, and thus supports the safety of SDD for uncomplicated PCI procedures.   
Transfemoral and Transradial Approach 
Percutaneous coronary interventions are most often performed via a transfemoral (TF) or 
transradial approach.  Traditionally, PCI was performed via a TF approach.  The TF approach is 
often associated with access site bleeding and major vascular complication, which are correlated 
with a risk of successive morbidity, mortality, and cost (Megaly et al., 2019).  Over time, TF 
approaches have improved through the use of vascular closure devices (VCDs) The use of VCD 
has facilitated earlier ambulation following PCI, though rates of vascular complication and 
bleeding are similar in comparison to manual compression (Jabara et al., 2008; Seto et al., 2018).  
The TF approach is associated with higher incidence of bleeding, vascular complications, and 
blood transfusion despite avoidance strategies with bivalirudin and VCDs when compared to 
TRA (Amin et al., 2017).   
The use of TRA is a fairly new practice, as its first reported use was in 1989.  The use of 
TRA was quickly adopted in Europe and Asia but was met with hesitation in the US (Elfandi & 
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Safirstein, 2018).  As data regarding the safety of TRA has surfaced, its use in the US has 
steadily increased (Elfandi & Safirstein, 2018).  Implementation of the TRA is often identified as 
one of the most significant improvements made to decrease complication rates.  Transradial 
approach is associated with fewer bleeding and access site complications, rapid ambulation, 
increased patient comfort, decreased bodily pain, earlier post-procedure recovery, and improved 
mortality outcomes in high-risk patient populations (Seto et al., 2018; Jabara et al., 2008; Koshy, 
George, and Das, 2020).  Within the US, the use of TRA is now recommended as the standard of 
practice when feasible.  From 2007 to 2017, the use of TRA increased from 1.2% to 37% within 
the US (Seto et al., 2018).   
The incorporation of TRA has improved the safety and feasibility of discharging patients 
who have met criteria for SDD following elective PCI (Alyasin, 2016; Israeli et al., 2017; 
Elfandi & Safirstein, 2018; Seto et al., 2018).  When compared to a femoral approach, radial 
access was associated with lower mortality rates, vascular complication rates, major adverse 
cardiovascular events (MACE), major bleeding, and vascular complications in a meta-analysis of 
24 studies (Ferrante et al., 2016).  Due to lower associated complications and cost savings, TRA 
is to be used whenever possible when discharging patients via SDD. 
Criteria for SDD 
 Though SDD has been safe and effective in low-risk patients, there is a wide variation in 
pre-procedural, peri-procedural, and post-procedural criteria that guide decision making in regard 
to length of stay following elective PCI.  Previous SCAI recommendations for SDD severely 
limited patients eligible for SDD, while the newest SCAI recommendations suggest assessing a 
patient’s readiness for discharge following PCI (Chambers et al., 2009; Seto et al., 2018).  Seto 
et al.  (2018) describes three categories used to determine readiness for discharge including 
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procedure, patient, and program.  Procedural factors comprise a successful procedure, adequate 
hemostasis, and no adverse complication.  Patient factors include clinical stability at baseline 
mental status with stable vital signs and comorbidities.  Program factors include the ability to 
safely monitor at home, appropriate evidence-based medical therapy, compliance with 
performance measures following PCI, and timely post-procedure follow up (Seto et al., 2018).   
Amin et al.  (2018) found that implementing a patient centered protocol based on the 
patient’s risk of complications rapidly increased the percentage of SDD from 0% to 77% in both 
low and high risk patients with no increase in adverse events.  The protocol utilized the NCDR’s 
mortality risk stratification models to identify a patient’s risk of bleeding, mortality, and acute 
kidney injury (AKI) with a safe contrast limit preoperatively.  The use of avoidance strategies 
was implemented based on patient risk.  Patients in both the SDD group and OO groups were 
similar and SDD was not associated with adverse outcomes (Amin et al., 2018).  The success 
rates of this study indicate that even higher risk and complex procedures can be safely and 
efficiently executed when proper risk assessment and preoperative screenings are implemented 
(Amin et al., 2018).  Implementation of SDD with the inclusion of patient-centered risk 
stratification and readiness for discharge factors from SCAIs guidelines has the potential to lead 
to safe and effective SDD for patients at higher risk for procedural complications.   
Evidence Based Practice Utilized in SDD Protocol 
The SDD protocol incorporates many current evidence-based practice (EBP) 
recommendations.  Pre-procedure criteria incorporates suggestions from Seto et al. (2018) which 
include available patient transportation following the procedure and adequate home support upon 
discharge.  Inversely, these recommendations were also incorporated into possible reasons to 
admit the patient for overnight observation.  Additionally, driving distance of less than 60 miles 
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was incorporated based on Chen, Lin, & Marshall’s (2018) recommendations of including 
patients that live less than one hour from the PCI facility.  However, if a patient does not meet 
the 60 mile criteria, the facility has opted to use its hotel to accommodate elective PCI patients 
for one night at no cost following his or her procedure.  Additional pre-procedure criteria 
developed by the clinical site include patients with an elective procedure or outpatient status, 
those not opposed to going home the same day as their procedure, compliance to medical 
therapy, and a candidate for SDD per the operating physician. 
Seto et al. (2018) recommended incorporating Centers for Medicare and Medicaid 
Services (CMS) defined reasons for prolonged observation into reasons that a patient may admit 
for overnight observation.  These include persistent nausea and vomiting, electrolyte and fluid 
imbalance, pain that is uncontrolled, arrhythmia, excessive bleeding, and unstable mobility and 
mental status.  These complications have been included in the exclusion criteria for SDD (Seto et 
al., 2018).  The protocol incorporates site specific reasons for possible overnight observation 
which include anticipated discharge after 9 PM, hemodynamic instability during or after the 
procedure, physician order, and frail, elderly patients.  
The post-procedure checklist also incorporates EBP recommendations.  Seto et al. 
recommends considering patient, procedural, and program factors to determine readiness for 
discharge when contemplating SDD as defined previously.  All patient, procedure, and program 
consensus recommendations as stated by Seto et al. (2018) have been utilized in the protocol 
post-procedure checklist.  Additionally, Seto et al. (2018) proposed a sample nursing discharge 
checklist that has been adapted and utilized in the post-procedure checklist for the clinical site.  
Recommendations include obtaining an EKG, assessing access sites, assessing readiness for 
discharge, completing discharge education regarding antiplatelet therapy, post-procedure 
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instructions, and numbers to call if complications develop, providing stent cards, scheduling 
follow up appointments, delivering medications via in-house pharmacies, and providing cardiac 
rehab information (Seto et al., 2018).  Site specific criteria added to the post-procedure checklist 
include physician approval of SDD, physician defined observation time, no significant anesthesia 
complications, ability to void after the procedure, and clearance by the discharging APRN.  See 
Appendix K for pre-procedure criteria and post-procedure checklists. See Appendix L for SDD 
protocol.   
Impact of PCI and SDD on Health Care 
 Many randomized controlled trials (RCTs), observational studies, and meta-analyses 
have confirmed low complication rates, high cost savings, increased patient satisfaction ratings, 
and increased bed availability as a result of selective SDD (Amin et al., 2018; Din et al., 2017; 
Madan et al., 2019; Shroff et al., 2016).  The following sections detail specifics regarding current 
evidence of SDD in relation to its impact on healthcare. 
Access to Healthcare 
 The implementation of SDD has shown to increase bed availability leading to improved 
bed utilization, an increase in access to healthcare, and improved cost effectiveness (Chen, Lin, 
& Marshall, 2018; Din et al., 2017; Madan et al., 2019).  In Canada, Madan et al. (2019) states 
that the institution of SDD following elective PCI has emerged as a solution to reduce 
overcrowding and bed shortages.  The implementation of SDD has the potential to increase bed 
availability and increase access to cardiovascular care (Din et al., 2017; Jabara et al., 2008; 
Koshy, George, & Das, 2020; Ramharrack et al., 2018; Shroff et al., 2016).  In contrast, others 
have argued that SDD increases pressure to discharge patients quickly, could limit recovery time, 
reduces opportunity for patient education, and could increase adverse outcomes (Chambers et al., 
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2009; Madan et al., 2019).  For proper implementation of a SDD protocol, patient specific 
education and readiness for discharge must be assessed to verify the appropriateness of SDD 
(Seto et al., 2018; Shroff et al., 2016). 
Cost Savings 
In 2007, the US Centers for Medicare and Medicaid Services (CMS) changed criteria for 
inpatient healthcare.  Within the changes made, PCI, that is not associated with acute coronary 
syndrome (ACS), is no longer eligible for inpatient reimbursement.  PCI is now considered an 
outpatient procedure by CMS unless the patient requires an inpatient stay that crosses two 
midnights (Amin et al., 2017; Seto et al., 2018).  CMS has provided justifiable medical reasons 
for moving a patient from an outpatient status to an observation status following elective PCI.  
These include prolonged or adverse effects from anesthesia; fluid or electrolyte imbalance, 
ongoing pain, bleeding, ischemia, or dysrhythmia.  These criteria justify OO and should be 
included in the SDD protocol (Seto et al., 2018). 
The change in reimbursement has increased financial pressure to eliminate OO for 
elective PCI (Seto et al., 2018).  Since the procedure is the most common cardiovascular 
procedure performed, cost is an important factor.  It is estimated to cost hospitals $2,000 to 
$4,000 dollars when outpatient PCI cases are kept for OO (Amin et al., 2017).  Costs associated 
with PCI procedures within the US are projected to reach 918 million dollars by the year 2030 
(Amin et al., 2017; Amin et al., 2018).  Strategies to reduce cost related to elective PCI are 
urgent. 
The implementation of SDD reduces cost to the hospital.  With the innovation of safe 
strategies to perform PCI, various studies have validated cost savings of SDD without negative 
effects on patient outcomes (Seto et al., 2018).  In a study conducted by Madan et al.  (2019), it 
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was found that SDD PCI costs about 1200 Canadian dollars less than OO, which is equivalent to 
883 US dollars.  In the study conducted by Amin et al.  (2018), the mean cost of SDD PCI was 
compared to OO PCI.  The adjusted hospital cost for SDD was found to be $7,331 per case lower 
than OO (Amin et al., 2018).  Though cost savings is not the only driving factor, SDD is 
associated with higher efficiency and cost reduction (Din et al., 2017).  It is estimated that 
discharging 50% of patients who undergo PCI via SDD could save the US healthcare system 
between $200 to $500 million dollars per year (Shroff et al., 2016).  Indirect cost savings can 
result from SDD implementation including the potential for decreased medical errors and 
adverse effects, increased bed utilization for incoming patients, and decreased facility resources 
use (Shroff et al., 2016). 
Evidence indicates that TRA and SDD significantly reduce hospital cost following PCI.  
Amin et al.  (2017) further investigated the costs associated with access site and SDD following 
PCI among Medicare beneficiaries.  The NCDR CathPCI registry was utilized to examine costs 
and outcomes associated with TRA and SDD.  Of the 279,987 patients eligible for SDD, TRA 
was utilized in 9.0% of patients and SDD was utilized in 5.3% of patients.  Utilization of TRA in 
comparison with TF resulted in lower adjusted costs of $916 per case.  Utilization of SDD in 
comparison with OO resulted in lower adjusted costs of $3,502 per case.  It is important to note 
that the cost difference between TRA and SDD and TF approach and SDD was $527 dollars.  
When utilizing both TRA and SDD, the adjusted cost was $13,389, whereas the adjusted cost of 
TF approach and OO was $17,076 with a difference per case of $3,689 (Amin et al., 2017).  
Using a hypothetical calculation from study results, Amin et al.  (2017) found that if a single 
hospital performed 1,000 elective PCI procedures in a year and 30% of patients underwent PCI 
via TRA with SDD, the potential cost savings was $1 million per year.  Using the same data, 
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Amin et al.  (2017) estimated that if 600,000 PCI cases were performed nationwide with 
approximately 50% being elective procedures eligible for SDD, potential US hospital cost 
savings from converting current practice to TRA with SDD was estimated at $332 million per 
year (Amin et al., 2017). 
Patient Satisfaction 
Same day discharge has been shown to improve patient satisfaction when compared with 
OO.  Evidence indicates that the majority of patients prefer to recover from a PCI procedure at 
home rather than spend the night in a hospital (Kim et al., 2013; Seto et al., 2018; Shroff et al, 
2016).  In a controlled trial without randomization, patients that underwent SDD were asked, 
“How did you feel about being discharged the same day?” Of the 145 patients surveyed, 144 
responded with “extremely satisfied” (Amin et al., 2018).  In a study of 300 randomized patients 
to SDD and OO, patient satisfaction was measured at 30 days following PCI.  Patients reported 
79% satisfaction with discharge via SDD while 49% reported satisfaction via OO.  Also, 37% of 
patients assigned to overnight observation reported that they would have preferred an earlier 
discharge, while 9% of SDD patients would have preferred to stay for OO (Kim et al., 2013).  
With the innovation of TRA, various studies have validated patient satisfaction and cost savings 
of SDD without negative effects on patient outcomes (Seto et al., 2018). 
Barriers to SDD & Gaps in Literature 
 After reviewing the literature, there were a few barriers that were identified.  At this time, 
there is a lack of acceptance of SDD strategies (Koshy, George, & Das, 2020).  The concept of 
SDD is a new model of care that is being implemented within the US, which often means 
providers have little experience with its implementation.  The lack of experience often leads to 
more conservative approaches.  For SDD, many facilities are utilizing more conservative 
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standards than current literature recommends, leading to fewer discharges via SDD (Chen, Lin, 
& Marshall, 2018).  An individual provider’s decision regarding SDD versus OO may be 
influenced by controllability, personal experience, competence, perceived benefit, and personal 
concerns (Chen, Lin, & Marshall, 2018).  The lack of invested interest and buy-in of SDD could 
impact the performance of a SDD protocol.  To implement successful change, proper planning, 
physician buy in, and communication is key (Koshy, George, & Das, 2020). 
 In addition to conservative implementation of SDD, poor adherence to guidelines and 
recommendations has been noted as a barrier within the literature (Chen, Lin, & Marshall, 2018; 
Koshy, George, & Das, 2020).  Chen, Lin, and Marshall (2018) implemented a SDD protocol in 
Australia and evaluated the process.  It was found that guideline adherence varied, with overall 
adherence ratings of 77.3%.   The variations were contributed to physician and individual clinical 
decision making.  At this time, there is no established benchmark for guideline adherence (Chen, 
Lin, & Marshall, 2018). 
 One gap in literature is the lack of consistencies in criteria for SDD in patients who 
undergo elective PCI.  While the 2018 recommendations from the SCAI are relatively new, there 
is no current research that uses the suggested criteria at this time (Seto et al., 2018).  In addition 
to the lack of consistencies regarding criteria for SDD, protocols regarding SDD implementation 
are not well described in the literature. 
Throughout the history of PCI procedures, the standard of care following uncomplicated, 
elective PCI included OO to monitor for potential complications.  Current recommendations 
conclude that advances in clinical practice have supported the implementation of SDD protocols 
following elective PCI (Seto et al., 2018).  Many studies have noted the safety and feasibility of 
implementing a SDD protocol following elective PCI in both low risk and high risk patients 
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(Abdelaal et al., 2013; Amin et al., 2018; Brayton et al., 2013; Din et al., 2017; Heyde et al., 
2007; Madan et al., 2019).  Following the review of literature, it is determined that the strength 
of evidence is sufficient to support the implementation of a SDD protocol at an inpatient facility 
in Pulaski County, Arkansas following elective PCI.  Barriers found during literature review 
must be addressed during the creation and implementation of this DNP quality improvement 
project.  Implementation of a safe, cost effective evidence-based practice SDD protocol has the 
ability to improve bed utilization and increase access to care while also preserving patient safety, 
improving patient satisfaction, and lowering healthcare costs. 
Theoretical Framework 
The utilization of EBP theoretical models aid in the implementation of current research 
findings into nursing practice (Schaffer, Sandau, & Diedrick, 2013).  According to Schaffer, 
Sandau, and Diedrick (2013), EBP models are useful for providing an organized approach to 
EBP implementation.  The use of models can help researchers avoid partial implementation, 
increase resource utilization, and facilitate outcome evaluation (Schaffer, Sandau, & Diedrick, 
2013; White, Dudley-Brown, and Terhaar, 2016).  Rosswurm & Larrabee’s model was used to 
guide the implementation team through the development and integration of EBP changes within 
the clinical site (Rosswurm & Larrabee, 1999).  This model was developed for implementation 
of EBP protocols within the inpatient setting.  The model utilizes six steps from an assessment of 
needed change at the clinical site to the integration and maintenance following intervention 
implementation.  The incorporation of best practices from clinically relevant research, expertise 
of clinicians, and patient preference leads to the most up to date EBP to ensure effective, patient 
centered care (Rosswurm & Larrabee, 1999).   
 33 
The Model for Change to Evidence-Based Practice from Rosswurm and Larrabee was 
selected as the theoretical framework most applicable to the implementation of the SDD protocol 
following elective PCI for multiple reasons.  First, the theory is driven to provide patient 
centered care with best practice (Rosswurm & Larrabee, 1999).  The SDD protocol included a 
set of pre-procedure criteria that were used to determine the discharge pathway based on the 
patient’s individual characteristics.  Secondly, the model heavily relies on the use of research 
evidence to guide implementation (Rosswurm & Larrabee, 1999).  This particular DNP project 
integrated extensive current evidence to create a safe and effective protocol following elective 
PCI.  Also, this model advocates for the collaboration between interdisciplinary teams to further 
enhance the dissemination of EBP (Rosswurm & Larrabee, 1999).  A large multidisciplinary 
team was assembled to implement the planned intervention at an inpatient facility in Pulaski 
Country, Arkansas.  Lastly, an aspect of the model is to evaluate the process and outcomes of 
project implementation (Rosswurm & Larrabee, 1999).  For this particular project, it was vital 
that processes were continually evaluated to make changes to better improve health outcomes of 
this patient population (Rosswurm & Larrabee, 1999).  See Appendix D for the theoretical 
framework and Appendix E for the conceptual model. 
Model for Change to Evidence-Based Practice 
 Rosswurm and Larrabee’s Model for Change to Evidence-Based Practice was constructed 
from both research and theoretical literature.  In this particular model, EBP, research utilization, 
and change are interconnected to implement EBP practice changes.  The model is composed of 
six steps that are used to implement EBP into clinical practice (Rosswurm & Larrabee, 1999).   
Step 1: Assess Need for Change in Practice 
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 The first step of the framework is to assess the need for practice changes with 
stakeholders.  An internal assessment in the form of a Needs Assessment was completed to 
ascertain potential barriers and common adverse effects following elective PCI to establish a 
safe, effective SDD protocol through key informant interviews.  A multidisciplinary team was 
assembled as suggested from Rosswurm and Larrabee’s framework (Rosswurm & Larrabee, 
1999).  The stakeholders included the president of the heart institute, the market director of the 
cardiovascular service line, an interventional cardiologist, and an advanced practice registered 
nurse. 
Following the needs assessment, it was determined that there was a lack of cardiac bed 
availability and very little utilization of SDD following elective PCI.  Internal evidence was then 
compared with external data from current literature.  As identified previously, current data 
indicates the safety and feasibility of SDD following elective PCI.  This data supported the need 
for a practice change within the organization (Rosswurm & Larrabee, 1999).  Key stakeholders 
expressed their interest in implementing change. 
Step 2: Link Problem Interventions and Outcomes 
 The second step of the framework is to link the problem interventions and outcomes 
(Rosswurm & Larrabee, 1999). During this phase, interventions were discussed that would 
improve patient outcomes and access to cardiovascular care at the clinical site.  It was 
determined that the intervention needed to improve patient outcomes based on EBP was the 
implementation of a SDD protocol following elective PCI.  Outcomes that were evaluated 
following EBP implementation included safety, cost effectiveness, and access to care. 
Step 3: Synthesize Best Evidence 
 35 
 The third step of Rosswurm and Larrabee’s framework is to synthesize best evidence to 
determine benchmarks.  The purpose of evidence evaluation is to establish whether or not the 
strength of evidence supports proposed practice changes (Rosswurm & Larrabee, 1999). 
After an internal assessment was completed, an extensive literature search was conducted to 
evaluate current research and clinical practice guidelines.  Internal evidence was compared to 
EBP from current literature.  The problem, practice intervention, and identified outcomes were 
key variables of the literature search and review.  Inclusion and exclusion criteria can be found 
within the review of literature.  The literature was critically appraised to identify strengths, 
weaknesses, and gaps.  An evidence table was used to evaluate study design, strength of 
evidence, and quality of evidence.  Following research synthesis, it was determined that the 
strength of the evidence was sufficient to support the implementation of a SDD protocol 
following elective PCI at the clinical site (Rosswurm & Larrabee, 1999). 
Step 4: Design Practice Change 
 The fourth step to Rosswurm and Larrabee’s model is design practice change (Rosswurm 
& Larrabee, 1999).  When designing the practice change, the current practices, resources needed, 
and feedback from key stakeholders were considered.  While designing the study, outcomes were 
defined.  Since the practice change was intended to affect the standard of care in a large hospital, 
a pilot study was used to determine additional components and changes in processes that were 
needed for further SDD protocol implementation (Rosswurm & Larrabee, 1999). 
Step 5: Implement & Evaluate Change in Practice 
 The fifth step of the model is used to implement and evaluate the change in practice.  
During this stage, the pilot testing for the implementation of a SDD protocol following elective 
PCI took place over a 6-week implementation period.  Data was collected and evaluated to 
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determine the effectiveness and outcomes of the practice change.  Results from the pilot test 
were disseminated amongst stakeholders.  Stakeholders then determined to continue to 
implement practice change (Rosswurm & Larrabee, 1999). 
Step 6: Integrate & Maintain Change in Practice 
 The last step of Rosswurm and Larrabee’s model consists of integrating and maintaining 
change in clinical practice.  Results of the pilot test were examined to determine whether or not 
results supported the integration of new practice as the standard of care.  The process was 
frequently monitored by the principal investigator (PI) and project outcomes were evaluated. 
Recommendations for future implementation were communicated to stakeholders and further 
process changes were initiated.  Stakeholders from the facility were involved in both planning 
and the implementation of practice change, leading to further confidence related to effective 
practice change and the feasibility of future change within that particular environment.  Staff was 
educated regarding practice changes.  Following future implementation, it is expected that the 
SDD protocol following elective PCI will become standard of practice.  During the final phase, 
results of practice change were disseminated, and the multidisciplinary team and stakeholders 
worked together to create plans for future implementation and practice change sustainability 
(Rosswurm & Larrabee, 1999).   
Evaluation of Outcomes 
 The aim of this DNP quality improvement project was to improve access to healthcare by 
creating and implementing a same day discharge protocol following elective PCI at an inpatient 
facility in Pulaski Country, Arkansas.  After the implementation period, data was collected to 
determine if the implementation of the SDD protocol following elective PCI increased access to 
cardiovascular care.  Chart reviews were conducted to analyze the effect of change 
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implementation.  Specific outcomes that were measured to evaluate the intervention’s 
effectiveness included bed utilization affecting access to cardiovascular care, safety of care, and 
cost savings. 
Implications for Practice 
 In summary, the Model for Change to Evidence-Based Practice by Rosswurm and 
Larrabee (1999) was used to create and implement change at an inpatient facility in Pulaski 
County, Arkansas through the creation of a SDD protocol following elective PCI.  The changes 
that were implemented reflect current guidelines and EBP recommendations that can have 
positive effects of patient outcomes, access to care, patient satisfaction, and hospital costs.  The 
problem was identified, a needs assessment was completed, and current evidence was evaluated 
to create EBP directed change.  Then, a research design was created with stakeholders to 
implement through a pilot study.  Though implementation failed during the planned 
implementation period, future implementation will begin in the coming months.  Following 
implementation, the SDD protocol can be integrated system wide if the practice change is 
successful.  Utilizing the model by Rosswurm and Larrabee acted as an outline and set of actions 
required to translate current knowledge and research into clinical practice to reduce the theory 
practice gap (White, Dudley-Brown, and Terhaar, 2016). 
Methodology 
Project Description  
 The DNP project was categorized as QI as the goal of the project was to improve 
outcomes or processes of the healthcare being delivered (Melnyk & Fineout-Overholt, 2015).  
The purpose of QI is most frequently to improve current health practices and improve patient 
outcomes of a specific population (Hickey & Brosnan, 2017).  This DNP QI project monitored 
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the implementation of an evidence based SDD protocol following elective PCI to improve access 
to cardiovascular care and improve health outcomes of patients with ischemic heart disease 
(Hickey & Brosnan, 2017).  
Project Design 
The DNP quality improvement (QI) project utilized a quasi-experimental research design 
aimed to increase access to cardiovascular care through the implementation of a SDD protocol 
following elective PCI at an inpatient facility in Pulaski County, Arkansas.  A quasi-
experimental approach was useful as it introduced an independent or treatment variable but did 
not require randomization or an experimental group (Melnyk & Fineout-Overholt, 2015; Moran, 
Burson, & Conrad, 2017).  This DNP project was unable to utilize randomization thus making a 
quantitative quasi-experimental design an appropriate approach (Melnyk & Fineout-Overholt, 
2015).  Convenience sampling was to be used as potential participants were scheduled for 
elective PCI procedures.  The project anticipated the ability to capture data from approximately 
2,000 elective PCI procedures between the pre-implementation and post-implementation periods. 
The DNP project employed a pre-implementation group and post-implementation group 
(Melnyk & Fineout-Overholt, 2015).  The intervention that was to be implemented was a SDD 
protocol following elective PCI.  The pre-implementation group included all patients who 
underwent an elective PCI procedure regardless of discharge timing the six weeks prior to SDD 
protocol implementation.  The post-implementation group included all patients who underwent 
an elective PCI procedure within the six-week implementation period.  The percentage of 
patients who discharged via SDD in the pre-implementation group were compared to the post-
implementation group.   
 39 
The overall desired outcome of the project was to improve access to cardiovascular care 
by creating and implementing a SDD protocol following elective PCI.  Following 
implementation, the project expected to increase the percentage of patients that undergo SDD 
following elective PCI.  Objectives of the project included the creation of a tool to determine 
each patient’s pre-procedure eligibility of SDD, the implementation of a SDD protocol following 
elective PCI for all identified patients who met pre-procedure criteria, and the evaluation of care 
management of patients who underwent PCI following SDD protocol implementation.  The 
project attempted to demonstrate the impact of implementation of a SDD protocol following 
elective PCI on access to care, patient safety, and cost savings.  The project aligned with the 
clinical site’s objectives and project objectives to increase access to cardiovascular care.  To 
achieve this objective, implementation of a SDD protocol following elective PCI was attempted 
to reduce OO and improve bed utilization.  The number of procedures performed during the pre-
implementation and post-implementation period were compared.  Project implementation 
occurred over a six-week period, but the data collection included the six-week pre-
implementation period and only four weeks during the implementation period. 
Setting 
 The DNP QI project took place in an inpatient facility within Pulaski County, Arkansas.  
This particular facility served as a major cardiovascular care facility for the central Arkansas 
region.  The project implementation was attempted within the Cath lab and two cardiology units 
within the facility.  Outpatient evaluation, procedure scheduling, and post-procedure follow-up 
were to take place at the facility’s corresponding cardiology clinic. 
Study Population 
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 The study participants included all patients with IHD who underwent elective PCI within 
the six weeks prior to protocol implementation and all patients with IHD who underwent elective 
PCI within the six-week implementation period.  Patients that were considered for SDD involved 
those who met inclusion criteria for SDD following elective PCI based on pre-procedural, peri-
procedural, and post-procedural criteria.  The inclusion criteria for SDD comprised patients over 
18 years old, patients undergoing an elective procedure, patients who are not opposed to 
discharge via SDD with home support, and patients with a driver present. Exclusion criteria for 
SDD comprised patients presenting with non-ST elevated myocardial infarction (NSTEMI) or 
ST elevated myocardial infarction (STEMI); noncompliance to medical therapy; lack of 
available driver; inadequate support at home; hemodynamic instability during or after PCI 
procedure; post-procedural complications; late cases that result in discharge after 9 PM unless an 
exception is made by a physician; and frail, elderly patients.  Inclusion and exclusion criteria 
were adapted from suggested criteria from Seto et al. (2018) and Rao et al (2021).  See Appendix 
K for the Pre-procedure Criteria Checklist.  The sample size was unknown during project 
planning, as the sample size was dependent on the number of patient’s scheduled for elective PCI 
procedures within the implementation period.  The facility reported completing approximately 
2,000 PCI procedures per year.  Sampling was gathered through convenience sampling without 
randomization. 
Subject Recruitment 
 All patients with IHD being scheduled for elective PCI during the implementation period 
were to be screened using the pre-procedure criteria checklist for SDD at the facility’s 
corresponding cardiology clinic.  Retrospective data was collected via chart reviews on all 
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eligible study subjects.  Consent has been waived by the University of Arkansas (UARK) 
Institutional Review Board (IRB) and clinical site IRB. 
Consent Procedures 
 This DNP project is a QI project that utilized a retrospective chart review. Consent was 
waived by both the UARK IRB and clinical site IRB.  Consent was not needed as the practice of 
SDD is projected to become the clinical site’s standard of care for elective PCI procedures.  The 
patients signed a procedure consent prior to the elective PCI. 
Study Measures 
 Conceptual Definitions.  For the purpose of this DNP project, the conceptual definition 
of the term same day discharge was an evidence-based change in practice that involved a patient 
discharging from the hospital on the same calendar day as his or her scheduled elective PCI 
procedure.   
 Operational Definitions.  For the purpose of this DNP project, the operational definition 
of the term same day discharge was described as a discharge that occured within 4 to 8 hours 
following elective PCI procedure completion on the same calendar day as the scheduled 
procedure.  SDD was be measured by conducting chart reviews to determine the number of 
patients that were discharged on the same calendar day as his or her scheduled procedure.  Same 
day discharge must occur at least 4 hours after procedure completion via TRA and at least 6 
hours after procedure completion via transfemoral access.  Pre-implementation and post-
implementation data were compared following implementation. 
Outcome Measures.  The outcome measures of this DNP project were intended to assess 
the impact of the implemented evidence-based practice change (Melnyk & Fineout-Overholt, 
2015).  To address the project’s specific aim and clinical outcome measure, the percentage of 
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discharges completed via the SDD protocol following elective PCI were measured.  
Retrospective chart reviews were conducted at the clinical site to gather data regarding all 
elective PCI procedures that occurred six weeks prior to project implementation and during the 
implementation period.  The outcome measures compared pre-implementation and post-
implementation data to determine the project’s impact.  Chart review data was used to determine 
if protocol implementation or other SDD methods led to increased access to cardiovascular care 
through an increase in the SDD percentage.  The inpatient facility estimated a baseline 
percentage of SDD at 15% out of the total number of elective procedures completed.  The goal 
for SDD was to increase to 50% or more of the total number of elective procedures completed by 
March 31, 2021. 
Additional outcome measures to be evaluated included the comparison of pre-
implementation and post-implementation data detailing the total number of patients who 
underwent elective PCI; the percentage of bed availability on two cardiology units; the length of 
stay following elective PCI; and the percentage of patients with access via TRA.  Baseline 
percentages and projected goals for these outcome measures were unknown before 
implementation.  Demographic data collected included age, sex, race, type of health insurance, 
and marital status will be gathered for all patients.  Missing demographic data included education 
level, income level, employment status, and job title. 
Process Measures.  The process measures of this DNP project were used to address the 
efficiency of implemented change.  The project utilized the Plan-Do-Study-Act cycle to plan, 
implement, observe, and modify change as needed during DNP project implementation (Melnyk 
& Fineout-Overholt, 2015).  When problems in processes arose, change was refined and 
implemented (Melnyk & Fineout-Overholt, 2015).  Process observation and compliance 
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monitoring took place twice weekly by this PI.  Process measures evaluated for the DNP project 
included the percentage of SDD patients identified using the pre-procedure criteria, percentage 
of adherence to the post-procedure checklist established to determine the patients’ readiness for 
discharge, percentage of patients discharged via SDD who met SDD criteria, and percentage of 
hotel usage in patient’s identified for SDD who lived further than 60 miles from the facility.  
Benchmark percentages were not found in literature; however, process measure goals were 
established as follows: 85% compliance of SDD patients identified using the pre-procedure 
criteria; 85% adherence to the post-procedure checklist; 50% of patients discharged via SDD 
who meet SDD criteria; and 100% compliance to hotel usage in patient’s identified for SDD who 
lived further than 60 miles from the facility. 
Balancing Measures.  Balancing measures of this DNP project were used to evaluate 
both positive and negative unintended effects of project implementation.  Balancing measures for 
the DNP project included patient safety and hospital cost savings.  Safety was measured through 
readmission and complication rates of patients who underwent discharge via both OO and SDD 
following elective PCI at 14 days.  To measure cost savings, a cost analysis was completed 
comparing SDD to OO following elective PCI.  Baseline data regarding balancing measures was 
not available during project planning.  
Benefits and Risks  
 Benefits of the DNP project included the implementation of an evidence-based practice 
intervention through SDD following elective PCI.  The benefits of PCI included improved blood 
flow to coronary arteries and improved quality of life (Abbott & Cutlip, 2020).  Additional 
benefits of SDD included the ability to recover in one’s home, decreased length of stay, and 
reduced exposure to the hospital environment.  The DNP project’s implementation of SDD had 
 44 
very minimal risks, as immediate post-procedural care was unchanged from patients who stay for 
OO; however, the patient or caregiver may feel stressed or anxious about caring for themselves 
following the procedure.  Procedural and post-procedural complications could occur with PCI; 
however, evidence indicates that adverse events most often occur during the first six hours of 
observation or after 24 hours, meaning OO is not superior to SDD (Jabara et al., 2008; Small et 
al., 2007).  Possible complications following PCI included bleeding, bruising, swelling, redness, 
or soreness at the access site and chest discomfort or pain (Abbott & Cutlip, 2020).  Patients that 
were discharged home via SDD were provided education regarding signs and symptoms to 
monitor for and numbers to call if complications or symptoms were to arise as standard practice.  
There was a minimal risk of potential loss of the patient’s privacy and confidentiality through 
data production and collection.  This PI took all necessary precautions to minimize the loss of 
privacy and confidentiality. 
Subject Costs and Compensation  
 There were no costs incurred by the patients as a result of this DNP project.  Patient 
compensation is not permitted and did not occur during this DNP project.  Patients who met 
criteria, who were willing to discharge home, and who lived further than 60 miles from the 
hospital met eligibility to stay in the facility’s hotel; however, the hotel cost was covered by the 
facility. According to the clinical site, the cost of the facility hotel was approximately $79 dollars 
plus tax per night as compared to inpatient OO with a calculated non-procedure cost of $1,479 
dollars per night. 
Resources Needed and Economic Considerations 
 There were costs associated with the implementation of the DNP project.  Approximately 
$110,000 per year was budgeted by the clinical site to pay the salary for the discharging APRN 
 45 
within the Cath Lab.  Approximately $500 dollars was spent by the facility to provide pre-
procedure and post-procedure instructions and educational materials to patients who discharged 
via SDD following elective PCI.  There were minimal costs associated with printing the pre-
procedure criteria and post-procedure checklists.  Additional resources that were used included 
this PI’s personal laptop and Microsoft Excel; however, no additional costs were required.  See 
Appendix R for the estimated SDD implementation budget. 
Implementation 
Study Interventions 
 The DNP project intervention was the implementation of an evidence based SDD 
protocol following elective PCI at an inpatient facility in Pulaski County, Arkansas.  The SDD 
protocol was created by the project stakeholders and PI based on current evidence-based practice 
from Seto et al. (2018) and Rao et al. (2021).  The validity and reliability of the SDD protocol 
was unknown during project planning as it had not been used previously in clinical practice. 
 Implementation has not taken place to date due to several barriers; however, the 
following paragraphs describe the intended intervention and implementation processes.  Patients 
were to be screened for SDD eligibility within the outpatient cardiology clinic before being 
scheduled for an elective PCI procedure.  Pre-procedure and post-procedure instructions were to 
be given to each patient upon procedure scheduling in the outpatient cardiology clinic.  
Following a successful, uncomplicated procedure and recovery period, SDD eligible patients 
were to be discharged home via the SDD protocol.  See Appendix I for educational materials and 
Appendix L for the SDD protocol. See Appendix O for implementation evolution over time.  
Pre-Implementation Phase 
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During the pre-implementation phase, many interdisciplinary team meetings were held to 
discuss current and future processes.  A SDD protocol following elective PCI was developed 
with key stakeholders, including an interventional cardiologist.  During the pre-implementation 
stage, checklists detailing pre-procedure and post-procedure criteria were created to determine 
patient eligibility for SDD based on clinical and socio-demographic factors.  The pre-procedure 
and post-procedure criteria checklists were based on current, evidence-based recommendations 
from the SCAI (Seto et al., 2018).  As tools were created during project planning, the validity 
and reliability were unknown before implementation.  See Appendix K for pre-procedure and 
post-procedure criteria checklists and Appendix L for the SDD protocol.  
After new processes were determined, this PI attended scheduled meetings with the 
nurses within the cardiology clinic, Cath lab, and two involved cardiology units to detail the 
background and significance of the problem; current evidence used to describe the safety and 
effectiveness of the intervention; projected start date; updated practices and processes; project 
expectations; and pre-procedure and post-procedure checklists.  During the scheduled meetings, 
this PI addressed any staff questions and concerns and left a telephone number for additional 
questions.  A frequently asked questions (FAQ) flyer was also created and emailed to 
management to deliver to the staff.  The clinical site administration took ownership for physician 
engagement beyond the physician that was involved in SDD protocol creation. 
 The facility began an independent pilot test utilizing updated SDD processes on patients 
who underwent electrophysiology (EP) procedures on June 1, 2020 with two EP physicians.  
Though this was not studied by this PI, the pilot test was used to better facilitate implementation 
of the SDD protocol following elective PCI.  The pilot test was very successful.  From August 
10, 2020 through April 1, 2021, there were 345 patients discharged via SDD processes following 
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EP procedures with two EP physicians. The estimated cost savings based on previous 
calculations was $510,255. 
Chart reviews to gather pre-implementation data were delayed due to a lack of access to 
the EMR at the clinical site.  Chart reviews began on March 10, 2021.  Baseline data gathered 
included the total number of elective PCI procedures completed in the six weeks preceding 
implementation, the number of patients that were discharged via SDD and OO, length of stay, 
procedural complications, post-procedural complications within 14 days following elective PCI, 
readmissions within 14 days following elective PCI, and demographic data.  It was intended that 
pre-implementation data and post-implementation data were to be compared.  Data governance 
requests were made at the clinical site to capture the data needed.  
Implementation Phase 
The elective PCI SDD protocol was approved by key stakeholders and piloting 
interventional cardiologist before project implementation, but the implementation phase did not 
unfold as originally expected.  The lack of physician engagement, administrative support, and 
clinical site communication led to implementation failure within the clinical site.  During the 
implementation phase, there were no patients discharged via the established SDD protocol.  The 
following sections detail variations in implementation, as well as specifics of planned, actual, 
and future implementation phases. 
Planned Implementation Phase. 
As stated above, implementation was not successful and was ultimately delayed by the 
clinical site.  This section will detail the intended implementation process steps from clinic 
procedure scheduling and eligibility screening to discharge via the SDD protocol.  See Appendix 
L for the SDD protocol.  
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When an elective PCI procedure was scheduled, the patient was to be advised that he or 
she might discharge home on the same day as the procedure.  Upon scheduling an elective PCI 
procedure, patients were to be screened for SDD eligibility using the pre-procedure criteria 
checklist and given pre-procedure and post-procedure educational handouts in the cardiology 
clinic.  See Appendix K for the pre-procedure criteria checklist and Appendix I for the pre-
procedure and post-procedure educational handouts.  Elective PCI procedures were to be 
scheduled as early in the day as possible and noted as “SDD” in the comments on the Cath lab 
schedule to alert the Cath lab nurses of a potential SDD candidate. 
Discharge planning was to begin upon the patient’s arrival to the Cath lab for the 
scheduled elective PCI procedure.  The patient would be assessed for distance from the hospital; 
proper home support; the presence of a driver; and the willingness to pay for medications prior to 
discharge.  If the patient lived further than 60 miles from the facility and the procedure was 
successful with no complications, arrangements for the facility’s hotel would be made by the 
Cardiovascular Service Line Director at no cost to the patient. 
As part of implementation, the physician asked that verification of new medications, 
specifically DAPT, be an included requirement for SDD eligibility.  Medication verification was 
incorporated into the SDD protocol.  As requested, the facility was to utilize the in-hospital 
“meds to bed” pharmacy to deliver all new medications to the patient before discharge. 
The use of the TRA was strongly encouraged, though it was not mandatory per the 
facility.  Same day discharge utilizing TRA was to occur at least 4 hours after procedure 
completion and at least 6 hours after procedure completion via transfemoral access.  If 
complications arose during the procedural or post-procedural periods, the patient was to stay for 
OO.  See Appendix K and Appendix L for details regarding possible reasons for OO.  
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The SDD protocol was established to guide decision making for SDD versus OO 
following elective PCI.  After a successful procedure was completed as identified by the 
patient’s physician, the nurses in the Cath lab or on the cardiology units were to continue 
evaluating the patient for complications and to use the post-procedure checklist to determine the 
patient’s readiness for discharge.  See Appendix K for the post-procedure checklist.  Once the 
patient met all discharge criteria per the post-procedure checklist and was without complication, 
the patient was to be evaluated by the discharging APRN.  The APRN was to assess access sites; 
complete education regarding new medications, disease process, incision care, and cardiac rehab; 
and give the patient all post-procedure information.  The post-procedure education materials 
detailed signs and symptoms to monitor for and numbers to call if a complication were to occur.  
The patients were to be advised to seek emergency care if bleeding or chest pain developed 
following his or her procedure.  Once deemed medically stable by the discharging APRN, the 
patient would either discharge home or to the facility’s hotel.  If the patient’s discharge was to 
take place after 6 PM, the patient would be moved to one of the two cardiology units to complete 
the remaining observation period and post-procedure checklist items.  Discharges to home were 
not be completed after 9 PM for safety reasons, unless specifically indicated by the operating 
physician.  The patients would then be called by the discharging APRN the morning after his or 
her discharge to assess for any complications.  See Appendix L for the SDD protocol.  
Actual Implementation Phase. 
The implementation phase was to take place between February 8, 2021 and March 20, 
2021.  As stated previously, the implementation phase of the DNP project was not successful for 
various reasons.  During the implementation phase, there were no patients that were sent home 
via the established SDD protocol and processes.  One interventional cardiologist agreed to be the 
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SDD protocol’s piloting interventionalist, though his schedule for elective PCI cases was very 
limited due to other obligations.  One major barrier was the lack of effective communication 
between the PI and the piloting interventional cardiologist.  Initiation of communication with the 
piloting interventionalist took place almost daily, but there were limited responses back to this 
PI.  This PI then spoke with another interventional cardiologist who voiced that he was unaware 
of the SDD protocol implementation taking place.  Moving forward, there were many efforts 
made to engage other interventional cardiologists, though none were ready to begin 
implementation immediately.  The PI continued to extend correspondence to the piloting 
interventionalist with little response and no successful SDD implementation.  The lack of 
physician engagement and hesitation led to implementation failure and subsequent delay.  It is 
likely that implementation will take place in the coming months, though exact timing is 
unknown.  See Appendix O for Implementation Evolution Over Time.  The following will detail 
portions of the implementation phase that were completed and others that did not occur. 
When an elective PCI procedure was scheduled, it was the standard of practice that the 
patient was advised that he or she might discharge home on the same day as the procedure.  
Upon scheduling an elective PCI procedure, the patient was given pre-procedure and post-
procedure educational handouts in the cardiology clinic.  Unfortunately, there was 0% adherence 
to pre-procedure eligibility screening using the criteria checklist during the implementation 
phase.  This was thought to be related to the lack of physician engagement. 
Elective PCI procedures were to be scheduled as early in the day as possible and noted as 
“SDD” in the comments on the Cath Lab schedule to alert the Cath Lab nurses of a potential 
SDD candidate.  No elective PCI procedures were scheduled via these established methods. As 
there were no participants that were sent home via the established SDD protocol, the post-
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procedure checklists were not utilized; no patients were discharged to the facility’s hotel; and the 
use of the in-hospital “meds to bed” pharmacy was not documented. 
 Chart reviews were intended to be conducted at least weekly to determine the total 
number of elective PCI procedures scheduled, procedure start time, the number of patients that 
were discharged via SDD, length of stay for patients who discharge via SDD, procedural 
complication, post-procedure complications, and readmissions or complications within 14 days 
following SDD.  See Appendix H for data collection sheet.  Due to a lack of access to the clinic 
site EMR, chart reviews were delayed until March 10, 2021, almost one week from 
implementation completion. 
Process observation took place at least twice weekly and deviations from protocol 
processes were noted.  Due to the lack of participation, there was no data regarding compliance 
of patient eligibility screening or post-procedure checklist use to be evaluated.  The request for a 
cost analysis of each elective PCI procedure was not processed before professional reporting, but 
previous calculations were used to estimate the hospital costs savings between OO and SDD.   
 Future Implementation Phase. 
 Future implementation of the SDD protocol at the clinical site is expected within the 
coming months, though the exact timing is unknown.  This PI would continue to recommend that 
the clinical site use the established SDD protocol and processes as outlined above to complete 
further implementation.  The discharging APRN will take over SDD multidisciplinary team 
leadership, though this PI will still be available to offer additional support if wanted or needed by 
the clinical site. 
Plan-Do-Study-Act Cycles. 
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During the implementation phase, Plan-Do-Study-Act (PDSA) cycles were used to 
address various issues as they surfaced.  When a problem or issue was identified, various 
strategies were utilized to modify processes and improve implementation strategies.  During the 
implementation phase, the following concepts were identified and addressed using PDSA cycles.  
See Appendix P for additional details regarding weekly PDSA cycles during the implementation 
phase.  
Pre-Procedure Checklist Compliance. 
During the implementation phase, it was identified that patients were not screened for 
SDD eligibility in the clinic using the pre-procedure checklist.  Efforts made to increase 
compliance included additional teaching with the clinic nurses, clinic schedulers, and physicians.  
These efforts did not increase compliance.  Both the hospital and clinic were non-compliant to 
pre-procedure checklist utilization.  There were no patients screened for eligibility using the 
established checklists.  To improve process measures compliance and meet to process measure 
goals in the future, additional teaching with the clinic nurses, clinic schedulers, and physicians 
must take place.   
Post-Procedure Checklist Compliance.  
During the implementation phase, the use of the post-procedure checklist was also non-
existent from the Cath lab and Cardiology unit staff.  Since there was very little physician 
engagement, there were no patients identified as potential SDD candidates, thus making the use 
of the post-procedure checklist obsolete.  Despite the lack of eligible patient identification, staff 
education, staff reminders, and increased observation were strategies used to increase 
compliance, though these were ineffective.  The post-procedure checklists were not used at all 
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during the implementation phase.  During future implementation, additional education, 
reminders, and observation must take place to ensure that process measure goals are reached. 
Physician Engagement & Buy-in.  
 Engagement and buy-in from the interventional cardiologists were issues identified early 
in implementation and was found to be the most notable barrier to implementation.  Though 
many physicians knew of potential efforts to implement SDD following elective PCI at the 
clinical site, not all were aware or involved in SDD protocol and process creation.  This PI began 
meeting with individual physicians to discuss the SDD protocol and processes during weeks two 
through six of implementation to gain physician trust and buy-in.  Following individual 
meetings, there was substantially more physician input and engagement; however, the physicians 
were not prepared to begin implementation immediately.  Due to this skepticism, no patients 
were discharged home via the SDD protocol. 
Communication and Identification of Potential SDD versus Overnight Observation.  
During implementation, the discharging APRN often found that she was having to ask the 
piloting interventional cardiologist on a case-by-case basis about potential same day discharge 
patients to no avail.  Several meetings were held to discuss possible solutions to improve 
communication from the clinic to the hospital.  There were many discussions regarding adding 
same day discharge procedures to the clinic and clinical site EMR to initiate staff decision 
making; however, this addition was ultimately vetoed by the clinical site administration as 
previously established processes were reinforced and felt to be adequate for SDD procedure 
scheduling based on the EP pilot study.  For future implementation, reinforcing the established 
scheduling processes will be vital to success. 
Post-Implementation Phase 
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Data extraction via chart audits began on March 10, 2021.  Originally, data collection 
was to include the six weeks prior to and six weeks of implementation, from December 27, 2020 
to March 20, 2021.  Unfortunately, the data collected only included a 10-week time period 
between December 27, 2020 and March 6, 2021 due to the lack of accessible clinical data despite 
data requests.  Since implementation and the utilization of the SDD protocol did not take place, it 
was not likely that the remaining data would contribute to project data and results. 
Following data extraction, data analysis was conducted. Originally, the pre-
implementation and post-implementation outcomes measures were to be compared, but after a 
lack of SDD protocol implementation, the data collected was analyzed as a whole to describe the 
practices of the clinical site over the 10-week period between December 27, 2020 and March 6, 
2021.  The data gathered represented the clinical site’s baseline data.  This PI utilized multiple 
UARK SMSS consultant sessions to review data collected, discuss statistical testing, and analyze 
data.  Following data analysis, the results were disseminated to the DNP project committee, key 
stakeholders, and the interdisciplinary team at the clinical site. 
Process Comparison 
A comparison of pre-implementation processes, proposed processes, and final processes 
was completed.  The pre-implementation processes featured patients recovering in the Cath Lab, 
moving to a cardiology unit, staying overnight, and discharging 24 hours or more after the 
procedure.  The proposed process flowchart included a same day discharge process that 
incorporated pre-procedure criteria assessment in the clinic; assessment and evaluation by the 
discharging APRN; medication delivery via the in-hospital “meds to bed” program; post-
procedure checklists used to determine readiness for discharge; and the use of the facility’s hotel 
for eligible SDD patients that lived further than 60 miles from the hospital.   
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The proposed process flow chart should also act as the final process flowchart. This PI 
would continue to recommend the proposed flow chart despite implementation failure and 
subsequent delay.  This process will continue to change as implementation occurs and can be 
modified as needed by the clinical site.  See Appendix B for pre-implementation and final 
process flowcharts.   
 
Project Timeline 
 The actual project timeline differed greatly from the initial, projected timeline.  Initially, 
implementation was projected to take place from October 2020 through March 2021; however, 
due to delays in clinical site IRB review and non-research designation and a lack of physician 
engagement and participation, implementation failed and was postponed.  There were no 
participants discharged via the established SDD protocol during the implementation period from 
February 8, 2021 through March 20, 2021.  Data gathering via chart reviews was initially 
projected to occur between October 2020 through March, though it actually took place between 
March 10, 2021 through March 24, 2021 due to clinical site EMR access delays.  Data was 
analyzed between March 25, 2021 and April 13, 2021 and later disseminated to the clinical site 
and the University of Arkansas doctoral committee during the DNP intensive.  See Appendix F 
for the Gantt charts depicting the original DNP project timeline and the actual DNP project 
timeline. 
Evaluation of Results 
Data Maintenance and Security 
A Microsoft Excel spreadsheet was created and used for data collection.  On March 10, 
2021, retrospective chart reviews were conducted by this PI to obtain data regarding all elective 
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PCI procedures completed in the pre-implementation and implementation periods.  Data 
collected for all subjects included the patient’s medical record number (MRN), operating 
interventionalist, procedure date, age, race, sex, marital status, primary language, insurance type, 
type of discharge, distance from hospital, procedural complications, post-procedural 
complications before discharge, complications within 14 days of discharge if applicable, 
readmission within 14 days of discharge if applicable, total length of stay in hours and minutes, 
access site used, and use of a closure device.  
Some data was unable to be collected due to delayed EMR access and the lack of SDD 
protocol implementation.  Missing data included income level, education level, employment 
status, and individual procedure cost.  Additionally, if implementation of the SDD protocol had 
taken place, information regarding process measure adherence would have been collected and 
included screening with the pre-procedure criteria checklist, facility hotel use, adherence to the 
post-procedure checklist, SDD of those who met eligibility criteria, and reasons for overnight 
observation if applicable.  See Appendix H for data collection sheets.   
All project data was stored electronically and only this PI had access to the data.  All 
collected patient data was saved and stored in a Microsoft Excel spreadsheet on this PI’s 
password protected desktop computer within the clinical site.  The computer was connected to a 
server maintained by the clinical site.  The document was password protected to increase subject 
privacy and confidentiality.  No other individuals had access to this computer.  Initially, the 
patients were identified by the MRN and procedure date on the Microsoft excel spreadsheet.  
Since consent was waived for the DNP project, the patient’s MRN and procedure date were 
deleted and destroyed on March 24, 2021 following data extraction, transcription, and 
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verification. The data was destroyed in such a way that the identifiers cannot be linked to patient 
data. 
Data Analysis 
Data analysis included descriptive statistical methods to summarize the baseline data and 
clinical site practices during the project implementation period.  Originally, inferential statistical 
methods were to be used, but the lack of data variations and SDD protocol implementation made 
inferential methods unnecessary.  Demographic data, outcome measures, process measures, and 
balancing measures were analyzed via descriptive statistics to describe the patient population and 
practices of the clinical site. 
  Due to the lack of participation using the SDD protocol, comparisons regarding SDD 
via the established protocol and its impact on readmission rates at 14 days, complication rates at 
14 days, TRA usage, and procedure cost were unable to be evaluated.  Though the SDD protocol 
implementation failed during the planned implementation period and was ultimately delayed at 
the clinical site, pre-implementation data and post-implementation data were compared and later 
combined to describe baseline data and clinical site practices.  Analyzing the data collected was 
useful to establish baseline data for the clinical site and to identify areas of focus for future 
implementation.   
Data was analyzed via Excel Tool Pack with the assistance of the SMSS tutors available 
from UARK to describe baseline data and clinical site practices over the 10-week data collection 
period.  There were 55 patients (N=55) that underwent elective PCI with 10 interventional 
cardiologists between December 27, 2020 and March 6, 2021.  An average of 5.5 elective PCI 
procedures were completed per week during the 10-week data collection period.  Of the 55 
procedures completed, 20 patients were discharged home via non-established SDD methods and 
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35 were discharged following OO.  See Figure 1 for the weekly breakdown between SDD vs. 
OO.  As displayed, there were no elective PCI procedures that occurred during week 8 as a result 





Breakdown of Overnight Observation versus Non-Established SDD Methods per Week 
 
Note: This breakdown does not represent implementation of the SDD protocol during the 




The mean age of the patients was 65.18 years old with a range from 41 years old to 88 
years old.  There were 39 males (70.91%) and 16 females (20.09%) in the sample of 55 patients 
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was Asian.  English was the primary language identified for the entire patient population.  
Thirty-four patients stated that they were married, 11 were single, 5 were widowed, 4 were 
divorced, and 1 was separated.  Of the 55 patients, 22 had only private insurance, 20 had both 
private and public insurance, 7 had only public insurance, 3 had federal insurance, and insurance 
information was unavailable for the 3 remaining patients.  Missing demographic data included 
education level, income level, employment status, and job title.  These were unable to be 
obtained due to a lack of SDD protocol implementation, inconsistent documentation, and delayed 
EMR access at the clinical site. 
Table 1 
Demographic Data for Elective PCI (N=55) 
Demographic Data for Elective PCI (N=55) 
 Frequency Percentage 
Age   
19-35 0 0.00% 
36-50 4 7.27% 
51-65 26 47.27% 
66-79 20 36.36% 
80+ 5 9.10% 
   
Race   
     White 34 61.82% 
     Black or African American 18 32.73% 
     Asian 1 1.82% 
     Pacific Islander/Hawaii 2 3.64% 
   
Gender    
     Male 39 70.91% 
     Female 16 20.09% 
   
Marital Status   
     Married 34 61.82% 
     Single 11 20.00% 
     Divorced 4 7.27% 
     Widowed 5 9.09% 
     Separated 1 1.82% 
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Primary Language   
     English 55 100.00% 
   
Insurance Type   
     Private 22 40.00% 
     Public 7 12.73% 
     Public + Private 20 36.36% 
     Federal 3 5.45% 
     Unavailable 3 5.45% 
 
Many of the interventional cardiologists expressed that they felt that SDD protocol 
implementation would likely require them to change their work schedules to accommodate for 
SDD as the procedures must be scheduled and completed early in the day.  This PI analyzed 
procedure start times to better describe the usual practice habits.  It was found that out of the 55 
procedure, 21 took place between 0700 and 0900 (38.18%); 15 took place between 1000 and 
1200 (27.27%); 17 took place between 1300 and 1700 (30.91%); and 2 took place at 1600 or 
later (3.64%).  As per the clinical site’s request, the SDD protocol incorporated recommended 
case completion times via TRA and TFA.  The SDD protocol states that cases via TRA must be 
completed by 5 PM and cases via TFA must be completed by 3 PM to be considered for SDD.  
This data indicated that at least 65.45% of the elective PCI procedures were scheduled and 
started at appropriate times (0700 to 1200) to facilitate SDD. Increasing early or mid-morning 
cases would help the clinical site capitalize on greater SDD eligibility. 
Outcomes Measures 
The objective of this DNP project was to evaluate how the implementation of a SDD 
protocol following elective PCI effected access to cardiovascular care.  Outcome measures were 
evaluated and compared pre-implementation data to post-implementation data to determine the 
impact of the DNP project.  Five outcome measures for the DNP project were identified during 
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project planning that included the percentage of SDD of the patients who underwent elective 
PCI; the total number of patients who underwent elective PCI; the percentage of bed availability 
on two cardiology units; the average length of stay; and the percentage of patients who 
underwent elective PCI with access via TRA. 
Retrospective chart reviews were conducted at the clinical site to gather data regarding all 
elective PCI procedures that occurred during the six weeks prior to project implementation and 
during the implementation phase.  Originally, data collection was to include the six weeks prior 
to and the six weeks of implementation, from December 27, 2020 to March 20, 2021.  
Unfortunately, the data collected only included a 10-week time period between December 27, 
2020 and March 6, 2021 due to the lack of accessible clinical data despite data requests. 
 Outcome Measure #1: Percentage of Same Day Discharge. 
The specific aim, and the first outcome measure, was to increase the percentage of SDD 
from the estimated baseline rate of 15% to 50% by March 31, 2021.  According to one of the 
interventional cardiologists, the quality metric goal for SDD following elective PCI was 25% or 
greater, though this PI was unable to verify this metric with clinical site administration.   
To address the project’s specific aim and clinical outcome measure, the percentage of 
discharges completed via SDD following elective PCI were to be measured; however, no 
discharges occurred according to established SDD processes.  Despite the lack of SDD protocol 
implementation, data from the 10-week collection period was analyzed to relay accurate baseline 
data to the clinical site and to describe current clinical practice. 
As stated above, the estimated baseline percentage of SDD reported from the clinical site 
prior to implementation was 15%; however, the percentage of elective PCI SDD from October 
2019 through September 2020 was 25.3% out of the total number of elective procedures 
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completed.  During the 10-week data collection period, the percentage of SDD increased from 
previous percentages.  Data from the pre-implementation period indicated that 15 of 35 patients, 
or 42.86%, discharged via non-established SDD methods while 5 of 20 patients, or 25%, 
discharged via non-established SDD methods during the planned implementation period.  It is 
likely that statewide inclement weather over week 8 of the planned implementation period 
played a role in both the decreased number of elective PCI procedures completed and the 
variation in SDD percentages during the pre-implementation and planned implementation 
periods.  When both the pre-implementation and planned implementation period data were 
combined, it was found that 20 out of the 55, or 36.36%, were discharged via other non-
established SDD methods.  The outcome measure of increasing the SDD percentage to 50% by 
March 31, 2021 was not met. See Figure 2. 
Of the 55 elective PCI procedures performed, 19 of 55 were performed by three 
interventional cardiologists who do not regularly operate from the clinical site.  Of these 19 
elective PCIs performed, 8 patients discharged via non-established SDD methods.  If the 
procedures performed by these three were excluded, 36 procedures were performed by regular 
interventional cardiologists with 12 of 36 discharge via non-established SDD methods for a 
percentage of 33.33% during combined pre-implementation and post-implementation periods.  
Figure 2 
Percentage of Same Day Discharge 
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Note: The SDD protocol was not implemented during the planned implementation period. Also, 




Outcome Measure #2: Total Number of Patients who Underwent Elective PCI. 
 The second outcome measure was to compare the total number of patients who 
underwent elective PCI during the pre-implementation phase to the post-implementation phase. 
Data comparisons are skewed as the pre-implementation data collection period included six 
weeks, while the post-implementation data collection period included only four weeks.  It was 
found that 35 patients underwent elective PCI during the pre-implementation phase and 20 
patients underwent elective PCI during the post-implementation phase.  See Figure 3. 
Figure 3 
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Note: Pre-implementation period represents 6 weeks of data as compared to 4 weeks during the 




Outcome Measure #3: Percentage of Bed Availability. 
 The third outcome measure established was to compare the percentage of bed availability 
on two cardiology units during the pre-implementation and post-implementation phases. 
Unfortunately, this data was not able to be obtained despite many requests made by this PI to the 
clinical site administration.  Data that was obtained included the average daily census during the 
previous fiscal year; however, staffing shortages skewed bed availability numbers as beds were 
blocked at times to assist with staffing shortages.  In addition to staffing shortages, COVID-19 
caused many patients to delay seeking care and further skewed bed availability numbers.  During 
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10 out of 18 available beds on 2 east.  The clinical site will need to continue following bed 
availability percentages to further evaluate SDD protocol implementation effects on access to 
cardiovascular care.  See Figures 4 and 5 below. 
Figure 4 
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The fourth outcome measure established was to compare the length of stay following 
elective PCI between the pre-implementation and post-implementation phases.  The average 
length of stay of patients who underwent elective PCI during both the pre-implementation phase 
and the post-implementation phase combined was 1372.18 minutes or 22.87 hours.  See Figure 6 
below.  The average length of stay during the pre-implementation phase was 1143.40 minutes as 
compared to 1772.55 minutes during the post-implementation phase. The difference in the 
averages was 629.15 minutes.  During the post-implementation period, there were two patients 
that had a substantially longer length of stay due to post-procedure complications.  These outliers 







Average Length of Stay in Minutes: Pre-Implementation & Post-Implementation Combined  
        
   Average Length of Stay in Minutes   
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Figure 7 
Average Length of Stay in Minutes: Elective PCI 
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 Outcome Measure #5: Percentage of Access via TRA. 
 The fifth and final outcome measure established was to compare the percentage of 
patients who underwent elective PCI via TRA between the pre-implementation and post-
implementation phases.  Because of the lack of SDD implementation, data from the pre-
implementation and post-implementation phases were combined.  It was found that 26 patients 
underwent access via TFA, 27 patients underwent access via TRA, and 2 patients underwent 
access via both TFA and TRA.  Additionally, there were two patients in which the right femoral 
vein was used and one patient in which the right jugular vein was used for transvenous pacing 
purposes in addition to the catheterization access site.  See Figure 8. 
Figure 8 
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The process measures of this DNP project were used to address the efficiency of 
implemented change at the clinical site.  The project utilized Plan-Do-Study-Act cycles to plan, 
implement, observe, and modify change as needed during DNP project implementation (Melnyk 
& Fineout-Overholt, 2015).  When problems with processes arose, change was refined and 
implemented in an effort of continuous quality improvement (Laverentz & Kumm, 2017; 
Melnyk & Fineout-Overholt, 2015).  Process observation and compliance was monitored twice 
weekly by the PI.  During the implementation phase, PDSA cycles were used to identify barriers 
to implementation at weekly intervals.  See Appendix P for weekly PDSA Cycles.  During 
implementation, different strategies and processes for SDD were identified and modified as 
needed using the PDSA cycles.  See Appendix O for Implementation Evolution Over Time. 
There were four process measures that were evaluated for the DNP project.  These 
process measures included the percentage of SDD patients identified using the pre-procedure 
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patients’ readiness for discharge; percentage of patients discharged via SDD who meet SDD 
criteria; and percentage of hotel usage in patient’s identified for SDD who live further than 60 
miles from the facility.  Benchmark percentages were not found in current literature; however, 
process measure goals were established as follows: 85% compliance of SDD patients identified 
using the pre-procedure criteria; 85% adherence to the post-procedure checklist; 50% of patients 
discharged via SDD who met SDD criteria; and 100% compliance to hotel usage in patient’s 
identified for SDD who lived further than 60 miles from the facility.  Unfortunately, none of the 
process measure goals were met due to failed and subsequently delayed SDD protocol 
implementation at the clinical site.  Some patients were discharged via other SDD methods, 
though they were not discharged using the established SDD protocol.  Please see the below for 
details regarding individual process measures.   
Process measures are conveyed using descriptive statistics and displayed via Run Charts.  
The Institute for Healthcare Improvement (IHI) (2021) states that run charts are used to depict 
data over time.  Run charts are often used to display how well or poorly a certain project process 
is performing (Institute for Healthcare Improvement [IHI], 2021). See Appendix S for run charts 
with associated data inputs. 
Process Measure #1: Compliance of Patient Identification Using the Pre-Procedure 
Criteria.  
The first process measure identified was cardiology clinic staff compliance of using the 
pre-procedure criteria to identify patient eligibility for SDD.  The goal was to reach 85% 
compliance each week during the implementation period.  The delay of implementation led to 
0% compliance of checklist use.  See Figure 9.  The lack of compliance was likely due to the 
lack of physician engagement and will be discussed in further detail later as a limitation. 
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Figure 9 
Pre-Procedure Checklist Compliance: Identification of Patient Eligibility for SDD 
  
Process Measure #2: Compliance Using Post-Procedure Checklist. 
The second process measure identified was Cath lab staff compliance of using the post-
procedure checklist to determine patient readiness for discharge.  The goal was to reach 85% 
compliance each week during the implementation period.  The delay of implementation led to 
0% compliance of checklist use.  See Figure 10. 
Figure 10 


















Process Measure #3: Compliance of SDD for Patients who Met SDD Criteria. 
The third process measure addressed compliance of discharging SDD eligible patients via 
SDD following elective PCI.  The goal was to reach 50% each week during the implementation 
period.  Physician hesitation, the delay of implementation, and the lack of participants led to 0% 
compliance.  There were no patients that were screened using the SDD protocol’s criteria or 


























Compliance of SDD for Patients who Met SDD Eligibility Criteria 
 
Process Measure #4: Compliance of Utilizing Facility Hotel. 
The final process measure identified was compliance of utilizing the facility hotel for 
patients who lived further than 60 miles from the clinical site.  The goal was to reach 100% 
compliance each week during the implementation period.  Due to the delay of implementation 
and physician hesitation, there was 0% compliance of utilizing the facility’s hotel.  No patients 
were discharged to the facility’s hotel during implementation.  See Figure 12. 
An average distance from the hospital was calculated.  It was found that the average 
distance that the patients lived from the hospital was 53.6 miles.  See Figure 13.  Twenty-one 
patients within the sample lived further than 60 miles from the hospital.  Of the 21 patients that 
lived further than 60 miles from the hospital, 9 patients discharged on the same day and traveled 
the entire distance home despite facility hotel availability, none of which had post-procedural 
complications.  One of the 21 patients who lived further than 60 miles from the hospital had a 
post procedure complication that required OO.  Complications are discussed below.  Based on 
this information, it can be inferred that 20 patients could have potentially discharged to the 
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Compliance of Utilizing the Facility’s Hotel for Patients who Lived Further than 60 miles from 
the clinical Site. 
 
Figure 13 
Average Distance from the Hospital: Elective PCI 
     
   Average Distance from Hospital   
   53.6   
        
 
Balancing Measures 
Balancing measures of the DNP project were used to evaluate both positive and negative 
unintended effects of project implementation.  Balancing measures for the DNP project included 
patient safety and cost savings.  Safety was measured through readmission and complication 
rates of patients who underwent SDD following elective PCI at 14 days.  Cost savings was 
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delayed at the clinical site, there were no additional unintended effects discovered, either positive 
or negative. 
Balancing Measure #1: Safety 
  The first balancing measure identified was to monitor the safety following the 
implementation of a SDD protocol after elective PCI.  Despite the lack of implementation of the 
SDD protocol, safety was evaluated through the conduction of chart reviews on all patients who 
underwent elective PCIs within the 10-week data collection period.  There were zero 
complications or readmissions within 14 days of discharge identified via chart reviews of all 55 
patients who underwent elective PCI within the pre-implementation and post-implementation 
periods.  As stated previously, 20 of the 55 patients discharged via non-established SDD 
methods.  Of the 20 patients, there were no complications or readmissions identified via chart 
reviews.  This finding further supports the safety of implementing the SDD protocol within the 
coming months.   
Additionally, chart reviews included procedural and post-procedural complications 
before discharge.  Evaluation of these complications was not originally included during project 
planning; however, they were identified as important values for measuring implementation 
safety.  This information was only collected to verify that patients who had complications were 
kept for OO.  Of the 55 patients, three had procedural complications (5.45%) and five had post-
procedural complications (9.09%).   
The three procedural complications included two patients with bradycardia requiring 
transvenous pacing and one patient who had significant complications including bleeding at the 
access site, hematoma at the access site, cardiac tamponade, coronary artery dissection, and 
perforation.  One patient who had procedural bradycardia requiring temporary pacing discharged 
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via non-established SDD methods as bradycardia resolved during the immediate post-operative 
period.  The five post-procedural complications included one patient with a hematoma, one 
patient with a contrast allergy, one patient with post procedure bleeding, one patient with ST 
depression on EKG in lateral leads, and one with atrial fibrillation requiring amiodarone and 
Cardizem infusions before rhythm conversion.  Of these with complications, one patient had 
both procedural and post-procedural complications.   
One of the patients who had procedural bradycardia requiring temporary pacing 
discharged via non-established SDD methods as bradycardia resolved during the immediate post-
operative period and was felt to be safe for discharge by the operating physician.  All others with 
procedural and post-procedural complications were appropriately monitored via OO.  The 
average length of stay for patients who experienced either a procedural or post-procedural 
complication before discharge was 2483.29 minutes or 41.39 hours. 
Balancing Measure #2: Cost Savings 
The second balancing measure identified was to evaluate the cost savings when 
comparing SDD to OO following elective PCI.  Originally, this PI was to calculate an average 
cost of SDD versus OO using individual procedural costs.  The request for a cost analysis of each 
elective PCI procedure was not processed at the clinical site before professional reporting.  
Instead, previous calculations were used to estimate the hospital costs savings between OO and 
SDD.   
The clinical site conducted a proforma in January of 2020 that noted a 5.4% increase in 
Cath lab volume over the previous year.  The increase in case volume caused difficulties with 
throughput in all the cardiac areas which led to consistently full cardiac units.  The proforma 
analyzed the average cost of an atrial fibrillation ablation minus the procedure costs to determine 
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the difference in hospital cost between OO and SDD.  It was calculated that the average cost of 
OO minus procedural costs was $2,787 compared to $1,307 for those who discharged via SDD.  
The total cost savings of SDD equated to approximately $1,479 dollars per case. The clinical site 
felt that the cost savings for OO versus SDD would be the same following elective PCI. 
During the 10-week data collection period, 20 of the 55 patients, or 36.36%, who 
underwent elective PCI were discharged home via non-established SDD processes.  If the 
clinical site had met its goal for increasing the percentage of SDD to 50% by the end of the data 
collection period, there was a potential of an additional $11,092.50 dollars in hospital cost 
savings during that period of time alone using the previous calculations.   
 The clinical site averaged 5.5 elective PCI procedures during the 10-week data collection 
period.  If the clinical site was able to continue the average of 5.5 elective PCI procedures per 
week, they would have completed 286 elective PCI procedures in 52 weeks.  If the goal of 
discharging 50% via SDD were met (143 of 286), there would be a potential for $211,497 dollars 
in hospital cost savings within 52 weeks at a rate of 5.5 elective PCI procedures per week. 
Interpretation of PDSA Findings & Evaluation of Project Results 
After reviewing information yielded from Plan-Do-Study-Act (PDSA) cycles completed 
during the implementation phase, various conclusions were identified.  The goal of the DNP 
project was to increase SDD percentages from the baseline of approximately 15% to 50% or 
more of the total number of elective procedures completed by March 20, 2021.  The overall goal 
of increasing the percentage of SDD to 50% was not achieved.  Following six weeks of the 
planned implementation period, there were no patients discharged via the established SDD 
protocol.  Of note, there were some SDDs completed by individual physicians; however, the 
discharges were not completed using this PI’s established SDD protocols.   
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Additionally, there were many barriers that were identified before and during 
implementation that caused deviations in developed processes and a lack of SDD protocol 
implementation.  These barriers included limited staffing in the IRB department at the clinical 
site causing a prolonged IRB waiting period; inclement weather with subsequent elective 
procedure cancellation; breakdowns in communication between administration, SDD team, and 
physicians; lack of physician engagement and buy-in; issues with access to project data; and lack 
of identification of potential SDD patients.  Notably, the most substantial barrier was physician 
engagement.  Many physicians expressed that they were unaware of the established SDD 
protocol until implementation had begun with the piloting interventional cardiologist.  This led to 
physician hesitation, limitation of SDD participants, and implementation delays.  Another barrier 
of this DNP project was the lack of access to the clinical site’s EMR.  This led to delayed data 
collection.  
Originally, the DNP project was projected to include a maximum of 1,000 SDD 
participants during the implementation phase; however, implementation delays, a shortened 
implementation period, and the lack of physician engagement severely limited DNP project 
participation.  The lack of participation and shortened implementation period negatively 
influenced the validity and reliability of DNP project results. 
When compared to the SDD program established by Chen, Lin, and Marshall (2018), this 
DNP project might have had similar results if the implementation period were the same length.  
In Chen, Lin, and Marshall’s (2018) study, 308 patients underwent PCI during the six-month 
implementation period.  Of the 308 who underwent PCI, 258 did not meet pre-procedure criteria.  
Of the remaining 50 patients, 47 met criteria and 3 did not meet criteria but were considered 
eligible by the physician.  Of the 50 patients that were determined to be eligible, only 22 were 
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sent home via SDD.  It was noted that both physician preference and individual clinical decision 
making contributed to deviations from the SDD guideline implementation (Chen, Lin, and 
Marshall, 2018).  The results of the DNP project were consistent with Chen, Lin, and Marshall’s 
(2018) findings.  
The DNP SDD protocol implementation results were not as what were originally 
expected.  The clinical site conducted a pilot study for electrophysiology (EP) procedures using 
the established SDD processes.  The pilot study was very successful as strong EP physician 
engagement and leadership was crucial in the process changes and success of EP SDD 
implementation.  It was expected that PCI SDD protocol implementation and results would be 
similar to the EP pilot study; however, poor PCI physician engagement and leadership led to the 
lack of the PCI SDD protocol implementation.  Koshy, George, and Das (2020) reviewed current 
literature regarding SDD following elective PCI and noted difficulty in changing culture, lack of 
physician buy-in, and conservative practice as barriers to implementation.  These barriers were 
consistent with the DNP project and subsequently impacted performance of the SDD protocol 
(Koshy, George, & Das, 2020). 
Evaluation of Project Results. 
The overall goal of the DNP project was to improve access to cardiovascular care at an 
inpatient facility in Pulaski County, Arkansas through the creation of a SDD protocol following 
elective PCI.  This gap in care was not improved through the implementation of the SDD 
protocol during the implementation period as implementation failed and was subsequently 
delayed at the clinical site.  The SDD percentage was higher during the 10-week data collection 
period as compared to the previous four quarters and the estimated baseline percentage; however, 
the increases were not a result of DNP project implementation.  
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Overall, the project was not very successful due to the lack of physician engagement.  To 
improve this gap in care in the future, physician engagement and buy-in must occur so that 
patients can be sent home via the SDD protocol following elective PCI.  After it was identified 
that the interventional cardiologists had not been engaged, positive adjustments were made that 
led to positive changes.  Physician buy-in substantially increased following individual meetings 
with this PI, though the cardiologists were hesitant to begin implementation immediately.  
The clinical site made negative adjustments during DNP project planning that led to poor 
project implementation.  The clinical site administration voiced and owned plans for physician 
engagement early during DNP project planning.  Unfortunately, the engagement efforts were not 
effective.  This PI was met with significant resistance and hesitation once different strategies 
were initiated to increase physician engagement during implementation.  The SDD protocol is 
still projected to become the standard of practice at the clinical site per the hospital 
administration, but physician engagement and buy-in must be achieved for implementation to be 
successful.  For future implementation of the SDD protocol, the interventional cardiologists must 
be included in decision making.  Though the project was not successful during the planned DNP 
implementation period, implementation will continue to take place at the clinical site over the 
coming months and years. 
Discussion 
 At this time, the impact of SDD protocol implementation is somewhat unknown as 
implementation has not occurred to date.  There were barriers, limitations, and bias that led to 
the delay of SDD protocol implementation that will be discussed below.  Of note, the clinical 
site still expects to implement the SDD protocol following elective PCI using this PI’s 
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protocol; however, efforts to increase physician engagement and buy-in must take place before 
implementation will begin. 
Healthcare Quality Impact 
The implementation of a SDD protocol following elective PCI was created based on 
current, evidence-based practice recommendations from the SCAI (Seto et al., 2018).  Evidence 
indicates that advances in clinical practice have made selective SDD following elective PCI a 
safe process that is associated with high patient satisfaction and no adverse effect on patient 
safety (Amin et al., 2018; Seto et al., 2018).  Regardless of discharge timing, the patient 
continues to receive high quality cardiovascular care at the clinical site.  Out of the 55 patients 
that underwent elective PCI procedures between December 27, 2020 and March 6, 2021, there 
were no documented complications or readmissions within 14 days of discharge.  Of these 55 
patients, 20 underwent SDD via non-established processes.  This data further supports the 
safety of SDD following elective PCI.  Though the established SDD protocol was not 
implemented at the clinical site, safety data and current evidence support further 
implementation efforts.   
Economic and Cost Benefits  
There are substantial economic benefits of implementing a SDD protocol following 
elective PCI for the clinical site.  As stated above, the clinical site conducted a proforma in 
January 2020 that recognized a 5.4% increase in Cath lab volume over the previous 12 months. 
The increase in case volume caused difficulties with throughput in all the cardiac areas which led 
to consistently full cardiac units.  The proforma analyzed the average cost of an atrial fibrillation 
ablation minus the procedure costs to determine the difference in hospital cost between OO and 
SDD.  It was found that the non-procedural cost difference between one night of OO and SDD 
 81 
was $1,479 per case.  The clinical site felt that the cost savings for OO vs. SDD would be the 
same following elective PCI.  During the 10-week data collection period, 20 of the 55 patients, 
or 36.36%, who underwent elective PCI were discharged home via non-established SDD 
processes.  If the clinical site had met its goal of increasing the percentage of SDD to 50% by the 
end of the data collection period, there was a potential of an additional $11,092.50 dollars in 
hospital cost savings during that period of time alone using the previous calculations.   
Within the last 4 reported quarters, October 2019 through September 2020, there were 
324 elective PCI procedures completed with an average SDD percentage of 25.3%. If the clinical 
site had met its goal of increasing the percentage of SDD from 25.3% to 50% during that time, 
there was a potential cost savings of $239,598 dollars by discharging 162 of the 324 patients via 
SDD.  It was estimated that the savings acquired with SDD PCI during the last four quarters was 
$121,236.59 which is a difference in potential savings of $118,361.41 if the goal had been met.  
Increasing the percentage of SDD following elective PCI during future implementation could 
drastically increase clinical site cost savings.  Shroff et al. (2016) estimated that discharging 50% 
of patients who undergo PCI via SDD could save the US healthcare system between $200 to 
$500 million dollars per year.   
Additionally, if SDD protocol implementation increases access to cardiovascular care 
with improved bed utilization as expected, there remains an opportunity for additional revenue 
due to previously impossible patient admissions.  The hospital hired a discharging APRN for 
approximately $110,000 dollars per year who has been discharging all eligible patients following 
elective EP procedures.  The clinical site expects that she will facilitate discharges following 
elective PCI procedures as well. The clinical site must continue to justify the discharging APRN 
position with increased revenue following SDD protocol implementation. If implementation is 
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successful and has a substantial financial impact, it is likely that the SDD protocol will become 
the standard of practice at the clinical site and within other facilities in the health organization. 
Limitations 
 There were many limitations that were identified during the DNP project 
implementation. The limitations that were identified included physician engagement, clinic 
engagement, administrative support, implementation timeline, sample size, and Cath Lab 
scheduling. These limitations likely impacted results of the DNP project. 
Factors Affecting Project Result 
As previously stated, there were a number of factors that were identified as limitations 
during DNP project implementation. The following factors listed below may have negatively 
affected the results of the DNP project. 
Physician Engagement & Buy-In. 
 As stated previously, the lack of physician engagement and buy-in was the chief barrier 
in the implementation of the SDD protocol following elective PCI. The lack of engagement 
affected project results negatively and ultimately caused the failure of implementation efforts.  
The clinical site administration voiced and owned plans for physician engagement early during 
the DNP project.  Unfortunately, the engagement efforts that were utilized were not effective.  
Though many physicians were aware of upcoming changes, not all were involved in the 
multidisciplinary team meetings in which the SDD processes and protocol were established.   
Many voiced that they were not aware of the established SDD protocol until implementation 
was set with the piloting interventional cardiologist.  
There were many efforts made to minimize this limitation.  This PI encountered 
significant resistance and hesitation from the interventionalists when various strategies were 
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utilized to increase physician engagement.  This PI created educational flyers for the physicians 
that detailed the background and significance of the problem; the current evidence regarding 
safety of SDD following elective PCI; the success of the EP SDD protocol implementation at 
the clinical site; the proposed SDD PCI protocol; and additional information regarding what 
would be required from the physician for implementation.  This flyer was emailed to the 
physicians by administration. Following delivery of the physician flyer, no further physician 
support was gained.  
The most notable efforts made to improve engagement was through individual, in-
person meetings.  This PI conducted individual, in-person meetings with almost all 
interventional cardiologists to gain support and engagement, but the efforts to begin 
implementation during the set implementation period were futile.  This PI did meet with one 
physician that was very encouraged by the efforts to implement the SDD protocol.  This 
particular physician has since spear-headed efforts for future implementation. 
This limitation must be addressed for future implementation.  Since attempted project 
implementation began with the piloting interventionalist, individual and group meetings with 
the interventionalists have taken place with ever improving group support.  It is likely that SDD 
protocol implementation will take place within the coming months at the clinical site. 
Clinic Engagement & Procedure Scheduling. 
 Clinic engagement may have limited project implementation as there were no efforts 
made by the nursing staff to begin screening patients for SDD eligibility when scheduling 
elective PCI procedures.  Efforts made to minimize this limitation included emailed staff 
education, frequent reiteration of education, and frequent contact with clinic managers via 
zoom meetings. None of the strategies that were used improved engagement. This lack of 
 84 
engagement was likely due to the lack of physician engagement.  In future implementation, the 
SDD processes must be reinforced with the clinic staff to effectively implement the SDD 
protocol.  The physicians suggested that the clinic schedulers should ask about patient 
eligibility with each elective PCI procedure that was scheduled. 
Administrative Support. 
 The lack of administrative support was a notable limitation for the DNP project. As 
stated previously, administration took ownership of important project roles that were not 
fulfilled.  This lack of communication contributed to implementation failure.  After this PI 
realized there was an apparent lack of physician engagement and buy-in, this PI and the 
director of performance excellence at the clinical site met with administration to determine an 
action plan to improve physician engagement and to minimize the limitation.  Following the 
meeting with administration, this PI began efforts to gain physician buy-in and engagement 
through individual, in-person meetings with the interventionalists. 
Implementation Timeline & Sample Size. 
 The implementation phase of the DNP project was limited to 6 weeks, December 27, 
2020 to March 20, 2021, and data collection was limited to 4 weeks, December 27, 2020 to 
March 6, 2021, due to limited access to data.  During project planning, the implementation 
period was projected to take place over a six-month period; however, this was not possible due 
to time constraints and delays.  The limited timeline inhibited true project implementation.  A 
longer implementation timeline would have allowed more time for support and implementation 
given the project’s barriers.  A lengthened timeline would have also allowed a larger sample 
size.  Statewide inclement weather during the second week of the planned implementation 
period forced elective PCI procedure cancellation and further limited the potential sample size.  
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This PI attempted to minimize this limitation through conducting individual meetings with the 
interventional cardiologists to gain support to begin implementation.  Though SDD protocol 
implementation did not take place during the established implementation period, the clinical 
site expects that implementation will begin in the coming months.  
Cath Lab Scheduling & Staffing. 
Other potential limitations were Cath lab scheduling and Cath lab staffing. According to 
the clinical site, there was one fewer Cath lab in rotation due to poor lab staffing.  The 
problems with staffing decreased the clinical site’s ability to complete as many procedures as 
expected during the established implementation period.  Though SDD protocol implementation 
failed, the lack of Cath labs could have created limitations on the number of procedures that 
could be completed and further difficulties with patient throughput.  This PI spoke with 
administration regarding this limitation. 
Factors that Limit Transferability 
The established SDD protocol was created specifically by and for the clinical site.  Due 
to the specificity of this DNP project and patient population, the SDD protocol and processes 
could not be used in other units within the facility.  After future implementation by the clinical 
site, implementation results may be utilized to initiate change in other facilities within and 
outside the hospital system.  Though similar processes could be utilized, variations must be 
considered to make the protocol successful for other facilities. 
Of note, the discharging APRN was a huge asset in the implementation of SDD of EP 
procedures and will be vital in continued SDD PCI efforts.  Other facilities may or may not 
have the Cath lab volume to support a similar position.  If the facility is not able to support the 
position, the SDD protocol would require additional process changes. 
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Factors that Affected Internal Validity 
Despite the failure of SDD protocol implementation, there were factors identified that 
either affected or will affect internal validity in future implementation. These include patient 
and physician bias. 
 Patient Bias. 
 There was a potential for bias of the patient concerning their opinion and preference 
regarding SDD following the elective PCI procedure.  When the SDD protocol is implemented, 
patient preference will affect who is discharged home via SDD verses OO and thus will affect 
the results of implementation.  The clinical site must take all necessary precautions to minimize 
patient bias. 
 Physician Bias. 
 Another potential bias identified was physician bias.  This bias affected project results 
tremendously as the apprehension, lack of engagement, and lack of buy-in caused project 
implementation failure.  Efforts must be made to relieve apprehension and improve physician 
engagement to decrease the potential for physician bias and during future implementation. 
Sustainability 
 At this time, the usefulness of the SDD protocol following elective PCI is unknown.  
With the success of the EP SDD protocol, the clinical site is encouraged that implementation of 
the PCI SDD protocol will also be successful.  The clinical site has made a commitment to 
implement the SDD protocol following elective PCI within the coming months.  The facility 
has a vested interest in the success of this project due to its potential of increasing access to 
cardiovascular care, cost savings, and patient satisfaction.  The facility will continue efforts to 
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 This PI would recommend that the clinical site continue SDD protocol implementation 
efforts as it has the potential for substantial impact on access to care, patient satisfaction, and 
hospital cost savings.  In future efforts, both administration and physician engagement and buy-
in will continue to be key factors for project success.  As implementation begins, it will be 
important that the discharging APRN owns implementation and continually refines the process 
as is necessary.  It will also be important that administration shows greater support to the 
discharging APRN. 
Practice Implications 
Implementation of the SDD protocol has the potential to spur necessary practice 
changes.  After the SDD protocol is implemented, it is likely that it will become the standard of 
practice for the clinical site and will be implemented in other facilities within the health 
organization.  Though the SDD protocol was not utilized, there were patients that were sent 
home via other SDD methods as opposed to OO.  Of the patients that discharged via SDD 
methods, none had complications or readmissions within 14 days of discharge.  This further 
supports the safety of SDD following elective PCI.  Healthcare quality and safety will be 





 There are no current national, state, or site healthcare policies associated with this 
project.  The effects on state or national policies are unclear at this time; however, there have 
been efforts from the clinical site’s national system to move towards SDD following elective 
PCI.  The clinical site voiced that they intend to continue implementation efforts with the 
potential of creating a SDD policy and expanding to other facilities within the state if 
implementation is successful.  After further implementation, data analysis will take place to 
determine if the evidence supports the site’s goals of practice and if the protocol should become 
the standard of practice with expansion into other facilities. 
Dissemination 
Site and DNP Committee Reporting 
This PI will disseminate the baseline data to the multidisciplinary team and key 
stakeholders during a SDD meeting in April 2021 via video conference.  Based on previous 
attendance success, video conference methods will be used as they consistently had higher 
attendance.  Though implementation did not take place as planned, this PI will discuss the 
baseline data and specific strategies that can be used to improve implementation in the future.  
The clinical site has expressed that they would like this PI to remain part of the 
multidisciplinary team for future implementation of the SDD protocol. 
 This PI will also present the project results and baseline data to the doctoral committee 
at the University of Arkansas Eleanor Mann School of Nursing on April 14, 2021 at 1300 





At this time, the DNP project results will not be professionally reported as 
implementation did not take place; however, this PI will consider publication after 
implementation takes place if desired by the clinical site.  The clinical site has expressed some 
interest in publication after further implementation.  If implementation is successful, it is likely 
that results will be utilized to initiate change in other facilities within the organization.  This PI 
would be glad to assist in the presentation of the SDD protocol result and discuss SDD 
processes at other facilities as desired by the clinical site. 
The nursing journals that have been considered for future publication include the 
Journal of Nursing Care Quality and the Journal of Cardiovascular Nursing. This PI would 
also consider submitting an abstract for poster presentation at either a Sigma Theta Tau or an 
American Association of Nurse Practitioners conference during 2022. 
Conclusion 
 Cardiovascular disease remains the leading cause of death worldwide with significant 
disease prevalence throughout the United States.  There is an ever-increasing shortage of 
cardiovascular bed availability that leads to decreased access to cardiovascular care.  The 
clinical site completed a proforma in January 2020 that noted an increase in Cath lab volume of 
5.4% in the previous 12 months that was causing difficulties in throughput in cardiac areas and 
shortages of bed availability in the cardiac units. 
 A multidisciplinary team created and attempted to implement a SDD protocol following 
elective PCI to combat the lack of cardiac bed availability as evidence supports the safety of 
implementation with associated improvements in access to cardiovascular care, hospital 
savings, and patient satisfaction.  The SDD protocol that was created incorporated all current 
evidence regarding SDD following elective PCI. Strengths of the DNP project included the 
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incorporation of a discharging APRN, hotel accommodations for patients who live greater than 
60 miles away from the hospital, and the in-house “meds to bed” program to deliver all new 
medications prior to discharge.  Unfortunately, implementation was delayed by the clinical site 
due to a lack of physician engagement and buy-in.  The SDD protocol has not been 
implemented at this time. 
Overall, the project was not successful during the planned implementation period. 
Though implementation was not successful, data from December 27, 2020 through March 6, 
2021 was analyzed to serve as baseline data for future implementation at the clinical site.  It 
was found that baseline SDD rates were higher than previously estimated as physicians were 
utilizing SDD on occasion via non-established processes.  During the 10-week data collection 
period, it was found that 36.36% of patients were discharged via other SDD methods.  The 
clinical site’s goal was to increase the percentage of patients that underwent SDD following 
elective PCI from 15% to 50% by March 31, 2021. Though improvements were made in the 
percentage of SDD, there remains a substantial potential to increase SDD percentages. 
Currently, the project’s contribution to nursing practice knowledge and further 
implications are unknown as implementation has not taken place.  Further research in this area 
is needed to provide the Central Arkansas community with greater access to cardiovascular 
care.  This SDD protocol should be implemented at the clinical site in the near future to 
continue to improve access to cardiovascular care.  Following successful implementation, it is 
likely that the PCI SDD protocol will become the standard of care within the facility and will 
be implemented in other facilities within the health organization.  Additional research 
conducted should include evaluation of the patients’ perceived feelings, patients’ satisfaction, 
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5 RCT and 8 







for randomized trials 
and Cochrane 
Collaboration and 
MOOSE group for 
observations studies. 
 
Sample sough to find 
reports of studies 






Key terms: same day, 
same day discharge, 
outpatient, day case, 
day care, short stay 
AND PCI, PTCA, 
angioplasty, and 
coronary angioplasty.   
 
No language 
restrictions.   
 
Data extracted include 
study design, sample size, 
population demographics, 
coronary angiographic 
characteristics, access site 
for PCI, procedural 
adjuvant pharmacotherapy, 
procedural success rates, 
outcome, ad follow-up data. 
 
Absolute # of events for 
each outcome was extracted 
for SDD and OO groups 
and entered into statistical 
software. 
 
DerSimonian and Laird 
random effects model with 
weights calculated using 
the Mantel-Haenszel 
method to acute for 
differences in studies to 
account for study variation. 
 
Dichotomous outcomes 
data measured and reported 
as odds ratio (OR) with 




studies examined with 
Cochran’s Q statistic and I2 
statistic test, with I2 value 
<25% considered low 
heterogeneity, 25% to 50% 
Systematic review and comprehensive 
meta-analysis completed on all available 
data comparing SDD after PCI with OO to 
evaluate impact on clinical outcomes. 
 
12 of 13 studies was single center (n=4,182) 
patients and 1 was a multi-center 
observation al study (n=107,018).   
 
Location: 3 in US, 3 in Canada, 5 in 
Europe, and 2 in Asia. 
 
Involved a total of 111,830 patients (2039 
in randomized trials and 109,791 in 
observational studies with 4,179 (3.7%) in 
SDD and 107,651 (96.3%) in OO group. 
 
Mean age = 62+/- 4.9 years. 
 
64% men, 32% DM, 82% HTN, 79% 
dyslipidemia, 39% prior PCI, 23% prior 
CABG. 
 
Found that utilization of TRA is lower in 
US than other countries.  In 12 studies 
conducted outside of US, TRA usage was 
45%, but with the large US observational 
study, TRA was only used in 3%. 
 
Of the 2,039 patients in randomized trials, 
1023 were in the SDD group and 1016 to 
OO group.  Of the 1023 assigned to SDD, 
851 were successfully discharged home, 
and 172 developed an indication for OO 
and crossed into OO.  Reasons included 









controlled trials & 
observational studies 
comparing SDD and 
OO following PCI, 
clinical and outcome 
data for up to 30 days 
following index PCI 
procedure available 








studies reporting only 




outcome data on 




chronology of events 
but patients kept for 
OO, studies with 
mixed outcome data 
between diagnostic 
and interventional 
procedures or missed 
outcome data for 
both SDD and OO, 
with no ability to 
separate. 
moderate, and value >50% 
was considered substantial 
heterogeneity. 
 
Funnel plots were 
constructed and inspected 
visually for evidence of 
publication bias.   
 
Sensitivity analysis was 
performed according to 
study design (randomized 
and observational) and 
population size to 
determine the effect of the 
largest study on the 
outcome and meta-analysis.   
 
 
few were a result of social reasons or 
refusal after randomization. 
 
After length of stay after PCI in SDD group 
ranged from 4 to 11 hours  with >77% sent 
home between 4 and 8 hours. 
 
Selection criteria for SDD varied between 
studies, with the majority agreeing on the 
following criteria: elective PCI for stable or 
unstable angina, low to moderate risk ACS, 
successful, uncomplicated PCI, stable 
clinical condition post-PCI, and patient 
willingness to go home with the ability to 
reach emergency care within 40 to 60 
minutes, and adequate social support. 
 
In the randomized groups, total # of 
complications in SDD group was 67 of 
1023 (6.5%) versus 56 of 1016 (5.5%) in 
OO (OR: 1.20, 95%CI: 0.82 to 1.74). 
 
Total # of complications reported in SDD 
group in observational study was 148 of 
3,156 (4.7%) versus 10,272 of 106,629 
(9.6%) for OO (OR: 0.67, 95% CI: 0.27 to 
1.66). 
 
Incidence of rehospitalization within 30 
days after PCI between SDD and OO 
groups in randomized trials was 41 of 1023 
(4.0%) versus 37 of 1016 (3.6%). (OR: 
1.10, 95% CI: 0.70 to 1.74). 
  
Incidence of rehospitalization within 30 
days after PCI between SDD and OO 
groups in observational studies 131 of 1,645 
(8.0%) versus 10,147 of 105,827 (9.6%).  














N/A Literature search of 
CINAHL, Medline, 
PubMed, Clinical Key, and 
Turning Research into 
practice using OVID.   
 
Recent literature focuses on the safety and 
comfort of SDD via transradial approach 
(TR-PCI). 
 
It has been established that there are fewer 







discussion SDD PCI.   
 
Articles published between 
2007 and 2015 were 
included, as this include the 
recent nature of the practice 
and evidence of SDD PCI. 
 
Primary search terms 
include:  
SDD TR PCI, cardiac 
intervention, PCI, discharge 
plan, radial PCI, radial 
approach complications, 
anxiety post PCI, and 
anxiety after cardiac 
interventions. 
 
Primary assessment of each 
article based on title, 
abstract, year of 
publication, and conclusion 
in relation to safety and 
comfort of SDD TR-PCI. 
 
Exclusion criteria: articles 
exclusive to the discharge 
process post PCI, unstable 




recommendations from the 
British Cardiovascular 
Intervention Society (BCIS) 
and Cardiac Society of 
Australia & New Zealand 
(CSANZ).   
 
PCI as compared to Transfemoral PCI (TF-
PCI). 
 
Increased safety of TR-PCI is r/t to clinical 
advances such as drug eluting stents, 
reliable instantaneous pressure devices, and 
early mobilization—all of which are said to 
increase patient satisfaction and aid in SDD. 
 
First report of successful SDD was 
published as early as 1997. The patient 
experienced no adverse cardiac or bleeding 
complications within first 24 hours after 
PCI. 
 
Many studies conducted to examine the 
efficacy and safety of SDD TR-PCI 
demonstrate primary end points of MACE 
or bleeding within 24 hours and 30 days 
after discharge.   
 
Most important clinical question regarding 
SDD TR-PCI is its concern for safety 
versus OO. 
 
Abdelaal et al.  (2013) found that SDD had 
a similar risk-profile as OO.  They found 
similar rates of MACE, readmission, and 
overall complications between SDD and 
OS. 
 
Brayton et al. (2013) collected data from 
14,032 patients who underwent TR and TF 
PCI of which 10,065 dc’d via SDD.  They 
found SDD PCI safe in patients carefully 
screened. 
 
Saad et al.(2015) looked at outcomes of 
elective PCI with SDD TR and TF versus 
OO. This study examined next day troponin 
levelsà did not appear to have short or 




Singh et al.  (2015) recruited 56 patients in 
SDD elective PCI TR group and compared 
with OO group.  The patients were followed 
at 24 hours, 30 days, and 6 months post 
procedure.  No MACE occurred in the SDD 
TR population. 
 
Alyasin (2016) states that for practice 
changes to occur, evidence based practice 
(EBP) guidelines/recommendations on 
screening must be present.   
 
It is noted that in 2009, the American 
College of Cardiology with SCAI 
recommended SDD after PCI (TR or TF 
approach) in elective, stable patients who 
undergo uncomplicated, single vessel PCI 
with no comorbidities. 
 
Hodkinson et al.  (2013) found both elective 
and selective acute patients can be 
discharged safely via SDD.  Found no 
association between death and 
rehospitalization in SDD PCI patients. 
 
The CathPCI Registry data shows SDD is 
safe with nearly equivalent rates of death 
and hospitalization at 2 and 30 days 
compared with OS patients. 
 
Alyasin (2016) demonstrates a table that 
shows examples of SDD PCI 
inclusion/exclusion criteria.   
 
Mavromatis (2013) suggests 10-20% of all 
patients who meet criteria for SDD might 
need to stay for OO. 
 
Bertrand et al.  (2008) EASY study found 
patients with acute coronary syndrome may 
benefit from OO due to risk of bleeding 




Valle et al. (2015) studied the impact of 
patient distance from PCI facility with no 
found association between increasing 
distance and adverse outcomes (including 
readmission and mortality at 30 days and 1 
year after SDD PCI). 
 
Important items that need to be addressed 
for safe SDD include observation time, 
social support, discharge lounge, and 
patient’s ability to handle stress and anxiety 
of early discharge. 
 
Alyasin (2016) notes recommended 
observation time should be 4 to 8 hours in 
patients without complications.  Previous 
literature demonstrated virtually no 
complications between 6 and 24 hours post 
PCI, leading to no benefit of observation 
after 6 hours. 
 
Patient must have access to social support 
and quick follow up after SDD.  Patients 
should be with responsible adult for at least 
first 24 hours after DC and should be 
educated on management of possible 
complications/bleeding and urgent follow 
up. 
 
Discharge lounges that include a 
multidisciplinary team can ensure 
successful SDD program. 
 
Current practice in UK and Australia: SDD 
via TR-PCI in uncomplicated cases with 4+ 
hours of observation.  Patients to receive 
written instructions including possible 
complications prior to discharge.  Patients 
should be functionally independent or have 
adequate home support following DC. 





























230 underwent SDD 
during intervention 
period. 
Researches utilized the 
National Cardiovascular 
Data Registry’s (NCDR) 
CathPCI risk assessment 
tools to identify each 
Risk were reviewed by interventional 
cardiologist in preoperative holding to 
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patient’s risk of bleeding, 
mortality, and acute kidney 
injury (AKI) preoperatively 
and developed a method for 
estimating safe contrast 
limits. 
 
The ePRISM clinical 
decision aid was developed 
to assess each patient’s risk 
before PCI.  Risks were 
reviewed by interventional 
cardiologist in preoperative 
holding to determine 
bleeding avoidance 
strategies and contrast 
limits. 
 
Following the procedure, 
the patient was called 
within 2 days to discuss 
patient status, medication 
compliance, access site 
issues, and patient 
satisfaction using an 11 
item questionnaire. 
 
3.5 years of control data 
obtained—uncertain if from 
EHR of NCDR  
CathPCI registry data.   
 
2 years of post-
implementation data was 
analyzed—uncertain of 
where data obtained from. 
 
SDD criteria recommended 
from SCAI expert 
consensus model was 
compared to their “patient 
centered” SDD population 
to determine the proportion 
of patients not meeting 
SCAI criteria for SDD.  
Procedural success was analyzed based on 
risk reduction and stability following the 
procedure.  If all agreed (nurse, MD, 
patient, and family) the patient completed 
SDD.   
 
SDD increased from 0% before the 
intervention to 14% in the first quarter, to 
nearly 78% in the last quarter regardless of 
transradial access.   
 
The association of SDD with outcomes of 
bleeding, AKI, and mortality was examined 
using fisher exact test. 
 
Association of cost of SDD was examined 
with propensity score analyses and 
propensity adjust. 
 
Adjusted cost associated with SDD 
estimated with total costs as dependent 
variable and SDD and quintiles of 
propensity score as covariates in linear 
regression model. 
 
In femoral access cases, SDD increased 
from approximately 1% in the third quarter 
to 69.23% in the third quarter of 2009 (pre-
intervention) to 69.23% in the third quarter 
of 2015. 
 
Characteristics of patients with SDD and 
those with OO were comparable. 
SDD discharge was not associated with 
adverse outcomes with 0% of patients 
experiencing bleeding and mortality, and 
only 0.4% of patients experiencing AKI.  
While OO reported events of death, 
bleeding, transfusion, and AKI events. 
 
Compared the OO group, the mean total 
cost of PCI for SDD was 6,710, or a cost 
saving in 39.15%, 
 
 110 
The adjusted per-patient cost difference 
between SDD and OO groups was $7331. 
 
It was estimated that if SDD rates stayed 
approximately 75% with an average of 250 
elective PCIs per year, the total annual cost 
savings would be approximately 1.8 million 
dollars. 
 
When compared to SCAI experts’ 
recommendations for SDD, it was found 
that 1628 or 92.9% of the patients were not 
eligible, leaving only 16 patients eligible for 
SDD.  Utilizing the novel “patient-
centered” approach allowed for an 
additional 214 patients to utilize SDD with 
no adverse outcomes.   
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Patient data collected 
from third quarter of 
2009 through third 
quarter of 2012.   
 
Created national 
dataset in which they 
linked Medicare 





provider ID number, 
date of birth, sex, and 
admission dates. 
 
749,366 of 831,357 
CMS 
claims/procedures 
were matched to 
CathPCI Registry. 
 
Of the 749,366 the 
following were 
Data collected from third 
quarter of 2009 through 
third quarter of 2012.   
 
Key data elements included 
access site, estimation of 
costs, and clinical 
outcomes.  If more than one 
access site used, the PCI 
was classified with access 
used for majority of the 
PCI. 
 
Used hospital-level, cost 
center-specific cost-to-
charge ratios to estimate 
cost associated with PCI 
care.  Cost was estimated 
using data from RIF using 
revenue codes as reported 
to Medicare.  When 
hospital revenue codes 
were mapped to specific 
cost centers, Cost to charge 
ratios were used to estimate 
costs.  When codes could 
not be mapped to cost 
Of 279,987, TRA performed in 25,301 and 
SDD occurred in 14,812 (5.3%) 
 
TRA and SDD occurred in 3,424(1.2%) & 
TFA and SDD occurred in 11,388 (4.1%). 
 
TRA and OO occurred in 21,877 (7.8%) 
and TFA and OO was the most common 
post-PCI pathway occurring in 243,298 
(86.9%). 
 
Demographics: Average age 71.8.  178,703 
males & 101,284 females.  White race 
253,126 (90.4% of cases).  See article for 
additional demographics. 
 
TRA and SDD occurred in younger men, 
with lower prevalence of cardiovascular risk 
factors and comorbidities.  Fluro times were 
higher in TRA, while contrast volume was 
lower. 
 
Hospital costs:  
1) Adjusted PCI costs of TRA vs TFA was 
$916, favoring TRA. 
2) Adjusted PCI costs of SDD vs OO was 
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clearly indicated for 





shock and cardiac 
arrest within 24 
hours, patients who 
died in hospital 
within 24 hours of 
PCI, and those with 
missing variables 
(cost, etc.).   
 
All Medicare fee for 
service beneficiaries 
undergoing PCI 
between July 1, 2009 
and December 31, 
2012. 
 
All inpatient and 
outpatient procedures 




using CMS RIF file 
with codes 00.66, 
36.06, and 36.07 & 
Outpatient identified 
using CMS 
Outpatient RIF and 
corresponding CPT 
codes of 92982, 
92980, 92981, 92984, 
G0290, and G0291.   
 
No consent needed 
from IRB. 
centers, the overall hospital 
cost-to-charge ratio was 
used to estimate costs.  
After cost-to-charge ratio 
determined, charges for an 
episode of care for each 
cost center was multiplied 
by cost-to-charge ratio.  
Costs were inflated to 2014 
dollars using medical 
consumer price index.  
Outliers were Winsorized 
by trimming the 99th 
percentile. 
 
Secondary outcomes= post 
PCI bleeding, vascular 
complications, blood 
transfusions, and length of 
stay. 
 
Developed 3 propensity 
score models: 
1) logistic regression model 
to predict use of TRA vs 
TFA 
2) logistic regression model 
to predict SDD vs.  OO 
3) multinomial logistic 
regression model to obtain 
predicted probabilities of 
TRA SDD, TRF SDD, and 
TRA OO with TRF OO as 
the comparator for all. 
 
Patient level variable for all 
3 propensity score models 
included: age, sex, race, 
smoking status, diabetes, 
hypertension, dyslipidemia, 
fam hx of CAD, prior MI, 
CABG, current dialysis, 
prior CVA, prior PVD , 
chronic lung disease, PCI 
indication, procedure status, 
3) Adjust PCI costs by various pathways—
see table.  TRA SDD was associated with 
cost savings when compared to all other 
pathways.  The most substantial difference 
in adjust cost was between TRA SDD (least 
frequent pathway) vs.  TFA OO (most 
common pathway) which results in $3,689 




Bleeding occurred in 2.8% of patientsà 
1.4% in TRA and 3.0% TFA (p <0.001).   
Rates of transfusion and vascular 
complications were significantly lower in 
TRA group as compared with TFA. 
Length of stay as 2.2 +/- 4.4days in TRA 
group compared to 2.4 +/- 3.5 days in TFA 
group.  A difference of 0.2 days favoring 
TRA.   
 
Budget impact analysis: 
For a hospital performing 1,000 elective 
PCI/year, impact of converting TFA OO to 
TRA SDD was examined.  If the hospital 
only sent 30% TRA SDD, potential cost 
savings of $1million annually. 
Nationwide, if 600,000 PCI procedure 
performed with 50% being elective 
procedures eligible for SDD, if 30% were 
converted to TRA SDD, potential savings 






severity of angina, current 
HF within 2 weeks, LV 
dysfunction, perioperative 
evaluation, prior cardiac 
arrest, # of diseased vessels, 
probability of bleeding 
according to NCDR 
mortality risk model, 
probability of restenosis 
according to NCDR target 
vessel revascularization risk 
prediction model, hospital 
type, and regional census 
divisions. 
 
Anticoagulation agents and 
LOS not included in 
propensity model as they 
were directly related to 
access site and casual 
pathway of costs. 
 
The following models yield 
adjusted costs of TRI vs.  
TRF and SDD vs OO:  
1) To estimate independent 
cost of access siteà 
generalized linear cost 
model using  inverse 
probability weighting 
(IPW), with total hospital 
cost as dependent variable 
and TRA as independent 
variable. 
2) Independent costs of 
SDD vs OO were estimated 
via a generalized linear cost 
model developed using 
IPW, with total hospital 
cost as dependent variable 
and SDD as independent 
variable. 
 
Individual weights were 
stabilized in IPW models to 
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account for effect of 
extreme weights in model. 
 
A generalized linear cost 
model estimated 
independent costs of 
various combinations of 
PCI care pathways.  Total 
hospital cost was dependent 
variable and various 
pathways was independent 
variable. 
 
Adjusted differences of 
secondary outcomes 
estimated using IPW 
generalized linear 
regression model for LOS 
and IPW logistic regression 
model for bleeding.   
 
Budget impact analysis 
utilized mean costs of care 
pathways to estimate 
impact of converting TFA 
OO to TRA SDD, TRA 
OO, and TFA SDD for a 
hypothetical hospital 
performing 1,000 elective 
PCI procedures annually 
and for the country 
performing 600,000 PCI 
procedure annually. 
 
SAS used with statistical 
significance for all tests 
defined as p < 0.05.   
Brayton, K.  
M., Patel, 
V.  G., 
Stave, C., 
de Lemos, 
J.  A, & 
Kumbhani, 



















Search number yield 
through database 
search=760.  695 
remained after non-
English articles 
removed.  After 
exclusion criteria, 84 
full text articles were 
Data collected via 
comprehensive lit. search 
using PubMed, SCOPUS, 
and the Cochrane Library in 
August of 2012. 
 
Key word searches of 
American Heart 
Transradial access site of 60.8% in RCTs 
and transfemoral access site of 70.0% in 
observational studies. 
 
Of the 7 RCTs (n=2,738), the mean follow-










eligible.  Following 
further assessment, 




N=12,803 patients in 
37 studies 
 
7 RCTs (n=2,738) 





with no identified 
years of retrieval. 
 
Studies published in 
English were 
included if they 
reported outcomes in 
patients successfully 
discharged home 
same day as PCI.   
 
Excluded studies: 
those that did not 
follow up at >or= to 
24 hours, transferred 
patients sent back to 
referring hospitals, 






study selection, and 
analysis adhered to 
QUORUM 
guidelines for meta-
analysis.   
 
Association (AHA), 
American College of 
Cardiology (ACC), and 
google scholar were also 
included. 
 
Data extracted by two 
reviewers.   
 
Extracted data included: 
total # of patients, # eligible 
for SDD, # actually 
discharged, and criteria for 
deferring discharge among 




diagnosis, age, sex, past 




Of the 30 observational studies (n=10,065), 
the mean follow-up time was 19.9 days.   
 
RCTs: 
Among randomized SDDs, 87.3% were 
successfully discharged via SDD post PCI. 
Nearly 1/2 of the cases of deferral of SDD 
occurred in one trial due to randomization 
before procedure.  Additional cause for 
deferral occurred due to access site 
complications, MD/patient preference, 
recurrent chest pain, noncardiac reasons, 
orthostasis, and arrhythmias. 
 
No difference was found between SDD and 
OO in primary endpoints (death/MI/TLR) 
(7.17% vs.  6.07%; OR: 0.90; 95% CI: 0.43 
to 1.87; p=0.78) or major bleeding/vascular 
complications (1.88% vs.  1.29%; OR: 1.69; 
95% CI: 0.84 to 3.40; p=0.15) in RCTs. 
 
For RCTs, data was combined to estimate 
pooled odds ratios (OR) and 95% CI for 
SDD compared to control. 
 
Observational Studies:  
14,032 patients were described as eligible 
for SDD, but 10,065 (71.7%) discharged 
home on same day.   
 
In observational studies, cumulative rate of 
each outcome for SDD was obtained from 
pooled analysis.   
 
Statistical analysis performed using STATA 
 
The primary composite endpoint of 
death/MI/TLR occurred at a pooled rate of 
1.00% (95% CI: 0.58 to 1.68), and major 
bleeding/vascular complications occurred at 
pooled rate of 0.68% (95% CI: 0.35 to 
1.32).  There were 15 reported deaths in 
SDD group, 11 of which occurred >24 
hours procedure and the remaining 4 were 
unclear regarding timing. 
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Search terms not 
listed within article 
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Review of Literature 
with no explicit 
sample size listed. 
The guidelines were 
developed by an expert 
consensus group from the 
Society for Cardiovascular 
Angiography and 
Intervention (SCAI).  The 
experts reviewed various 
RCTs, observational 
studies, systemic reviews, 
and meta-analyses to 
formulate recommendations 
in 2009.  They were 
developed using collective 
experiences reported in 
other countries and 
practical working 
knowledge of patterns and 
practice in the US.  These 
guidelines have since been 
updated. 
Before OO was used, patients often stayed 
at least 2 days in the hospital after 
uncomplicated PCI.  Patients remained on 
bedrest for 12-24 hours after sheath 
removal, which was frequently deferred 
until the morning following the PCI 
procedure. 
 
The current standard of care for a patient for 
uncomplicated elective PCI was an OOà 
which was a substantial decrease in 
observation time from previous.  Patients 
stayed for OO d/t concerns for abrupt vessel 
closure and resulting complications, access 
site complications, and management of 
comorbidities. 
 
The article defines various lengths of stay.  
Outpatient is defined as a same-day 
procedure.  The patient undergoes PCI and 
returns home or to a non-patient facility the 
same working day.  Observation is 
considered <24 hours.  For PCI, the patient 
stays for OO and then discharged <24 hours 
after procedure is completed. 
 
Facility requirements: 
Suggests having a unit committed for caring 
for only short-stay patients.  Suggests QI 
involvement in all aspects of care including 
complications, sentinel events, and patient 
satisfaction.  Recommends importance of 
education—reinforces that SDD should not 
compromise education processes. 
 
The article defines several factors that 
increase the risk of PCI: older age, 
decreased renal function (eGFR <60 
ml/min, reduced LV EF <30%, female 
gender, DM, HF (NYHA Class III or 
VII 
 116 
greater), more complex lesions, and a 
thrombus containing lesion.  These were 
found in multiple studies to increase risk of 
in-hospital mortality and adverse effects. 
 
Cautions about complications that may 
occur.  In-lab complications would be noted 
immediately and would prolong 
hospitalization.  The article cautions against 
complications like contrast-induced 
nephropathy and worsening CHF that 
would not develop immediately. 
 
It would be advised to use validated scoring 
models to assess “at risk” patients with for 
in-hospital mortality, and MACE after PCI. 
 
At the time of publication, there were 3 
randomized studies comprising <2000 
patients in which early discharge was 
compared to OOà all 3 employed 
screening criteria that excluded patients due 
to clinical, procedural, or social factors that 
would preclude SDD. 
 
It’s important to note that it was found in 
Jabara et al.   study that all complications 
occurred within 6 hours, with none 
occurring between 6 and 24 hours post-PCI 
(n=45). 
 
SCAIs statement supports the use of patient 
criteria to rule out patients that should not 
be sent home via SDD.  The 
recommendations suggest to include routine 
follow up and patient education. 
 
SCAI suggests specific protocols need to be 
developed based on individual practice 
patterns that extend beyond the definition of 
level of care alone. 
 
Recommendations for SDD Criteria: 
- Presentation with stable angina with no 
elevation in cardiac markers 
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-Asymptomatic with abnormal stress testing 
-No significant comorbidities including 
heart failure, significant or symptomatic 
chronic obstructive pulmonary disease, 
symptomatic peripheral vascular disease, 
known bleeding diathesis or coagulopathy, 
other significant organ system disease, or 
history of contrast allergy 
-Normal renal function with estimated 
glomerular filtration rate (eGFR) greater 
than or equal to 60ml/min 
-Normal or near normal left ventricular 
ejection fraction with no valvular 
regurgitation 
-Full load with a thienopyridine and no 
glycoprotein IIb/IIIa inhibitor used 
-Single vessel PCI with <28 millimeter 
stent, no balloon angioplasty alone, or other 
interventional devices used 
-Successful, uncomplicated procedure with 
no occurrence of: “no reflow,” acute vessel 
closure during procedure, vessel dissection, 
compromised side branch flow.   
-Immediate post procedure access site 
stabilization with the use of a closure device 
or secure manual compression, or via TRA 
or brachial artery cut down. 
-Patient and family willingness to discharge 
via SDD, appropriate home support, and 
rapid access to PCI facility and emergency 
services should complications occur 
 
Reports low incidences of TRA at 1.3% of 
PCI procedures from NCDR.   
 
Expert panel found it appropriate to re-
evaluate the level of care and LOS for 
patients undergoing PCI as a cost reduction 
strategyà identified four categories of care 
following PCI with definitions, inclusion, 
and exclusion criteria. 
 
States the biggest concern is to develop a 
system that does not cause harm or adverse 
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consequences to the patient due to 
premature discharge. 
  
State that recommendations may change as 
evidence surfaces. 
 
The recommendations state that if a patient 
can be managed as an outpatient, they 
should be paid APC-level reimbursement. 
 
Chen, Y., 





















































in 1000 patients. 
 
Of the 1000, 342 
PCIs were performed 




angiography with or 
without PCI between 
June 2016 and 
December 2016 were 






Process evaluation to help 
understand what 
contributed to the 
outcomes. 
 
6 month implementation 
period 
 
Lead author noted on-site 
observations assessing 
eligibility for SDD of all 
patients undergoing PCI.  
The number of patients 
undergoing PCI was 
documented with eligibility 
for SDD before, during, and 
after procedure.   
 
Staff adherence to guideline 
for SDD patients was 




made, seen by a cardiac 
rehab nurse and pharmacist, 
discharge information given 
to patient, complete 
discharge paperwork being 
provided to patient, EMR 
record entry made by senior 
medical officer, and next 
day phone follow up 
conductedà All variations 
SDD guideline was developed by nursing 
and medical leaders at the facility and 
implemented by the nursing management 
team. 
 
Established process:  
Eligibility for SDD assessed at 3 points: 
Before, during, & after PCI. 
The criteria guided the clinicians’ decision 
about safe discharge following PCI. 
Before: all patient assessed in outpatient 
setting before procedure. 
During: cardiologist would confirm the 
procedure was successful and performed via 
TRA as per the SDD guideline.   
After: patients were observed for 4 hours in 
short stay unit and sent home if no 
complications arose during observation 
period. 
 
Modifications to inclusion criteria were 
made 4 months after implementation 
beganà included patients >80 if 
appropriate on Fridays if senior medical 
officer was conducting follow up calls the 
next day. 
 
Of the 1000, 342 PCIs were performed on 
308 patients.  Among the 308, 12 patients 
were admitted twice and had 1 PCI on each 
admission; 22 had 2 PCIs during same 
admission. 
 
Of 308 who underwent PCI, 258 were 
ineligible prior to procedure.  Of the 50 
III 
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from procedure was 
recorded. 
 
Phone surveys were used to 
evaluate patient and relative 
satisfaction with SDD.  
Patients & relatives were 
called within 24 hours of 
discharge to ask about 
satisfaction with SDD 
process—surveys can be 
found online 
 
SDD compliance and 




remaining, 47 met eligibility criteria and 3 
did not meet criteria but were considered 
eligible. 
 
Of the 50 patients, only 22 patients were 
sent home same day.  The remaining 298 
were initially deemed eligible for SDD, but 
were admitted for OO. 
 
2 patients were discharged via SDD that did 
not meet renal requirements. 
 
Adherence to guidelines found that the 
highest rate of compliance=EKG attended 
to, follow up appoints with cardiologists 
made, and seen by cardiac rehab nurse and 
pharmacist before SDD.  Areas of poor 
compliance=discharge preparation and 
next-day follow up calls.  Adherence was 
variable over the 6 months evaluation 
period from 62.5% to 100%.  It is not clear 
what actual compliance percentages were 
and in what areas. 
 
It is noted that physician preference and 
individual clinical decision making 
contributed to variations on SDD guideline 
implementation. 
 
44/50 consented to completing satisfaction 
survey.  All were surveyed regardless of 
whether they remained eligible for SDD.  5 
patients were not able to be reached by 
phone. 29 relatives consented to study with 
27 completing the survey (16 SDD relatives 
and 11 OO).   
 
There are no recorded results in the study 
regarding satisfaction.  It is stated that 
surveys were taken, but results were not 
available in the article. 
Din, J.  N., 
Snow, T.  


















with questions that covered 
interventional cardiologists’ 
current practice of LOS 
Chi-square test for comparison of 
proportions from independent samples used 
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Total of 505 
respondents:  
52% within US 
17% within Canada 
15% within UK 
16% elsewhere 
 
62% were SCAI 
members. 
following elective PCI & 
factors that influence LOS 
decision. Factors included 
patient, procedure, 
anatomic, complication, 
and social factors based on 
2009 SCAI consensus 
document.  
  
They used SCAIs 
definitions of outpatients 
(same day procedure), 
observation (<24 hours), 
and extended observation 
(>/= 24 hours), & inpatient 
admission (< or >24 hours) 
to describe LOS in the 
survey. 
 
Survey sent to 
interventional cardiologists 
in US via SCAI, to 
interventional cardiologists 
in Canada via CAIC, and 
the UK via BCS/BCIS 
 
It was also available on 
AHA’s “the heart” website. 
Measures of concordance used were kappa 
statistic and percent agreement. 
 
Statistical analysis performed using 
MedCalc software & Kruskal-Wallis test 
utilized GraphPad Prism.   
 
Total of 505 interventional cardiologist 
respondents:  
52% practicing in US 
17% within Canada 
15% within UK 
16% elsewhere 
 
62% were SCAI members 
 
Response rates from major PCI societies 
polls were SCAI 12%, BCIS 11%, CAIC 
44% 
 
Reported length of stay:  
24% practice outpatient PCI, 70% practice 
OO, and 6% practices extended obs or 
inpatient admission; however, there was a 
large geographic variationà SDD practices 
by 14% of US cardiologists and 32% of 
Canadian cardiologists (P=0.003) and 57% 
from UK (P<0.0001). 
 
Concordance with Guideline Criteria: 
59% were not aware of any guidance or 
statement defining LOS, though US 
cardiologists were more aware (49% vs 
32%, p=0.0003). 
 
In the US, 14% reported SDD, 80% 
reported OO, and 5% reported 
inpatient/extended observation (p=0.0003).   
 
It was found that when compared to SCAI 
recommendations, there were high rates of 
non-agreement in US cardiologists across 
the 41 parameters and complete outside of 
the US (55% vs 100%) (non-agreement 
defined as >25% respondents outside of 
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guideline)—found there was poor 
concordance between responding 
cardiologist and SCAI consensus with mean 
weighted kappa for all respondents being 
0.33 (95% CI 0.32-0.35). 
 
Poor agreement with guidance was found 
particularly low for patient factors and 
complication parameters with <50% 
agreement with recommendations.  
Percentage agreement with each category of 
recommendation was lower for non-US 
respondents compared with US 
respondents. 
 
Length of Stay after elective PCI by 
access site: 
Default use of TRA for PCI reported by 
46% US cardiologists and 68% of non-US 
cardiologists 
Patients with TRA had higher rates of 
outpatient PCI with SDD than those with 
TFA. 
 
In PCI via TFA, cardiologists reported 
higher rates of SDD if vascular closure 
device was used compared to manual 
hemostasis (31% vs 13%, P<0.0001).  
Though, even with VCD, SDD were not as 
high as TRA (31% vs 41%, P=0.008). 
 
Length of stay after elective PCI 
depending on Center/Operator volume:  
Centers with higher PCI volumes and 
higher volume individual operators were 




















NA Traditionally, patients go 
home following elective 
cath, but stay for OO when 
PCI occurs due to concern 




States the last recommended guidelines for 
LOS following elective PCI were in 2009 
from SCAI.  AHA/ACC /SCAI published 
guidelines for PCI in 2011; however, SDD 
was not addressed—article states that since 
publication, TRA in the US has been well 









early angioplasty, this 
occurred in as high as 25% 
of PCI proceduresà now 
DAPT and stent 
improvement has provided 
a rapid decrease in acute 
vessel closure—now 
reported in <1% of patients 
following PCI 
 
TRA (compared to TFA) 
has demonstrated a 
statistically significant drop 
in vascular access 
complications in numerous 
trials, across all patient 
subsets and clinical 
presentations.   
 
Recent studies demonstrate 
TRA with lower access site 
complications, quicker 
recovery times, decreased 
procedure costs, and higher 
patient satisfaction—all of 




occurred between 6 and 24 
hours post-PCI, which has 
been reproduced in 
additional studies. 
 
Safety benefits from TRA: 
when compared to TFA, 
TRA reduced adverse 
clinical outcomes including 
composite of major 
bleeding not related to 
CABG, MACE, and all-
cause mortality. 
Elfandi & Safirstein (2018) state that strict 
exclusions based on pre-existing conditions 
and age should not be a barrier to SDD, but 
rather they suggest selecting patients based 
on individual process and discretion of 
provider. 
 
Implementation of SDD:  
Success relies on hospital, provider, and 
patient receiving care.  Operator concerns 
are patient safety and procedural success 
with safe discharge.  Hospitals are 
experiencing increased demand for hospital 
beds and high volume of angiographic 
casesà they are under constant pressure to 
provide appropriate post-procedure care, 
education, and safe disposition 
 
A proposed solution is to shorten LOS 
and avoid need for bed/OO. 
 
Patients should be engaged in early DC—
ambulate ASAP, should leave with 
medications in hand via in-house pharmacy 
to alleviate some concern for 
anticoagulation compliance 
 
Social support plays crucial role in SDD. 
Home proximity to hospital also plays 
crucial role—should be included in 
eligibility criteria 
 
TRA has been associated with cost saving 
of $830 US dollars per PCI 
 
Cases that meet criteria should be 
completed earlier in the day given 
recommended 4-6 hours of observation 
post-procedure 
 
Staff involvement is vital to SDD protocol 
implementation.  Using a checklist of 
potential hazards in evaluating patient for 
SDD, staff plays a role in the ultimate 
outcome. 
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Contemporary stents (DES) 
provide easier 
deliverability, small 
crossing profiles, better 
trackability, and improved 
vessel patency as compared 
to older generation DES 
and BMS. 
 
Changes in antiplatelet 
therapy play an important 
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N=24 trials in meta-
analysis 
 
Patient #: 22,843 
with CAD 



























according to Preferred 
reporting items for 








Studies assess with risk of 
bias assessment tool for 
RCTs.   
 
Odds ratio with 95% CI for 
endpoints were calculated 
from available data.   
 
Trial specific ORs were 
combined with Mantel-
Haenszel fixed effect model 
or with DerSimonian and 
Laird random-effects model 
if heterogeneity was 




specific absolute risk 
differences with 95% CIs 
Impact of radial access was assessed across 
subgroups identified as stable CAD, 
NSTEMI, ACS, and STEMI. 
 
All Cause Death: 
TRA 176/11,359 (1.55%) compared to TFA 
247/11,114 (2.22%) 
OR 0.71 
95% CI 0.59 to 0.87 
 
Major bleeding:  
TRA 123/11,467 (1.07%) compared to TFA 
233/11,222 (2.07%) 
OR 0.53 
95% CI 0.42 to 0.65 
 
MACE:  
TRA 624/11,207 (5.56%) compared to TFA 
730/10,948 (6.67)  
OR 0.84 
95% CI 0.75 to 0.94 
 
MI:  
TRA 431/10,240 (4.21%) compared to TFA 
466/10,292 (4.52%) 
OR 0.92 
95% CI 0.80 to 1.05 
 
Stroke:  









that compared TRA 
and TFA for 
coronary intervention 




followed by PCI in at 
least 50% 
 
Exclusion: if TRA 
and TFA were 
compared in patients 
only undergoing 
diagnostic 
angiography or PCI 
in <50% cases 
 
Studies assess with 
risk of bias 
assessment tool for 
RCTs.   
 









for each endpoint, which 
were combined using fixed-
effects or random effects 
model as appropriate and 
reported the number of 
events avoided or caused 
per 1,000 patients treated 
with 95% CI. 
 
Heterogeneity among 
studies evaluated with 
Cochran Q Chi-square test 
with p<0.10 considered to 
indicate statistical 
significance.  I2 of 25%, 
50%, and 75% correspond 
to low, moderate, and high 
heterogeneity. 
 
Presence of publication bias 
was investigated using 
Harbord test and visual 
estimate with contour-
enhanced funnel plots. 
 
OR 1.05 
95% CI 0.70 to 1.59 
 
Major vascular complications:  
TRA 27/11,152 (0.24%) compared to 
123/10,897 (1.12%) 
OR 0.23 
95% CI 0.16 to 0.35  
 
High risk of bias found in 19 studies with 
low risk of bias found in 5 studies 
 
No evidence of publication bias detected by 
Harbord test for all endpoints, except for 
major bleeding 
 
Evidence for asymmetry found for the 
endpoints of major bleeding, major vascular 
complications and smaller asymmetry noted 
for all-cause mortality 
 
In overall population, TRA compared with 
TFA, was associated with a lower risk for 
all-cause mortality.  Rates of MI and stroke 
did not differ between TRA and TFA. 
TRA was associated with fewer bleeding 
events and major vascular complications.   
Effect of the TRA on all clinical endpoints 
was consistent across subgroups of stable 
CAD, NSTE ACS, and STEMI  
In subgroup pooled analysis of the RIVAL 
and MATRIX studies, TRA compared with 
TFA was associated with better clinical 
outcomes among centers with high radial 
expertise, but not among centers with low 
radial expertise. 
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patients were entered 
into the study 1 week 




SDD group: 403 
Patients interviewed via 
telephone at 24 hours, 3 
days, and 30 days post PCI 
and those with reported 
symptoms were referred to 
own cardiologist.   
 
Effect of SDD on costs was conducted via 
cost minimization analysis.   
 
Events were counted towards the patient’s 
randomized treatment allocation, regardless 
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between July 1, 2000 
and March 21, 2003.  
1453 PCI procedure 
were considered 
elective.  Patient 
chosen based on 





scheduled for elective 
PCI who were able to 
remain home before 
procedure and who 
did not have an acute 
coronary syndrome. 
Exclusion: ad Hoc 
PIC, catheters >6 
French, elective use 
of glycoprotein 
IIb/IIIa receptor 
blockers, long term 
systemic 
anticoagulation use, 
follow up difficult to 
obtain, care person 
not available at 
home, no transport 
home, patients who 
lived >60 minutes 
from the intervention 




Patients were asked 
for written informed 
consent provided that 
Data on complications were 
verified via EMR. 
 
Data regarding clinical 
events were obtained 
through EMR. 
 
Patient satisfaction was 
measured following SDD 
with a standardized 
questionnaire 3 days post 
PCI. 
 
A 1-year F/U was 
completed in all patients. 
 
 
Successful PCI occurred in 383 of 403 
patients in SDD group & 369 of 397 in OO 
group.   
 
During or immediately after PCI: Of 403 
in SDD group, 67 (17%) required extended 
observation & of 397 in OO group, 80 
(20%) required extended observation 
(P=0.26).   
 
During 4 hr observation following PCI: 
Of the 403 in SDD group, 10 (2%) required 
extended observation & of 397 in OO 
group, 5 (1%) required extended 
observation. 
 
Total 19% of SDD group and 21% of OO 
group were identified for extended hospital 
stay. 
 
Patients were observed 4 hours after 
observation for suitability for discharge.  Of 
SDD group, 82% (326 of 403) qualified ad 
79% (312 of 397) of OO group qualified as 
suitable for discharge. 
Actual SDD occurred in 77% of patients 
assigned to SDD group (311 of 403). 
In both randomized groups, 15 patients 
refused to comply with randomized 
assignment and chose opposite discharge 
policy. 
 
Among both groups, the primary end points 
as identified occurred in 9 (2.2%) of SDD 
group and 17 (4.2%) in the OO group (risk 
difference, -0.020; 95% CI, -0.045 to -
0.004; P for noninferiority <0.0001) 
 
Among all patients that qualified as suitable 
for early discharge, primary end point 
occurred in 1 of 326 (0.3%) SDD group and 
2 of 312 (0.6%) OO group (risk difference, 
-0.003; 95% CI, -0.014 to 0.007; P for 




PCI.   
their home 
circumstances were 
conducive for SDD. 
88% of patients completed patient 
satisfaction survey.  On scale of 0 to 100, 
SDD patients gave 5.0 higher mean score 
for discharge procedure compared to OO 
group. 
 
The mean difference of cost per patient was 
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indications in Canada 
at a hospital not 
capable of PCI, that’s 
why STEMI 
excluded.  Patients 
would be reviewed 
treated with 
angiography and if 
intervention needed, 
would transfer by 




excluded if: a 
diagnostic angiogram 
was performed with 
no indication of PCI, 
if PCI was performed 
in a different day.   
 
Data collected between 
January 2011 and June 
2017 
 
Baseline clinical and 
procedural data was 
assessed and documented. 
 
Planned to evaluate the 
impact of access site on 
clinical outcomes & 




defined using Bleeding 
Academic Research 
Consortium (BARC) 
definitions.  the Early 
Discharge After Transradial 
Stenting of Coronary 
Ateries (EASY) 
classification was applied 




variable using two sided t-
test and categorical 
variables were compared 




Data analyzed with SPSS 
Procedure: taken to cath lab and sheath 
exchanged/upside in sterile manner, then 
peri procedure anticoagulation and 
antiplatelet strategies were.  Access site was 
at the cardiologist discretion.   
 
If TRA, sheath was removed, and 
hemostatic wristband applied for 1 hour to 
achieve hemostasis.  For TFA, sheath was 
removed in cath lab followed by a closure 
device insertion or manual compression in 
holding room after achieving ACT <160 
seconds. 
 
Of the 352 patients, 36 were performed with 
TRA & TFA of 316.   
 
Patient demographics were similar. 
 
Lower hemoglobin levels and higher 
prevalence of peripheral vascular disease 
were observed in the TRA group. 
 
No patients in the TRA group experienced 
bleeding or access related complications; In 
the TFA group, 1 (0.3%) patient 
experiencing minor oozing, and 9 (2.8%) 
experienced access related complications 
(P=0.606)—among which 2 patients had 
post-procedural pseudoaneurysm that was 
treated with local injection of thrombin and 
1 patient required two PRBCs due to 
bleeding from femoral access site.  6 
patients had documented hematoma that 
was treated conservatively and 1 had a 
IV 
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catheter induced right aortic cusp tear that 
progressed to the ascending aorta. 
 
TRA group had significantly less contrast.   
 
Study shows that inter-facility SDD PCI 
after diagnostic angiogram appears to be 
feasible and safe; with lower associated 
complications and contrast use in the TRA 
group. 
 
The article further highlights that lack of 
adaptation to transradial approach, but also 
enforces the safety with no complications 
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procedure record and  
 
Conducted in large 
tertiary referral center 
on all patients who 
underwent TRA-PCI 
from 2004 to 2007.   
 
Normal Allen’s test 
confirmed before all 





Data collected in a large 
database 
 








Adverse clinical events 
were adjudicated by 2 
cardiologists unaware of 
patient histories 
 
Demographics: 59 +/- 11 
years; BMI 30 +/- 7, 13% 
female, 27% DM, 64% 
HTN, 71% HLPD, 6% 
PVD, 5% CKD.  Average 
LV EF 54% +/- 9%.   
 
Indications for intervention 
included stable angina 
(49%), unstable angina 
(31%), NSTEMI (17%) and 
STEMI (3%). 
After successful TRA under local 
anesthesia, a 6Fr sheath was accompanied 
by “cocktail” of intra-intravenous 
vasodilating agents (nitro 200 mcgs, and 
verapamil 2.5 mg, and 5000 IU heparin 
bolus).  All patients received heparin bolus 
with infusion continued at 80 to 100 IU/kg 
OR bivalirudin 0.75mg/kg bolus, followed 
by 0.2mg/kg per hour infusion—all 
anticoagulation terminated at end of 
procedure. 
 
At total of 24 (5.3%) postprocedural 
complications were observed and divided 
into 3 groups based on timing of occurrence 
using 0-6 hours, 6 to 24 hours, 34+ hours.   
 
Of the 24, 20 occurred during the first 6 
hours and 4 occurred after 24 hours. 
 
NO COMPLICATIONS OCCURRED 
BETWEEN 6 AND 24 HOURS—the 
assessed time interval between same-day 
and next-day discharge (primary 
endpoint) 
 
WITHIN 6 HOURS: 
Minor access bleeding occurred in 11 




630 lesions in 450 patients 
treated with 540 stents.   
and resolved with manual pressure and 
reassurance.   
 
Post-procedural MI observed in 8 patients 
(1.8%) of whom 4 (0.4%) had no EKG 
changes and were managed conservatively 
without sequelae.   
 
Intraprocedural dissection and hypotension 
occurred in 2 cases (0.4%)-cardiac enzymes 
next day, but otherwise treated medically 
 
4 patients (0.9%) experienced chest pain 
and EKG changes within first 6 hours—
emergent angiography in each case 
indicated acute thrombosis and repeat PCI 
was successful in all patients—with no in-
hospital mortality. 
 
AFTER 24 HOURS:  
4 postprocedural complications:  
-1 CVA 28 hours post-procedure 
-1 paroxysmal AFib 30 hours post-
procedure 
-1 referred for CABG 2 days after 
procedure for unsuccessful treatment of 
CTO 
-1 underwent emergent CABG after 
unsuccessful TRA-PCI of chronic right 
CTO and died 3 days after procedure 
 
Prolonged hospitalization: 
57 (13%) had prolonged hospitalization 
after TRA-PCIà 17 cases related to PCI 
procedure, but none related to TRA.  The 
rest of the extended hospitalization 
unrelated to PCI procedure 
 
12 patients (2.7%) were discharged on same 
day after successful uncomplicated TRA-
PCI—none had complications or 
readmissions 
 
Important to note the reduced access site 
complication rat 
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Also, NO complications occurred 
between 6 and 24 hours, further 
supporting SDD—the rare but dangerous 
complication is subacute stent thrombosis 
that usually occurs between 3-5 days, but 
would not impact the choice of SDD vs.  
OO 
 
The most commonly cited reason for OO 
included surveillance for access site 
complications, periprocedural events, and 
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<75years old with 
type A or B lesion 
who received closure 
device after PCI. 
 
Exclusion: recent 
ACS & 3+ stents 
placed. 
 
March 2008 and 
March 2010 
undergoing elective 
PCI via TFA at 2 
medical centers 
 
Randomized into OO 






Data collected by trained 




coping difficulty scale 
(PDCDS) via an interview 





immediately before hospital 
discharge.  Computer 
assisted telephone interview 
used at 1 day after PCI for 
SDD and 7 and 30 days for 
all participants. 
 
With sample size of 300, 
had 80% power to conclude 
noninferiority if lower 
bound of 95% CI for the 
difference in prevalence of 
high coping for participants 
randomized to SDD 
compared to OO was <12 
percentage points—
established by 
investigators, no clinical 
threshold guides difference 
in high coping using 
PDCDS available 
Mean age of 55.9; 26% women, 33% white, 
15% black, 35% Latino, 22% Asian. 
 
Regardless off SDD or OO, >96% reported 
being ready to discharge before discharge 
21% SDD and 20% OO had scored of zero 
indicating no coping difficulties.   
 
High coping ability found in 79% SDD 
(95% CI 73-86) and 77% OO (95% CI 70-
84)—difference of 2%—found that SDD is 
non-inferior to OO in terms of patient 
coping. 
 
Clopidogrel adherence: 39 (13%) had low 
adherence by 30 days—26 had score<6 and 
13 had discontinued clopidogrel 
  
15% SDD had low adherence and 11% OO 
had low adherence to clopidogrel 
 
No patients in SDD group reported chest 
pain or MI within first day, though 3 
reported visiting their doctor, and 1 went for 
an emergency visit.—though no data 
available for reasons for follow up care is 
available—none experienced 
rehospitalization or death at 30 days. 
 
At 30 days, 111 in OO group and 3 in SDD 
reported chest pain.  other than CP, <5% 
reported adverse events with no significant 
difference across groups at 7 and 30 days. 
I 
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Baseline data included 
sociodemographic, 
smoking, pre-discharge 
scale for readiness for 
discharge, anxiety, post-
procedure pain, and post-
discharge care 
coordination.   
 
Post-discharge at 7 & 30 
days: assessed with 10 item 
PDCDS and about 
satisfaction with discharge.  
Items measured on 11-piont 
scale (0-10) with range in 
scores from 0-100, with 
higher scores indicating 
greater coping difficulty 
and less satisfaction.  
Adherence to clopidogrel 
assessed by using Morisky 
Medication Adherence 
Scale-8-scores range with 
low adherence to 
clopidogrel defined as 
scores <6.  Patient asked if 
satisfied with timing of 
discharge-would you have 
wanted to stay longer or go 
home earlier? If you had 
another procedure, what 
would you want to do? 
 
T tests & Chi Squared used 
with SAS.  p<0.05 
79% of SDD and 49% of OO reported being 
satisfied.  At 30 days, only 9% of patient 
discharged via SDD reported wanting to 
have stayed longer, whereas 37% of OO 
would have preferred to discharge home via 
SDD. 
 
When asked about discharge timing if they 
had another procedure, 80% of SDD and 
69% of OO expressed preference of SDD, 
while 9% SDD and 20% OO reported they 
would want to stay for OO if they had 
another procedure, and 10% SDD and 15% 
OO reported no preference in discharge 
timing. 
Koshy, S.  
K.  G., 






















N/A Article selection not 
identified. 
Despite advances in practice, TFA remains 
most common approach, though TRA has 
lower risk of bleeding/quicker recovery 
times.   
 
Economics of SDD: 
-Cost savings of SDD mirrored with patient 
satisfaction with no significant added 
concern of safety. 
V 
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-Increasing pressure to effectively utilize 
hospital beds for those that require inpatient 
status 
-Risk of decreasing net returns associated 
with OO after uncomplicated PCI 
-Economic advantages comes from cost 
benefit related to decreased LOS.   
Cost savings associated with SDD: total 
saving $4984, room and board cost $1842, 
central supply cost savings $924à don’t 
know what it was being compared to, 
unclear in article 
-TRA PCI with SDD improves payment 
without compromising outcomes, increasing 
patient satisfaction, and reducing bleeding 
risk. 
SDD & Outcomes: 
-Found to be safe with no additional 
mortality or morbidity 
-SDD after successful PCI after 4-6 hours 
observation 
-Safety for SDD in patients with ACS 
established as non-inferior to OO after PCI 
-Evidence may indicate safety of SDD after 
high-risk ACS, if successful PCI and stable, 
but the consensus is not to send home 
STEMI 
 
SDD & Complex PCI: 
-First studies completed on low risk PCI 
patients 
-Recent study looked at safety of SDD after 
PCI of CTOà found SDD was comparable 
to OO with consideration of MACE at 24 
hours 
 
Barriers to Implementation: 
-Conservative recommendation—often the 
culture of the cardiologists 
-Difficulty in changing culture that has been 
practice for over 20 years 
-Lack of Buy-in  
-Change of this capacity requires extensive 
planning and strategies for success—must 
involve administration and hospital staff 
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-Might look at medication non-adherence as 
a balancing measure, as SDD may affect 
compliance 
-Suggest nurse led phone calls could result 
in increased self-management of angina and 
medication compliance 
-Should consider travel time to facility 
-Must include process measures as a study 
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Sample size from 
patients older than 18 
years who underwent 
elective PCI in 
Ontario, Canada from 
October 1, 2008 to 
March 31, 2016. 
 
Exclusions: those 




procedures, those not 
linked to the cardiac 
registry, and those 
who had >1 
overnight stay.  If 
patients had multiple 
PCI during study 
period, the first 
procedure was used, 
and further 
procedures excluded. 
Data was obtained via 
CorHealth Ontario Cardiac 
Registry by coordinators at 
each of the 17 cardiac 
centers providing PCI.   
 





comorbid conditions found 
relevant.   
 
Additional risk factors, 
comorbidities, ER visits, 
and hospitalizations were 
identified using the 
Canadian Institute for 
Health Information (CIHI) 
discharge abstract database, 
the same day surgery 
database, and the national 
ambulatory care reporting 
system. 
Of the 35,972 patients who underwent 
elective PCI during study timeframe, 
10,801 (30%) underwent SDD while 25,171 
(70%) stayed for OO. 
 
Inverse probability of treatment weighting 
propensity score was used to determine 
differences in baseline and clinical 
characteristic between SDD and OO. 
 
No significant difference between groups 
for primary end point at 30 days. 
 
In the propensity weighted cohort, SDD had 
no significant difference in 30-day death 
rates or hospitalization for ACS (1.3% 
versus 1.6%; hazard ratio: 0.84 [95% CI, 
0.65-1.08]; P=0.17) compared to OO. 
 
There was a trend of lower 30 day all cause 
hospitalization in SDD group (5.8% versus 
6.4%; P=0.056). 
 
SDD and OO had no significant difference 
in 30 day rates of mortality or coronary 
revascularization. 
 
SDD costs were roughly 1200 Canadian 
dollars less than OO. 
 
Increasing SDD can potentially reduce 
length of stay costs, increase hospital 
efficiency, and improve patient satisfaction.   
 
SDD also allows otherwise full bed to 
become up for other inpatient admissions 
IV  
 133 






















M.  N., 





























































Cochrane, & Embase 
 
Keywords: chronic 





Limited to English. 
 
Included studies that 
compared outcomes 
of TRA versus TFA.  
TRA group included 
patients who had RA 




compared radial only 
verses femoral or 
radial/femoral CTO 
PCI cases. 
Two investigators worked 
together to extract data—
discrepancies were settled 
through consensus 
 
Data extracted includes 
study, patient, and lesion 
characteristics & outcomes 
of interest. 
 
All statistical analyses and 
plots performed using 
review manager software 
and EZR. 
 
Percentages used for 
categorical variables with 
SD for continuous 
variables.  Categorical 
variable compared using 
fisher exact or Chi-Square 
test.  Continuous variable 
compared using 
independent-t tests, all tests 
were 2 tailed with P value 
</= to 0.05 as statistically 
significant.  Summary 
results recorded as OR with 
95% CI-calculated at 95% 
level for overall estimates 
effects. 
 
DerSimonian and Laird 
random-effects model and 
random effects generic 
variance methods were 
used to calculate ORs and 
mean differences.   
 
Potential publication bias 
was assessed using Egger’s 
Baseline characteristics:  
TFA: younger; DM, HTN, prior MI, PCI, 
and CABG more prevalent.  Lesions likely 
>20 mm long, higher J-CTO score, and 
higher PCI failure rate.  Less likely to have 
mod-severe calcification—more likely in 
right coronary artery or left main coronary 
artery.   
 
TRA: associated with lower risk of access 
site complication (OR 0.34; 95% CI 0.22-
0.51; p<0.001) and major bleeding (OR 
0.22; 95% CI 0.10-0.45; p<0.001) 
compared with TFA. 
 
With sensitivity analysis, TRA was still 
associated with lower risk of access site 
complication and major bleeding. 
 
There was no difference between contrast 
volume (mean difference -20.9mL; 95% CI 
-51.15 to 9.34; P=0.18) or fluoroscopy time 
(mean difference -2 minutes; 95% CI -5.7 to 
-1.5 minutes) use between the groups.   
 
TRA had similar risk of pericardial 
tamponade (OR: 0.85; 95% CI 0.24 to 3.02; 
P=0.8) perforation (OR 0.93; 95% CI 0.5 to 
1.7; P=0.83) emergent CABG (OR 0.79; 
95% CI 0.29 to 2.11; P=0.63), and Q wave 
MI (OR 0.52; 95% CI 0.24 to 1.21; P=0.13) 
compared to TFA.   
 
There was no difference in technical issues 
between TRA and TFA. 
 
Radial only CTO was compared to other 
access sites.  It was found that TRA CTO 
was associated with significantly lower 
incidence of access site complications (OR 
0.36; 95% CI 0.21 to 0.61; P<0.001) and 
major bleeding (OR 0.27; 95% CI 0.12 to 
I 
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test by visual exam on 
funnel plot. 
0.6; P=0.002).  There was no difference 
found in technical issues, contrast or 
fluoroscopy time, and the incidence of 
coronary perforation or tamponade. 
Ramharrac
k, D.  V., 
Jurgens, C.  
Y., and 
Shlofmitz, 



























Between January 1, 
2012 and June 30, 




(2,174) performed by 
1 interventional 
cardiologist was 




Included all elective 
PCI procedures 
including stable and 
unstable angina, 
patients presenting 
with ST elevation MI 
and non-ST elevated 




Periprocedural details were 
recorded in PCI registry 
from patients EMR.   
 
Data included patient 
demographic information, 
procedural information, 
vessels disease and lesion-
specific information, 
cardiac presentation, pre-
intervention risk factors, 
major events after PCI, and 
discharge information. 
 
Readmission data was 
acquired using the 
hospital’s registration 
system used for clinical and 
financial reporting.  A 
query for patients’ 
readmission/reason for 
admission was created.   
Patients were deemed safe for SDD 
following at least 6 hours of recovery per 
the MDs discretion based on the patient’s 
clinical picture. 
 
70.4% of patients were discharged via SDD.   
 
Random forest plot analysis indicated 6 
predictors of SDD.   These variables 
included: age, cardiac presentation, angina 
classification within 2 weeks of PIC, 
contrast, indication for PCI, and previous 
PCI on same admission. 
 
Positive logistic regression utilizing a 
model with all 6 predictors suggested the 
model was able to differentiate between 
patients with SDD and OO after PCI was 
statistically significant (x2(7.12, N=2174) = 
511.12, P= <.005). 
 
The strongest predictor of the phenotype of 
SDD was cardiac presentation with stable 
angina. 
 
Data analysis completed R version 3.2.3 
with SPSS. version 20. 
Primary analyses between group differences 
were calculated using independent t tests for 
continuous variable and Chi-squared or 
Fischer exact tests, as appropriate 
 
Readmission within 24 hours of SDD 
following PCI was 0.91% (14 of 2174) 
 
High complexity cases, patients with 
multiple comorbidities, and different 





















Data collected using 
CardioReport Coro (clinical 
All patients received standard practice care 





























































who underwent PCI 
on the ambulatory 
cardiac care unit 
between April 1, 
2007 to April 30, 
2016. 
 
1,073 were managed 
with SDD.   
 
563 were admitted 
for overnight 
observation for at 
least one night. 
 
 
and procedure information 
obtained) 
 
All uncomplicated cases were monitored for 
4-6 hours then sent home with EKG 
completed before DC. Patients instructed to 
call if they had symptoms (Exclusion 
criteria established). 
Patients had troponin and CPK assays 
performed at local PCP & called to verify 
their status the following day after PCI. 
 
The difference between outcomes of SDD 
and OO were compared, with special 
attention to immediate outcomes. 
 
Of the 563 patient that were admitted for 
OO during the observational period, 60 
patients (3.7%) experienced adverse effects 
during PCI.  52 patients (3.2%) experienced 
adverse events 4-6 hours after PCI, and 450 
patients (27.5%) were hospitalized without 
adverse events for monitoring. 
 
Radial access was attempted in 97% of 
patients.  If radial access failed, 50% used 
contralateral radial artery and 50% used 
femoral artery. 
 
Overnight group: increased proportion of 
women, DM, three vessel disease, LAD 
stenting, and prescription of triple 
antithrombotic therapy.  Radial access used 
less often. 
 
SDD group:  
No MACCE recorded within 24hours after 
PCI.   
No early deaths or stent thromboses.   
2 patients readmitted for chest pain, but no 
repeat PCI required.   
Troponin elevation to 5x upper limit of 
normal (>70ng/mL) was noted in 38.6% of 
patients with CPK value above upper limit 
(195 U/L) noted in 12.7%.   
 
Most of the reasons that 450 without 
adverse events stayed for OO was due to 
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living >1 hour from hospital, late case PCI, 
existing renal dysfunction, and difficult or 
lengthy procedure. 
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Review of literature 
with no explicit 
sample size listed.   
 
 
The guidelines were 
developed by an expert 
consensus group from the 
Society for Cardiovascular 
angiography and 
intervention (SCAI).  The 
experts reviewed various 
randomized clinical trials, 
observational studies, 
systematic reviews, and 
meta-analyses to formulate 
the most current 
recommendations regarding 
SDD following PCI.   
The guideline is an update from the SCAI’s 
2009 document titled “Defining the length 
of stay following percutaneous coronary 
intervention.” 
 
The guideline provides a concise 
description of results from prospective 
studies of SDD following PCI since the 
previous guideline was published. 
 
Studies have further demonstrated the safety 
of SDD in patients undergoing PCI and 
have been able to quantify that most 
complications occur within 6 hours or >24 
hours after PCI. 
 
Many studies have validated patient 
satisfaction and costs savings with no 
negative effects on patient outcomes.   
 
The updated guideline provides new criteria 
to assess a patient’s readiness for discharge 
following PCI.   
 
These criteria fit into three categories: 
procedure, patient, and program, or the 
“three Ps.” 
 
Procedure factors: successful procedure, 
adequate hemostasis, and without 
complication) 
 
Patient factors: clinically stable, at baseline 
mental status and vital signs, stable 
comorbidities.   
 
Program factors: safe monitoring at home, 
appropriate guideline-directed medical 
therapy, compliance with PCI performance 




Ultimately, discharge planning after PCI 
should be a medical decision made based on 
the provider’s discretion based on what is 
best for the patient. 
Shroff, A., 
Kupfer, J., 
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No sample specified 
 
Literature search of 
Pub-Med from 
January 1, 1995 to 




and outpatient, day 
case, ambulatory, and 
same day” 
 








No formal inclusion 
and exclusion criteria 
were applied, and 
formal meta-analytic 
techniques were not 
used 
Results in both Columns: 
 
Timing of PCI 
complications:  
-Early complications 
include abrupt vessel 
closure, acute stent 
thrombosis, and access site 
complications  
-Delayed complications 
(several hours after 
successful PCI) include 
access site bleeding, non-
access site bleeding, 
development of CHF, 
delayed contrast reactions, 
subacute stent thrombosis, 
complications related to 
sedation, and arrythmias. 
-Studies found that 
likelihood of complications 
between 6 hours and 24 
hours was extremely low 
-Some studies show no 
measurable differences in 
total complications in 
MACE between SDD and 
OO 
 
Choice of access site:  
-The choice of TRA and 
TFA does not appear to 
effect safety of SDD 
-More importantly, it was 
seen that SDD in patients 
that have been 
appropriately selected is 
safe (as safe as OO) 
-The overall incidence of 
complications (bleeding 
and vascular related 
Procedural Outcomes:  
-Patients to be sent home via SDD should 
have a successful PCI, no compromise of 
side branch at least 2 mm in diameter, and 
no postprocedural chest pain 
-Occurrence of any of the above should 
result in OO 
 
Stabilization of vascular access:  
-Concerns of vascular access complications 
related to access site bleed or vessel 
disruption has been key in continued OO 
-Vascular access site complications have 
decreased tremendously with use of TRA 
refinement of TFA and sheath removal, 
reduction in size of arterial sheath, and 
vascular closure devices 
-Primary benefits of TRA are reduced 
vascular access complications, improved 
patient comfort, and decreased recovery 
time 
-VCDs reduce time of hemostasis and 
ambulation compared to manual pressure—
should utilize if using SDD 
 
Provision for DAPT:  
-Essential after stent placement 
-Must include patient education to discuss 
indication, adverse effects, and duration 
after PCI 
-Must plan to ensure patient understanding 
of new meds 
-Also suggests the use of in-hospital 
pharmacy before discharge 
 
Post-Procedural Process: 
-4 to 6 hours of observation seems to be 
efficient 
-May need to consider time of day of 




does not appear to increase 
risk of rehospitalization & 
mortality 
 
Economic impact:  
-Notes EASY study found 
50% relative reduction in 
health system costs, saving 
1,086 dollars per patient in 
US; EPOS found savings of 
$350 per patient in US 
-CMS classifying PCI as 
outpatient procedure, 
meaning not getting 
reimbursed for OO 
-Estimated that US could 
save 200 to 500 million per 
year if 50% utilized SDD 
after PCI 
-Important to note that 
there are other potential 
savings including 
potential for reduction of 
medical errors and 
complications, increased 
bed availability for new 
patients, and cost-savings 
for facilities.   
 
Assessment of suitability 
for SDD:  
-Many validated tools 
available in predicting PCI 
risk and mortality based on 
many characteristics, but 
there are currently no scales 
to predict risk in lower risk 
patients 
-Factors such as frailty, 
present of social support, 
and health literacy, may be 
important in determining 
suitability. 
-Education with written instruction with 
prompts and teach backs should be included 
-Contact names and numbers should be 
provided if a complication occurs 
-Follow up the next day to assess for 
complications, address questions, and 
confirm receipt of adherence to DAPT 
 
Program Imperatives:  
-Must be hospital specific 
-Focus on developing standardized protocol 
for ID’ing patients 
-Understand 25% to 35% may not be 
suitable for SDD 
-Criteria should be developed with 
interdisciplinary teams 
-Patient should be at baseline ambulatory 
level at baseline 
-If complication occurs or if there is a 
concern for inability to provide care, the 
patient should stay for OO. 
Nursing Perspectives:  
-suitable patients should be targeted early in 
the day to facilitate timely discharge 
-Recovery staff must observe for 
complications  
-Clear criteria should exist 
 
Barriers:  
-Conservative recommendations from SCAI 
in 2009—severely limited patients able to 
go home—age >70, abnormal renal 
function, DM taking insulin, contrast 
allergy, presence of any chronic disease, 
multivessel disease, left main disease, 
proximal left anterior descending disease, 
bifurcation disease, saphenous vein graft or 
internal mammary disease, and use of 
glycoprotein IIB/IIIA inhibitors. 
-Physician resistance 
 
Growing evidence indicates hospital 
environment as hazardousà infectious 
colonization, accidents, drug errors, and 
posthospitalization stress syndromes—
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one approach is to realize patients may 












































determined to be 
intermediate or high 
risk— were admitted 
for OO post-
procedure—these are 




determined to be low 
risk and discharged 






complications, and timing 
of post-procedural events. 
 
All data was collected form 
retrospective chart reviews. 
 
All patients referred were 
assessed for adequate 
collateral circulation with 
Allen’s test.   
 
Procedure Technique: -
Sheath inserted under local 
anesthesia.   
-Patients given vasodilating 
mixture of verapamil and 
nitroglycerine post sheath 
insertion to protect against 
radial spasm.   
-Heparin 5000 IU given 
following sheath insertion.   
-Patients all pre-treated 
with aspirin and clopidogrel 
75mg/day with 300-600 mg 
dose if clopidogrel naïve.   
-Sheath was removed 
immediately with 
application of hemostasis 
clamps. 
-Air released in stages 1-2 
hours following the 
procedure.   
-Clamp removed 2-3 hours 
following the procedure. 
-Pressure dressing applied 
after removal. 
 
Characteristics: Mean age=66; 76% Male; 
20% had previous MI and 23% prior 
revascularization.   
 
Age, Sex, DM, & HTN similar between 
groups. 
 
Procedure indication: 29% emergent, 54% 
urgent, and 17% elective—important to 
note a significantly higher OO in urgent and 
emergent cases. 
 
In the inpatient intermediate and high risk 
group, 90% of patients had type B2 or C 
lesions.  The majority of type A or B1 
lesions were discharged home via SDD. 
 
Post-procedure complications of 1,174:  
-Bleeding: 13 had bleeding within 6 hours 
of the procedure.  No bleeding occurred 
between 6 and 24 hours. 
-Neurological symptoms: 8 (0.7%) had 
neuro deficits (4 transient/minor; & 4 with 
CVA with 3 having persisting neuro 
deficits).  All of these occurred during or 
immediately following procedure.  None 
occurred between 6 and 24 hours. 
-Emergent CABG: 6 patients (0.5%) 
required emergent CABG—all of which 
were performed immediately due to 
procedural complications.  No patients 
needed CABG between 6 and 24 hours. 
-5 (0.4%) returned to cath lab within 24 
hours—2 of which had unrecognized 
dissection related to initial procedure and 3 
were found to have unchanged angiographic 
appearance.  One patient returned between 6 
and 24 hours, though it was due to a guide 
dissection during initial procedure that 
involved his entire RCA, requiring multiple 




-7 (0.6%) had post-procedural pericardial 
effusions requiring drainage, all of which 
were evident within 6 hours. 
 
There were 22 patients that had 
complications outside of 24 hours and 
within 7 days including: access site 
hematoma (1) non-access site bleeding (5), 
emergent CABG (1), return to cath lab (4), 
and Death (11).   
 
It was found that even in higher risk 
patients, complications occurring between 6 
hours and 24 hours is rare.  Important to 
note that 2 patients of 1,174 did have post-
procedure complications between 6 and 24 
hours, though clinical deterioration was 
evident within 6 hours—most nontarget 
vessel complications will occur within 6 
hours while target vessel closure usually 









Appendix D: Theoretical Framework 
Rosswurm & Larrabee’s A Model for Change to Evidence-Based Practice (1999) 
 142 
Appendix E: Conceptual Model 
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Appendix F: Gantt Charts  
 
 
9/23/20 11/12/20 1/1/21 2/20/21 4/11/21 5/31/21
Proposal Presentation
Obtain IRB Approval from Facility and UARK
Conduct Chart Reviews
Conduct Educational Sessions with Staff
Implement SDD following Elective PCI
Collect Data
Analyze Data
Prepare for DNP Presentation to Committee
Prepare for Dissemination to Clinical Site
Prepare for Project Dissemination
Initial DNP Quality Improvement Project Timeline
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Appendix G: Statement of Mutual Agreement for DNP Guidance 
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Appendix H: Data Collection Sheets 
 




















Patient Marker & Procedure Date were deleted following data 
extraction 
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     Marcia L. Atkinson, MHSA 
 
Fellows of the American College of Cardiology  
www.chistvincent/heartclinic.com 
 
Instructions for Out-Patient Cardiac Catheterization  
 
1. Your Cath has been scheduled for: _________________________________  
 
2. Please arrive at ___________ AM/PM and report to St. Vincent Infirmary in Little 
Rock, AR. The address is 2 St. Vincent Circle. Enter the main entrance and check 
in at Jack Stephens Cath Lab on the first floor. 
 
3. Please do not have anything to eat or drink after midnight the night prior to your 
procedure. If your procedure is scheduled after 12:00 PM (noon) you may have a 
clear liquid breakfast before 08:00 AM. This should consist of sprite, Kool-Aid, 
bouillon, Jell-o, grape juice, etc. 
 
4. You may take your medications with a sip of water unless you are instructed 
otherwise by your nurse. 
 
5. Bring your current medications, detailed medication list, and an overnight bag. 
 
6. If you have sleep apnea, please bring your CPAP machine with you to the 
hospital.  
 
7. Following your procedure, you will be taken to the recovery area and will have a 
2-6 hour recovery period. Come prepared to stay at least one night in the 
hospital. If you have an angioplasty, you may have to stay in the hospital 
overnight. YOU WILL NEED A DRIVER TO TAKE YOU HOME FROM THE HOSPITAL 
WHEN YOU ARE DISCHARGED. 
 
8. Other Instructions: 
______ Diabetic: ____________________________________ (Please hold 
Metformin, Glucophage, Avandamet, Xigduo, Glumetza, Fortamet, Riomet, and 
Glucovnace the day of the procedure and for two days after. 
______ Coumadin/Pradaxa (Dabigatran)/Xarelto (Rivaroxaban)/Eliquis (Apixaban) 
therapy: (Please hold coumadin/warfarin for 3 days prior to procedure. Please hold 
Xarelto, Pradaxa, and Eliquis for two days prior to procedure.) If you are taking Plavix 
or Aspirin, please do not stop these medications. 
______ Diuretic: ____________________________________ (Please hold 
Furosemide (Lasix), Torsemide, Hydrochlorothiazide (HCTZ), Bumex (Bumetanide), 
and Metolazone the morning of procedure. 
 
If you have any questions regarding this procedure, please feel free to contact our 
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     Marcia L. Atkinson, MHSA 
 
Fellows of the American College of Cardiology  
www.chistvincent/heartclinic.com 
 
Post-Procedure Instructions following Percutaneous Coronary Intervention 
(PCI) & Outpatient Cardiac Catheterization (GROIN) 
 
Incision: 
• Your incision may be covered with a gauze or clear tape dressing: if so, the dressing 
should be removed 24 hours after procedure. If you spend the night in the hospital, we 
will do this for you prior to discharge. If you go home the same day as your procedure, 
please remove your dressing the following day.  
 
• You may shower 24 hours after the procedure. Do not tub bathe, swim, or soak for 5 
days.  Please do not apply lotion, cream, ointment, and/or powder to your incision for 
5 days. 
 
• For pain, you may take over the counter Tylenol as needed. 
 
• Notify a provider if you notice bleeding (Go to the emergency room if it is 
uncontrolled), drainage, swelling, redness, fever, numbness, or tingling in your leg. 
 
Diet After Discharge:  
• You should continue or begin to eat a heart healthy diet. 
 
Activity After Discharge: 
• Please rest and relax today. No lifting, pulling, pushing, or strenuous activity for 5-7 
days. 
 
• Driving is not permitted for 24 hours following your procedure. 
 
Special Instructions:  
• Drink plenty of water for the next couple of days. 
 
• If you are a diabetic and on metformin or Glucophage, hold this medication for 48 
hours after your procedure.  
 
Smoking:  
• If you smoke, stop now. You can get help at: Arkansas Tobacco Quitline 1-800-QUIT-
NOW or visit https://www.bewellarkansas.org/ 
 
Follow-up: 
• You will have a follow up appointment in the cardiology clinic within 2 to 6 weeks. Your 
appointment may be scheduled before you leave the hospital. If so, the date will be 
included in your discharge paperwork. 
 
 
PLEASE CALL MEDICAL EXCHANGE AT 501-663-6900 WITH ANY QUESTIONS/CONCERNS WEEKDAYS  
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     Marcia L. Atkinson, MHSA 
 
Fellows of the American College of Cardiology  
www.chistvincent/heartclinic.com 
 
Post-Procedure Instructions following Percutaneous Coronary Intervention 
(PCI) & Outpatient Cardiac Catheterization (RADIAL) 
 
Incision: 
• Your incision may be covered with a gauze or clear tape dressing: if so, the dressing 
should be removed 24 hours after your procedure. If you spend the night in the 
hospital, we will do this for you prior to discharge. If you go home the same day as your 
procedure, please remove your dressing the following day.  
 
• You may shower 24 hours after the procedure. Do not tub bathe, swim, or soak your 
wrist for 5 days. Please do not apply lotion, cream, ointment, and/or powder to your 
wrist area for 5 days. 
 
• For pain, you may take over the counter Tylenol as needed. 
 
• Notify a provider if you notice bleeding (Go to the emergency room if it is 
uncontrolled), drainage, swelling, redness, fever, unusual pain, numbness, or tingling 
in your wrist. Notify a provider if your arm becomes pale or cool. 
 
Diet After Discharge:  
• You should continue or begin to eat a heart healthy diet. 
 
Activity After Discharge: 
• Please rest and relax today.  
 
• No flexing or hyperextending your right or left wrist for 24 hours. No lifting, pulling, or 
pushing with your wrist for 5 days. 
 
• Driving is not permitted for 24 hours following your procedure. 
 
Special Instructions:  
• Drink plenty of water for the next couple of days. 
 
• If you are a diabetic and on metformin or Glucophage, hold this medication for 48 
hours after your procedure.  
 
Smoking:  
• If you smoke, stop now. You can get help at: Arkansas Tobacco Quitline 1-800-QUIT-
NOW or visit https://www.bewellarkansas.org/ 
Follow-up: 
• You will have a follow up appointment in the cardiology clinic within 2 to 6 weeks. Your 
appointment may be scheduled before you leave the hospital. If so, the date will be 
included in your discharge paperwork. 
 
 
PLEASE CALL MEDICAL EXCHANGE AT 501-663-6900 WITH ANY QUESTIONS/CONCERNS WEEKDAYS  





Appendix J: Needs Assessment Questionnaire with Analysis 
 
Needs Assessment Questionnaire 
 
The purpose of this questionnaire is to gather information regarding the care of patients who undergo 
procedures with same day discharge.  The information obtained will be used to improve health outcomes 
and discharge processes within this patient population.  All of the information collected from interviews 
will be confidential.  The interview should take approximately 15 minutes to complete. 
 
Role: Administration (2), MD (1), APRN (1), RN (2) 
Employment Status: Full time (6) 
 
1. Other than hospital costs & patient satisfaction, what health outcomes are improved by sending 
patients home same day? Each participant (6) spoke openly about their thoughts.  Common themes 
with percentage of participants that mentioned theme is listed below. 
• Decreased Bleeding due to transradial approach (66.67%) 
• Increased Use of Transradial access for PCI (66.67%) 
• Increased Access for other patients due to more available cardiac beds (100%) 
• Increased Self Care Management (50%) 
• Decreased Exposure to Nosocomial Infections (50%) 
 
2. What causes patients to be re-admitted or seen acutely ill following procedures? What is the 
usual time frame? Only asked to MD (1).  Identified reasons for readmission or acute illness are 
listed below. 
• Chest pain 
• Hematoma 
• Kidney Injury 
• Usually seen within 7 days; mostly 24-48 hours following procedure 
 
3. What are the most common complications experienced by patients before discharge? Question 
only asked to target group (4).  Each participant spoke openly about their thoughts.  Common themes 
and number of times mentioned are listed below. 
• Bleeding (4/4) 
• Occlusion (2/4) 
• Chest Pain (3/4)  
 
4. What percentage of PCI patients have transradial approach? Target group members (4) were 
prompted with the following. 
• <50% (25%) 
• About 50% (75%) 
• >50% (0%) 
 
5. What poor health outcomes are seen that we need to address in our policy? Each healthcare team 
member spoke openly about their thoughts.  Common themes with percentage of participants that 
mentioned the themes are listed below. 
• Bleeding due to transfemoral approach with increased bed rest time (50%) 
• Readmission (33.3%) 
• Inadequate Self Care (50%) 
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6. Do you believe that certain aspects of the discharge process need to be improved? If so, what do 
you believe we could incorporate into the discharge process? Each participant (6) spoke openly 
about their thoughts.  Common themes with percentage of participants that mentioned theme is listed 
below. 
• Self-Care (83.3%) 
• Personalized Education (66.67%) 
• When to seek medical care (50%) 
• Meds to bed (66.67%) 
• Medication knowledge (50%) 
 
7. Do you feel that the patients are given all the tools they need to be successful at home following 
discharge? If no, explain why.  (Examples: proper education related to medications, health, diet, 
etc.) Each participant (6) spoke openly about their thoughts.  Common themes with percentage of 
participants that mentioned theme is listed below. 
• No (50%)—Some feel that patients do not have the knowledge regarding medication and self-
care that they need to be successful at home before discharge. 
• Yes (50%) 
 
8. Do you feel that the staff is prepared to make changes in terms of the same day discharge 
process? Each participant (6) spoke openly about their thoughts.  Percentages of answers are listed 
below. 
• Yes (66.67%) 
• Some Yes, Some No (33.33%) --Some feel that most of the staff will welcome change, while 
others will be resistant to new processes 
• No (0%) 
 
9. Where do you think we may find resistance to change? Each participant (6) spoke openly about 
their thoughts.  Percentages of answers are listed below. 
• Physicians (100%) 
• Nurses (33.36) 
 
10. Do you feel that management will support ideas to improve the same day discharge process? 
Each participant (6) spoke openly about their thoughts.  Percentages of answers are listed below. 
• Yes (100%) 
• No (0%) 
 
11. Are you willing to help develop a program that seeks to streamline the same day discharge 
process? Each participant (6) spoke openly about their thoughts.  Percentages of answers are listed 
below. 
• Yes (100%) 







Appendix K: Same Day Discharge Pre-Procedure Criteria & Post-Procedure Checklist 
 
Elective PCI Same Day Discharge Protocol 
Overall Goal = Same Day Discharge (SDD) for all patients whenever feasible 
Cases via femoral access to be completed by 3 PM to consider SDD 
Cases via radial access to be completed by 5 PM to consider SDD 
 
Certain exceptions can be made for cases completed after above cut off times; exceptions can be 
made for in-town patients on a case-by-case basis; however, the guest house may be utilized 
after 9 PM 
**Physicians reserve the right to hold a patient for observation at their discretion** 
 
Pre-Procedure Criteria Checklist for Same Day Discharge for PCI Cases 
____ Elective procedure/Outpatient status (not presenting with NSTEMI/STEMI) 
____ Not opposed to discharge same day following procedure 
____ Does not live alone or has support staying overnight 
____ Driver available to take patient home following the procedure 
____ Lives within 60 miles from hospital (if >60, guest house arrangements to made/paid by clinical site) 
• Patients to be discharged from Cath lab by 6PM 
• Guest house arrangement to be made for discharge expected after 9 PM (unless exception 
made by physician or discharging APRN) 
____ Compliance to medical therapy 
____ Candidate for SDD per MD discretion 
 
Possible Reasons for Overnight Observation following Elective PCI 
• Lack of Dual-Antiplatelet Therapy in hand before discharge 
• Cases completed after cut-off time for SDD discharge based on access site** 
o Radial Cases completed by 5 PM 
o Femoral Cases Completed by 3 PM 
• Postoperative complications (persistent N/V, fluid/electrolyte imbalance, uncontrolled pain, 
arrhythmia, excessive bleeding, unstable LOC/psychotic/mobility) 
• Hemodynamic instability during or after procedure 
• MD discretion 
• Inadequate support at home 
• Lack of transportation 
• Frail, elderly patients 
 
**Patients to be discharged from Cath lab by 6 PM.  If unable to be released from the hospital at 6PM, the 
patient should be moved to 2NW/2E for remaining observation period.  Cut off for safe discharge 
home=9PM unless exceptions to be made for in-town patients on a case-by-case basis by operating 




Appendix K: Same Day Discharge Pre-Procedure Criteria & Post-Procedure Checklist 
 
Elective PCI Same Day Discharge Post-Procedure Checklist 
 
____ Physician performing procedure has deemed this patient a same day discharge candidate 
 
____ New home medications in hand, delivered by Meds to Bed program from Heartland Pharmacy 
  Prescribed aspirin, P2Y12, Statin, and Nitro as appropriate 
 
____ Completed Observation (4 hours flat time for radial access; 6 hours PLUS 1 hour with observed 
ambulation for femoral access) before discharge 
 
____ Post-Procedure EKG Completed 
 
____ Stable vital signs 
 
____ Mental status at baseline 
 
____ Functional status at baseline 
 
____ Baseline comorbidities stable (ex.  DM, CHF, COPD, PAD, ESRD) 
 
____ No significant anesthesia complications 
 
____ Successfully voided post-procedure 
 
____ Successful procedure including but not limited to: 
  Single or multivessel PCI, proximal LAD or bifurcation PCI 
  Uncomplicated CTO attempt 
  Regardless of number, length of stents used 
 
____ Radial and/or Femoral Access Sites are WNL per discharge APRN (adequate hemostasis) 
 
____ Provide/Document education related to antiplatelet therapy, post-procedure instruction, and 
numbers to call for concerns/complications) 
 
____ Patient and/or caregiver readiness for discharge (understands postoperative instructions & 
restrictions) 
 
____ Patient has copy of stent card 
 
____ Adequate home support and transportation home 
 
____ Follow up appointment scheduled for 2-6 weeks with Cardiologist 
 
____ Verify consult to Cardiac Rehab has been ordered & cardiac rehab info included in discharge 
paperwork  
 
____ Clearance by Discharge APRN 
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Appendix O: Implementation Evolution Over Time 
Implementation Evolution Over Time 
Implementation 
Timeline 
Progress New Changes 
      
19-Nov-20 University IRB Approval   
  
31-Jan-21 Awaiting Clinical Site IRB 
Approval 
  
   
1-Feb-21 Non-Research Designation from 




designation to both clinical 
site and UARK. 
   
3-Feb-21 SDD Interdisciplinary team 
meeting 
SDD team decided to 
incorporate SDD orders into 
clinic EMR to assist in 
procedure scheduling and 
potential SDD patient 
identification. Information 
was sent to IT. 
 
“Soft” implementation date 
set for February 8th, 2021 and 
full implementation set for 




SDD algorithm was updated 
to include “DAPT in hand” to 
the protocol 
   
8-Feb-21 Soft Implementation No patients were sent home 
via SDD processes on 2/8. 













Request for improved 
physician engagement and 
physician fact sheet/education 




12-Feb-21 Efforts to increase physician 
engagement 
Individual meetings with 
interventional cardiologists 
began; though were 
postponed due to inclement 
weather and Cath lab elective 
procedure cancellations. 
   
19-Feb-21 End of Implementation Week 2 Zero Elective PCI SDDs. 
   
16-Feb-21 Physician Education Physician fact sheet/education 
completed and emailed to 
administration as requested. 
   
17-Feb-21 SDD Interdisciplinary team 
meeting 
Identified that there were no 
further elective PCIs 




Additional efforts for 
physician engagement were 
activated. PI to conduct 
individual meetings and reach 
out to interventional 
cardiologists via text. 
   
19-Feb-21 Continued efforts to increase 
physician buy-in and engagement 
Meetings conducted with 2 
interventional cardiologists 
during rounds. 
   
20-Feb-21 End of Implementation Week 2 Zero Elective PCI SDDs. 
   
23-Feb-21 Telephone meeting with one 
interventional cardiologist to gain 
support and engagement 
Identified the need to verify 
that the patient going to go 
home via SDD processes is 
outpatient. Also identified that 
if there is another attending, 




An additional interventional 
cardiologist agreed to review 
SDD processes. 
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25-Feb-21 SDD Interdisciplinary team 
meeting 
Emails were sent to Cath lab 
and telemetry unit nurse 
managers to schedule in-
services. 
   
27-Feb-21 End of Implementation Week 3 Zero Elective PCI SDDs. 
   
1-Mar-21 In-person meeting with one 
interventional cardiologist to gain 




information to present to the 
interventional cardiologists 
during their monthly meeting. 
 
Emails were sent to 
administration (Cath lab 
manager and Cardiovascular 
service line director) 
requesting data.  
   
2-Mar-21 SDD Interdisciplinary team 
meeting 
Clinic staff reported that they 
would not be incorporating 
SDD orders into clinic EMR 
as EP schedulers have had 
success adding to order notes. 
   
4-Mar-21 Data Request Data was also requested from 
Director of Performance 
Excellence. 
   
6-Mar-21 End of Implementation Week 4 Zero Elective PCI SDDs. 
   
8-Mar-21 Data Request Data was requested from 
clinical site NCDR CathPCI 
liaison. 
   
10-Mar-21 Data Received Data received from clinical 
site NCDR CathPCI liaison.  
   
13-Mar-21 End of Implementation Week 5 Zero Elective PCI SDDs. 
   
18-Mar-21 Meeting Scheduled Interdisciplinary team 
meeting scheduled for 3/22/21 
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to discuss future 
implementation. 
   
20-Mar-21 End of Implementation Week 6; 
Implementation Completed 
Zero Elective PCI SDDs. 
   
21-Mar-21 Pre-implementation period chart 
reviews 
Pre-implementation period 
chart reviews completed. 
   
22-Mar-21 Implementation period chart 
reviews 
Implementation period 
(February 7, 2021 through 















Appendix P: PDSA Cycles 
PDSA Cycle #1 
OBJECTIVE: Arrange a meeting with the interdisciplinary team regarding final steps before implementation 
Change Idea: Arrange a meeting with the interdisciplinary team regarding final steps of project planning while awaiting IRB approval and 
implementation. 
  Person Responsible  Due Date 
Plan:  An interdisciplinary team meeting will be arranged by the principal investigator 
regarding final steps of project planning and same day discharge processes while awaiting IRB 
approval and project implementation. During this meeting, the process from the initial visit in 
the cardiology clinic to the telephone follow up after discharge will be walked through to 
determine if there are any other process adjustments that should be made prior to 
implementation.  
  Principal Investigator 01/21/21 
Do: Email correspondence took place with the clinical site director of performance excellence 
to determine possible meetings times. A text was sent to several physicians regarding planned 
meeting time. An email was sent from the President of the Heart Institutes executive assistance 
on 1/21/21 to the interdisciplinary team regarding a meeting for 1/27/21.  
  Principal Investigator 01/21/21 
Study: Meeting invitations were sent as of 1/21/21. Now, I will prepare for the meeting by 
creating an agenda and incorporate all previous suggestions from the previous meeting to 
improve the same day discharge processes within the clinical site. Once the clinical site gives 
me feedback and/or requests revisions, the changes will be incorporated into the protocol and 
re-submitted. Following IRB approval from the clinical site, an implementation date can be 
established. 
  Principal Investigator 01/24/21 
Act: Following the upcoming interdisciplinary meeting, I will incorporate any further 
recommendations for process changes before project implementation. 





PDSA Cycle #2 
OBJECTIVE: To communicate with Clinical Site IRB regarding approximate IRB approval timeframe. Prepare meeting agenda. 
Change Idea: Meeting preparation and IRB communication.  
  Person Responsible  Due Date 
Plan:  Complete meeting agenda and review DNP project proposal for refresher regarding 
current evidence, implantation plans, data analysis, & project measures. Communicate with the 
interdisciplinary team regarding upcoming meeting. 
 
Call and speak to Clinic regarding IRB review update and projected review timeline  Principal Investigator 1/29/21 
Do: Create a meeting agenda including SDD processes and potential failures. Send a reminder 
regarding upcoming meeting. Speak with piloting Interventional Cardiologist, regarding SDD 
implementation with his elective PCIs. 
  
Call Clinical Site IRB/leave voicemail if needed for IRB protocol update. Principal Investigator 1/29/21 
Study: A meeting agenda was completed on 1/28/21 with Director of Performance Excellence. 
A reminder was sent on 1/29/21 for next week’s meeting on behalf of the President of Heart 
Institute. Telephone call with piloting interventional cardiologist took place on 1/28 to re-
schedule the meeting for 2/4/21 based on his availability and to discuss implementation. He 
stated he is ready for implementation following our upcoming meeting. 
 
Clinical Site IRB was called on 1/26/21 regarding an update on the IRB protocol review. 
Clinical Site IRB stated that it will likely be 2/3/21 before they are able to review the IRB 
protocol. An email was sent to the Research Council Chair, regarding possible pull with IRB. 
Principal Investigator & Director 
of Performance Excellence 1/28/21 
Act: Will complete the meeting on 2/4/21 and continue to review and revise the meeting 
agenda as needed. Will need to follow up with Clinical Site IRB this next week for another 




PDSA Cycle #3 
OBJECTIVE: Hold interdisciplinary team meeting and establish an implementation date. 
Change Idea: This PI will hold an interdisciplinary team meeting to establish an implementation date for PCI Same Day Discharge on 2/4/2021.  
  Person Responsible  Due Date 
Plan:  Finalize and review meeting agenda with Director of Performance Excellence, at the clinic 
site. Agenda items to include PCI Same Day Discharge processes from start to finish, continued 
issues with SDD procedure scheduling, Further Nursing Staff education for the clinic and hospital, 
scheduler education, Meds to Bed Program, potential failures, and establishing an implementation 
date. 
 
This PI received final word from Clinical Site IRB on 2/1/2021 that assigned the project as quality 
improvement/non-research. Due to this information, setting an implementation date during the 
meeting is essential. Principal Investigator 2/3/21 
Do: Make final edits and review the meeting agenda with Director of Performance Excellence. The 
meeting agenda items are as above. Create a typed agenda to send out to team members. Send a 
reminder to the Piloting Interventional Cardiologist and his Nurse Practitioner via text. Send a 
meeting reminder to the interdisciplinary team via email with the zoom meeting link and password.  
Make all final edits to previously used process maps and algorithms. 
  
Share the news of the Clinical Site IRB non-research designation with Dr. Stewart, Dr. Kilmer, & 
Dr. Bradley. 
Principal Investigator & Director 
of Performance Excellence 2/3/21 
Study: The meeting agenda was reviewed and finalized with Director of Performance Excellence at 
the clinical site on 2/3/2021. A reminder was sent on 2/3/2021 and on 2/4/2021 to the interventional 
Cardiologist and his APRN. An additional meeting reminder to the entire interdisciplinary team 
meeting was sent on 2/3/2021 on behalf of President of the Heart Institute with the zoom meeting 
link and password. The meeting was then completed on 2/4/2021 by this PI and the Director of 
Performance Excellence. Many great ideas were identified during the meeting to improve processes 
including adding an option in the clinic and hospital EMR to include same day discharge procedures 
so that they are better captured for data collection and evaluation. Initial implementation was set for 
Monday, February 8th, with one elective PCI on the schedule.    
 
An Email was sent to Dr. Stewart, Dr. Kilmer, & Dr. Bradley on 2/1/2021 to notify them of the 
clinical sight IRB designation. 
Principal Investigator & Director 
of Performance Excellence 2/3/21 
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Act: Following the meeting, I will update all education for the clinic and hospital staff. I will begin 
working on physician education as requested. I will also make final changes to the protocol 
algorithm to include "DAPT in hand" to the protocol. Once all edits are made, I will re-distribute the 
Same Day Discharge Protocol/Algorithm documents to the interdisciplinary team and share the 
education with the nurse managers for the clinic, two cardiac nursing units, and the cath lab. I will 
also call IT to begin working on adding same day discharge procedures for improved scheduling for 
same day discharge procedure. I will be present for implementation on Monday morning for the first 
elective PCI. During my presence, I will observe process adherence. Principal Investigator 2/8/21 
 
 
PDSA Cycle #4 (Week 1 of Implementation) 
OBJECTIVE: Begin SDD PCI implementation, complete process observation, and create further physician education/fact sheet for PCI SDD.  
Change Idea: This PI will begin project implementation and complete process observation to ensure Same Day discharge processes are being executed 
correctly.  
  Person Responsible  
Due 
Date 
Plan:  Begin “soft” implementation with the piloting interventional cardiologist’s elective PCI procedures 
starting on February 8th, 2021. 
 
Complete process observation in the Cath Lab on 2/8/2021 to reinforce previous education regarding the 
same day discharge processes. Process observation to include adherence to physician identification, pre-
procedure checklists, and post-procedure checklist adherence, guest house use, meds to bed program use, 
etc. 
 
Create a fact sheet/educational flyer regarding the Same Day Discharge processes for elective PCI. Due to 
a lack of physician engagement, this PI will continue to seek engagement by carrying out individual 
meetings with interventional cardiologists.  Principal Investigator 2/8/21 
Do: Implement the Same Day Discharge for elective PCI on 2/8/2021. 
 
Complete process observation on 2/8/21, 2/11/21, and 2/12/21.  
 
Create a typed fact sheet/educational flyer regarding the SDD processes and current research. Attach the 
pre- and post-procedure checklists for review. Attach the SDD protocol algorithm for review. Principal Investigator 2/12/21 
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Study: Same Day Discharge processes for elective PCI were implemented on 2/8/21; however, the 
piloting interventional cardiologist had two patients who underwent elective PCI but he did not send his 
patients home via same day discharge processes.  
 
Process observation was completed on 2/8/21 and 2/11/21. This PI could not complete process observation 
on 2/12/21 due to inclement weather and procedure cancellation. During process observation, it was noted 
that physician to discharging APRN was not taking place. It was also noted that clinic identification and 
pre-procedure checklists were note applicable as the procedures were scheduled prior to implementation. 
Post-procedure checklists were not utilized as patients did not go home via SDD processes. 
 
The physician fact sheet/educational flyer regarding the SDD processes and current research was 
completed on 2/12/21 and sent to the Director of Performance Excellence on 2/12/21. Principal Investigator 2/12/21 
Act: Implementation must be stronger in following weeks. To increase physician engagement, this PI will 
conduct individual meetings with the interventional cardiologists to gain support. Additionally, the 
physician flyer will be sent out for the physician’s review. 
 
This PI will need to continue to reinforce SDD processes to increase process adherence. Additional 
educational sessions will be held for newer employees. An email will be sent by the unit managers to 
reinforce established SDD processes and highlight differences from EP SDD processes, included in-hand 
medication verification. This PI will also call the schedulers at the clinic within the next week to discuss 
any issues with SDD identification and scheduling. As procedures are scheduled for the next week, this PI 
will continue process observation with emphasis on post-procedure checklists and variances from EP SDD 
processes. 
 
Once approval has been gained from the clinical site, the physician education will be sent to all pertinent 












PDSA Cycle #5 (Week 2 of Implementation) 
OBJECTIVE: Improving Communication with the interventional cardiologists 
Change Idea: This PI will begin talking with interventional cardiologist to gain support and momentum for Same Day Discharge Project.   
  Person Responsible  
Due 
Date 
Plan:  Begin individual meetings with interventional cardiologists in the hospital to gain support 
and momentum for SDD PCI. 
 
Distribute the fact sheet/educational flyer regarding SDD processes for elective PCI to the 
Market Administrator so that it can be given to the cardiologists. 
 
Complete process observation in the Cath Lab.   Principal Investigator 2/19/21 
Do: Complete process observation on 2/19 
 
Distribute the completed fact sheet/educational flyer regarding the SDD processes and current 
research to the Market Administrator on 2/16. Attach the pre- and post-procedure checklists for 
review. Attach the SDD protocol algorithm for review. 
 
Conduct meetings with 2 interventional cardiologists in the hospital during rounds on 2/19.   Principal Investigator 2/19/21 
Study:  The Fact Sheet/educational flyer regarding SDD processes and additional files were sent 
to the market administrator on 2/16. 
 
This PI met with 2 interventional cardiologists during rounds on 2/19. At this time, they both 
voiced that they would look over the SDD processes and reach out. This PI will send a reminder 
in the following week. 
 
Process observation was completed on 2/19. Same day discharge processes were not being 
utilized at that time due to inclement weather. Elective PCI cases were cancelled for the entire 
week.  Principal Investigator 2/19/21 
Act:  Implementation must be stronger in following weeks. To increase physician engagement, 
this PI will continue to conduct individual meetings with the interventional cardiologists to gain 










This PI will need to continue to reinforce SDD processes to increase process adherence as 
implementation has been very slow. Additional educational sessions will be held for newer 
employees as they were not able to take place due to inclement weather. An email will be sent 
by the unit managers to reinforce established SDD processes and highlight differences from EP 
SDD processes, included in-hand medication verification in the upcoming week. This PI will 
also call the schedulers at the clinic within the next week to discuss any issues with SDD 
identification and scheduling as the clinic was closed. As procedures are scheduled for the next 
week, this PI will continue process observation with emphasis on post-procedure checklists and 

























PDSA Cycle #6 (Week 3 of Implementation) 
OBJECTIVE: Improving physician engagement and physician recruitment 
Change Idea: This PI will continue talking with interventional cardiologist to engage and recruit them gain for Same Day Discharge PCI. 
  Person Responsible  
Due 
Date 
Plan:  Continue individual meetings with interventional cardiologists in the hospital to gain 
support and momentum for SDD PCI.  
 
Contact interventionalist to schedule individual meetings.  
 
Complete process observation within the Cath Lab.  
 
Conduct Touch Base Meeting with the interdisciplinary team.  
 
Discuss process failures and determine strategies to avoid further failures.   Principal Investigator 2/25/21 
Do:  Conduct telephone meeting with one interventional cardiologist on 2/23 and prepare to 
conduct another in-person meeting with another interventional cardiologist on 3/1.  
 











Conduct touch base meeting with SDD interdisciplinary team on 2/25. 
Discuss process failures and avoidance strategies on 2/23 with the interventional cardiologist 











Study:  This PI met with 1 interventionalist cardiologist over the phone on 2/23. At this time, he 
voiced he would continue looking over SDD processes and reach out. 
 
This PI was able to establish an in-person meeting with another interventionalist on 2/26 for 
March 1st at 3 PM. 
 
Process observation was completed on 2/19. Same day discharge processes were not being 
utilized at that time due to no cases with the participating interventionalist cardiologist. One 
patient was sent home using some of the same day discharge processes; however, this patient 
should have never been considered for our same day discharge processes as the patient did not 
meet criteria. This was discussed with the discharging APRN and the cardiologist. We have 
included another line on the post-procedure checklist that asks the recovery nurse if the patient is 
inpatient vs. outpatient. Additionally, it was decided that this PI should conduct additional in-

























Act: Again, implementation must be stronger in following weeks. To increase physician 
engagement, this PI will continue to conduct individual meetings with the interventional 
cardiologists to gain support. 
 
This PI will prepare for the meeting on 3/1 by reading over the SDD protocol and all 
checklists/criteria on 2/28. The meeting will take place on 3/1/21 at 3 PM in the Cath Lab. 
 
This PI will re-distribute post-procedure checklists to the Cath lab and nursing staff of the 2 
telemetry units.  
 
This PI will contact the nurse managers for the Cath lab and 2 telemetry units to coordinate in-































This PI will need to continue to reinforce SDD processes to increase process adherence as 
implementation has been very slow.  
 
As procedures are scheduled for the next week, this PI will continue process observation with 












PDSA Cycle #7 (Week 4 of Implementation) 
OBJECTIVE: Improving physician engagement and physician recruitment 
Change Idea: This PI will continue talking with interventional cardiologist to engage and recruit them gain for Same Day Discharge PCI. 
  Person Responsible  
Due 
Date 
Plan:  Conduct in-person meeting with one interventional cardiologist. 
 
Conduct a SDD touch base meeting with interdisciplinary team. 
 
Brainstorm ideas for improving physician engagement and continue individual meetings with 
interventional cardiologists in the hospital to gain support and momentum for SDD PCI.  
 
Communicate with piloting interventional cardiologist regarding scheduled procedures. 
 
Complete process observation within the Cath Lab.   
  Principal Investigator 3/5/21 
Do: Conduct meeting with one interventional cardiologist on 3/1/21 at 3PM.  
 
Conduct a SDD touch base meeting with interdisciplinary team on 3/2/21 at 12:30 PM. 
 
Continue to talk with the team about strategies to gain physician support and hold meetings as 
needed. Completed on 3/5/21. 
 





























Study:  This PI met with 1 interventional cardiologist on 3/1/21 who expressed great interest 
and support of SDD efforts, but he requested more baseline statistics to bring to the next 
interventional cardiologist monthly meeting. This data was requested on 3/1/21 from the 
interdisciplinary team. This interventional cardiologist verbalized that he would like to meet 
again following data procurement.  
 
SDD meeting was completed on 3/2/21. It was decided by the clinic staff that SDD orders would 
not be incorporated into GEMMS, but rated SDD would be added to the notes as they were with 
EP procedures. 
 
This PI spoke with the interdisciplinary team on 3/5 regarding the lack of SDD cases. Additional 
brainstorming regarding physician engagement took place. The cath lab manager and site 
champion were asked to participate in the efforts. 
 
This PI sent a text to the discharging APRN and the piloting interventional cardiologist on 
3/4/21 to discuss potential SDD candidates of upcoming cases on 3/5/21. No correspondence 
was reciprocated. 
 
Process observation was completed on 3/5; however, SDD processes were not being utilized at 






































Again, implementation must be stronger in following weeks. To increase physician engagement, 
this PI will continue to conduct individual meetings with the interventional cardiologists to gain 
support. 
 
This PI will continue to discuss the post-procedure checklists with Cath Lab staff and 2 
telemetry units. 
 
This PI will need to continue to reinforce SDD processes to increase process adherence as 
implementation has been very slow.  Principal Investigator 3/5/21 
 171 
 
PDSA Cycle #8 (Week 5 of Implementation) 
OBJECTIVE: Improving physician engagement and physician recruitment 
Change Idea: This PI will continue efforts to improve physician engagement with individual meetings and touch base communication. 
  Person Responsible  
Due 
Date 
Plan:   
Conduct in-person communication with as many interventional cardiologists as possible during 
rounds. 
 
Reach out to various employees at the clinical site to gain access to the EMR and gather project 
data. 
 
Obtain requested data of an interventional cardiologist regarding physician habits and baseline 
data from NCDR CathPCI Liaison. 
 
Communicate with piloting interventional cardiologist regarding scheduled procedures. 
 
Complete process observation within the Cath Lab.   
  Principal Investigator 3/9/21 
Do: Conducted in-person meetings with 2 interventional cardiologists during rounds on 3/9 & 
3/11 
 
Reached out to various employees at the clinical site to gain access to the EMR and gather 
project data on 3/8 and 3/9.  
 
Obtain requested data of an interventional cardiologist regarding physician habits and baseline 
data on 3/11/21 form NCDR CathPCI Liaison. 
 




































Study:  This PI briefly met with two interventional cardiologists during rounds on 3/9 and 3/11 
to discuss potential SDD implementation. No further correspondence from the cardiologists took 
place following communication. 
 
This PI reached out to various employees at the clinical site to gain access to the EMR and 
gather project data on 3/8 and 3/9. The liaison for the NCDR CathPCI Registry for the clinical 
site was able to forward all data regarding PCI procedures between December 27, 2020 through 
March 6, 2020 on March 9, 2021.  Data regarding the average daily census during the previous 
12 months was obtained from the Clinical Site Champion on 3/9/21. 
 
This PI obtained requested data from an interventional cardiologist regarding physician habits 
and baseline data on 3/11/21 form NCDR CathPCI Liaison. After data was received, the data 
was forwarded to the interventionalist on 3/12/21. A meeting will be set after the 
interventionalist reviews the data. 
 
This PI sent a text to the discharging APRN and the piloting interventional cardiologist on 
3/11/21 to discuss potential SDD candidates of upcoming cases on 3/12/21. No correspondence 
was reciprocated. 
 
Process observation was completed on 3/12; however, SDD processes were not being utilized at 

























Act: Implementation will not likely take place for the remainder of the implementation period 
due to the lack of engagement.  To increase physician engagement, this PI will continue to 
conduct individual meetings with the interventional cardiologists to gain support. 
 
This PI will follow up with the interventional cardiologist who requested data. A meeting should 
be set within the upcoming 2 weeks to discuss next steps. 
 
This PI will continue to reach out to the discharging APRN and piloting interventional 





















This PI will need to continue to reinforce SDD processes to increase process adherence as 









PDSA Cycle #9 (Week 6 of Implementation) 
OBJECTIVE: Discuss Implementation Sustainability with the Clinical Site 
Change Idea: This PI will hold a meeting with the Director of Performance Excellence at the clinical site to discuss plans for future 
implementation and project sustainability. 
  Person Responsible  
Due 
Date 
Plan:   
Discuss the end of implementation with DNP preceptor. 
 
Discuss sustainability with clinical site director of performance excellence.  
 
Reach out to NCDR CathPCI Liaison at the clinical site regarding the remaining clinical data. 
 
Complete process observation within the Cath Lab.   
 
Schedule meeting with interventional cardiologist regarding baseline data from NCDR CathPCI 
Registry 
  Principal Investigator 3/19/21 
Do:  
End of the implementation period was discussed with Preceptor on 3/18. 
 
A meeting was held with the Director of Performance Excellence at the clinical site to discuss 
plans for future implementation and project sustainability on 3/16. 
 






















Process Observation completed on 3/19/21. 
 









Study:   
The end of the implementation period was discussed with Preceptor on 3/18. We discussed 
barriers, limitations, and bias that led to the failure of implementation. We also discussed ways 
in which barriers, limitations, and bias could be minimized or avoided for future 
implementation. 
 
During the meeting with the Director or Performance Excellence (DPE) this PI expressed her 
continued interest in project success despite implementation period completion. The DPE voiced 
that he would like the PI to remain part of the multidisciplinary team during future 
implementation. 
 
An email sent to NCDR CathPCI Liaison at the clinical site regarding the remaining clinical data 
on 3/18/21. Further follow up will take place on 3/22 if needed. 
 
Process observation was completed on 3/19; however, SDD processes were not being utilized at 
that time due to no identified cases with the piloting interventionalist cardiologist. 
 
This PI scheduled a meeting with the interventional cardiologist to discuss baseline data. The 

















This PI will use the barriers, limitations, and bias that were discussed with her preceptor to 
incorporate into final paper and dissemination. Additionally, methods to minimize or avoid these 
limitations for future implementation will be discussed.  
 
Meeting will take place on 3/22/21 at 16:30 with Discharging APRN, interventional 
cardiologist, and DPE.  
 
Additional emails will be sent on 3/22 to NCDR CathPCI Liaison at the clinical site regarding 






















Appendix Q: Demographic Table 
Demographic Data for elective PCI (N=55) 
 Frequency Percentage 
Age   
19-35 0 0.00% 
36-50 4 7.27% 
51-65 26 47.27% 
66-79 20 36.36% 
80+ 5 9.10% 
   
Race   
     White 34 61.82% 
     Black or African American 18 32.73% 
     Asian 1 1.82% 
     Pacific Islander/Hawaii 2 3.64% 
   
Gender    
     Male 39 70.91% 
     Female 16 20.09% 
   
Marital Status   
     Married 34 61.82% 
     Single 11 20.00% 
     Divorced 4 7.27% 
     Widowed 5 9.09% 
     Separated 1 1.82% 
   
Primary Language   
     English 55 100.00% 
   
Insurance Type   
     Private 22 40.00% 
     Public 7 12.73% 
     Public + Private 20 36.36% 
     Federal 3 5.45% 










Appendix R: Estimated SDD Implementation Budget 
Estimated Budget for SDD Protocol Implementation 
Discharging APRN within the Cath Lab $110,000/year 
Printed Patient Materials and Folders $500.00 
Additional Resources (printed checklists, PI’s laptop, Microsoft 
Excel, etc.) 
No Additional Costs 
Total Initial Cost:  110,500.00 
**Additional costs will be required for long-term implementation as the Discharging 































Appendix S: Run Charts with Associated Inputs 
 
 
Date / Observation Value Median Goal 
Week 1 0 0 85 
Week 2 0 0 85 
Week 3 0 0 85 
Week 4 0 0 85 
Week 5 0 0 85 


























Appendix S: Run Charts with Associated Inputs 
 
 
Date / Observation Value Median Goal 
Week 1 0 0 85 
Week 2 0 0 85 
Week 3 0 0 85 
Week 4 0 0 85 
Week 5 0 0 85 































    
Date / 
Observation Value Median Goal 
Week 1 0 0 50 
Week 2 0 0 50 
Week 3 0 0 50 
Week 4 0 0 50 
Week 5 0 0 50 






























Week 1 Week 2 Week 3 Week 4 Week 5 Week 6
Percentage of SDD Compliance for Patient Who Met Eligibility
Percentage
 180 




Observation Value Median Goal 
Week 1 0 0 100 
Week 2 0 0 100 
Week 3 0 0 100 
Week 4 0 0 100 
Week 5 0 0 100 



































Week 1 Week 2 Week 3 Week 4 Week 5 Week 6
Facility Hotel UtilizationPercentage
 181 
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